[{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"576076021100855297"}],"author_id":"116716199","text":"RT @WHO: New WHO #hepatitis B guidelines give treatment recommendations that rely on simple, inexpensive tests http://t.co/Ymyfnhqde0 #HepB","possibly_sensitive":false,"public_metrics":{"retweet_count":82,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":111,"end":133,"url":"http://t.co/Ymyfnhqde0","expanded_url":"http://goo.gl/ifrdXG","display_url":"goo.gl/ifrdXG"}],"hashtags":[{"start":17,"end":27,"tag":"hepatitis"},{"start":134,"end":139,"tag":"HepB"}],"annotations":{}},"id":"576079038126690304","created_at":"2015-03-12T17:55:20.000Z","conversation_id":"576079038126690304","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"576075291698794497"}],"author_id":"116716199","text":"RT @WHO: Effective medicines exist that can prevent people with #hepatitis B developing liver cirrhosis and liver cancer so they live longe…","possibly_sensitive":false,"public_metrics":{"retweet_count":74,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":64,"end":74,"tag":"hepatitis"}],"annotations":{}},"id":"576079028286795778","created_at":"2015-03-12T17:55:18.000Z","conversation_id":"576079028286795778","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"576071036711628800"}],"author_id":"116716199","text":"RT @NICEcomms: For expert commentary on important new evidence, read Eyes on Evidence. March issue out now http://t.co/UWgi27UXHO","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":107,"end":129,"url":"http://t.co/UWgi27UXHO","expanded_url":"http://www.nice.org.uk/Media/Default/newsletter/Eyes-on-Evidence-March-2015.pdf","display_url":"nice.org.uk/Media/Default/…"}],"hashtags":{},"annotations":{}},"id":"576072293761286144","created_at":"2015-03-12T17:28:32.000Z","conversation_id":"576072293761286144","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: Directory of #generic #medicines: new French medicines agency decision\nhttp://t.co/fROs76DSs7","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":81,"end":103,"url":"http://t.co/fROs76DSs7","expanded_url":"http://ow.ly/KfQ2g","display_url":"ow.ly/KfQ2g"}],"hashtags":[{"start":23,"end":31,"tag":"generic"},{"start":32,"end":42,"tag":"medicines"}],"annotations":{}},"id":"576070513333764097","created_at":"2015-03-12T17:21:27.000Z","conversation_id":"576070513333764097","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"576064348520640512"}],"author_id":"116716199","text":"RT @TOPRANEWS: Nominations for the fifth Awards for Regulatory Excellence open on Monday: http://t.co/suSfRrA5Ay #RegAwards15 #regaffairs","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":[{"start":90,"end":112,"url":"http://t.co/suSfRrA5Ay","expanded_url":"http://bit.ly/1A9c6Kj","display_url":"bit.ly/1A9c6Kj"}],"hashtags":[{"start":113,"end":125,"tag":"RegAwards15"},{"start":126,"end":137,"tag":"regaffairs"}],"annotations":{}},"id":"576067547411456000","created_at":"2015-03-12T17:09:40.000Z","conversation_id":"576067547411456000","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"576061733695070208"}],"author_id":"116716199","text":"RT @IFAHEurope: EDeRidder: Need to stimulate &amp; protect all investments in innovation, not just for minor species – improve #dataprotection …","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":{},"hashtags":[{"start":127,"end":142,"tag":"dataprotection"}],"annotations":{}},"id":"576067421301264384","created_at":"2015-03-12T17:09:10.000Z","conversation_id":"576067421301264384","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"576059427595399168"}],"author_id":"116716199","text":"RT @IFAHEurope: EDeRidder: Obstacles to innovation in #veterinarymedicines #infoday15 http://t.co/qYYqnVkYEq","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/qYYqnVkYEq","expanded_url":"https://twitter.com/IFAHEurope/status/576059427595399168/photo/1","display_url":"pic.twitter.com/qYYqnVkYEq"}],"hashtags":[{"start":54,"end":74,"tag":"veterinarymedicines"},{"start":75,"end":85,"tag":"infoday15"}],"annotations":{}},"id":"576067368243367936","created_at":"2015-03-12T17:08:58.000Z","conversation_id":"576067368243367936","attachments":{"media_keys":["3_576059426513154048"]}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"576058888690208768"}],"author_id":"116716199","text":"RT @IFAHEurope: EDeRidder: Concerns that current authorising systems for #veterinarymedicines hinder innovation in #animalhealth &amp; producti…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":{},"hashtags":[{"start":73,"end":93,"tag":"veterinarymedicines"},{"start":115,"end":128,"tag":"animalhealth"}],"annotations":{}},"id":"576067305332973569","created_at":"2015-03-12T17:08:43.000Z","conversation_id":"576067305332973569","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"576056045526728704"}],"author_id":"116716199","text":"RT @IFAHEurope: HJukes: Must consider negative effects on #animalwelfare that may result from restrictions of antibiotic use in animals #in…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":{},"hashtags":[{"start":58,"end":72,"tag":"animalwelfare"}],"annotations":{}},"id":"576065836504449025","created_at":"2015-03-12T17:02:52.000Z","conversation_id":"576065836504449025","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: Exchange day with patient associations: Thematic workshop on reporting of adverse reactions by patients http://t.co/QynahJCnwX","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":114,"end":136,"url":"http://t.co/QynahJCnwX","expanded_url":"https://twitter.com/ansm/status/576055223627710464/photo/1","display_url":"pic.twitter.com/QynahJCnwX"}],"hashtags":{},"annotations":{}},"id":"576065482480066561","created_at":"2015-03-12T17:01:28.000Z","conversation_id":"576065482480066561","attachments":{"media_keys":["3_576055223116046336"]}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"576053830888103936"}],"author_id":"116716199","text":"RT @IFAHEurope: HJukes: Evaluation of the effectiveness of antibiotics is complex, difficult to link veterinary use with #AMR in man #infod…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":{},"hashtags":[{"start":121,"end":125,"tag":"AMR"}],"annotations":{}},"id":"576064675051388928","created_at":"2015-03-12T16:58:15.000Z","conversation_id":"576064675051388928","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @LV_MPA: Translation of PRAC recommendations on safety signals http://t.co/ZoVU0sQn9l","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":66,"end":88,"url":"http://t.co/ZoVU0sQn9l","expanded_url":"http://bit.ly/1Apnv4f","display_url":"bit.ly/1Apnv4f"}],"hashtags":{},"annotations":{}},"id":"576064203024384000","created_at":"2015-03-12T16:56:23.000Z","conversation_id":"576064203024384000","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"576038709168074752"}],"author_id":"116716199","text":"RT @DrugInfoAssn: Results of many #clinicaltrials not reported, reaction panel #webinar tmrw on data sharing http://t.co/HbCTbIcqZd http://…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"urls":[{"start":109,"end":131,"url":"http://t.co/HbCTbIcqZd","expanded_url":"http://buff.ly/1Bvw0Q8","display_url":"buff.ly/1Bvw0Q8"}],"hashtags":[{"start":34,"end":49,"tag":"clinicaltrials"},{"start":79,"end":87,"tag":"webinar"}],"annotations":{}},"id":"576063868897771521","created_at":"2015-03-12T16:55:03.000Z","conversation_id":"576063868897771521","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"576025571114635264"}],"author_id":"116716199","text":"RT @CPME_EUROPA: WHO/Europe #Vaccination App for Smartphones http://t.co/nTCABnRu9G @WHO_Europe","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":15,"username":"CPME_EUROPA","id":"440810430"},{"start":84,"end":95,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":61,"end":83,"url":"http://t.co/nTCABnRu9G","expanded_url":"http://bit.ly/1wZtcej","display_url":"bit.ly/1wZtcej"}],"hashtags":[{"start":28,"end":40,"tag":"Vaccination"}],"annotations":[{"start":21,"end":26,"probability":0.766,"type":"Place","normalized_text":"Europe"},{"start":49,"end":59,"probability":0.4376,"type":"Product","normalized_text":"Smartphones"}]},"id":"576025732679397376","created_at":"2015-03-12T14:23:31.000Z","conversation_id":"576025732679397376","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"576022048444645376"}],"author_id":"116716199","text":"RT @edqm_news: Webinar will show how the #PhEur has adapted its texts to remain up to date w/ advances in science &amp; medical practice http:/…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":41,"end":47,"tag":"PhEur"}],"annotations":{}},"id":"576025190523662336","created_at":"2015-03-12T14:21:22.000Z","conversation_id":"576025190523662336","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"576020051750420480"}],"author_id":"116716199","text":"RT @DrugInfoAssn: Complimentary #webinar April 8 w/ @Content_Analyst on how #machinelearning advancements improve #healthcare http://t.co/r…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":52,"end":68,"username":"Content_Analyst","id":"48823524"}],"urls":{},"hashtags":[{"start":32,"end":40,"tag":"webinar"},{"start":76,"end":92,"tag":"machinelearning"},{"start":114,"end":125,"tag":"healthcare"}],"annotations":{}},"id":"576025074429509632","created_at":"2015-03-12T14:20:54.000Z","conversation_id":"576025074429509632","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @Legemiddelinfo: The Norwegian Government has launched velgekte.no against #piracy and #trademark #counterfeiting","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":{},"hashtags":[{"start":78,"end":85,"tag":"piracy"},{"start":90,"end":100,"tag":"trademark"},{"start":101,"end":116,"tag":"counterfeiting"}],"annotations":{}},"id":"576014577143533570","created_at":"2015-03-12T13:39:11.000Z","conversation_id":"576014577143533570","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575991257731866624"}],"author_id":"116716199","text":"RT @FDAanimalhealth: Updated Listing of Veterinary #Feed Directive Distributor Notifications http://t.co/TbkCE6jTft","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":93,"end":115,"url":"http://t.co/TbkCE6jTft","expanded_url":"http://1.usa.gov/YblyK4","display_url":"1.usa.gov/YblyK4"}],"hashtags":[{"start":51,"end":56,"tag":"Feed"}],"annotations":{}},"id":"576013872903151616","created_at":"2015-03-12T13:36:23.000Z","conversation_id":"576013872903151616","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575991145265758208"}],"author_id":"116716199","text":"RT @FDAanimalhealth: Updated Listing of Approved Medicated #Feed Mill Licenses http://t.co/M8iTfMD248","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":79,"end":101,"url":"http://t.co/M8iTfMD248","expanded_url":"http://bit.ly/9h7CkO","display_url":"bit.ly/9h7CkO"}],"hashtags":[{"start":59,"end":64,"tag":"Feed"}],"annotations":{}},"id":"576013859267469313","created_at":"2015-03-12T13:36:20.000Z","conversation_id":"576013859267469313","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @luca__pani: The State of Health Vaccination in Europe Ministry of Health and Italian medicines agency meeting http://t.co/hlyjStoGm6","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"urls":[{"start":114,"end":136,"url":"http://t.co/hlyjStoGm6","expanded_url":"http://ec.europa.eu/health/vaccination/docs/20141223_state_health_vaccination_en.pdf","display_url":"ec.europa.eu/health/vaccina…"}],"hashtags":{},"annotations":[{"start":51,"end":56,"probability":0.8525,"type":"Place","normalized_text":"Europe"}]},"id":"576013821556494336","created_at":"2015-03-12T13:36:11.000Z","conversation_id":"576013821556494336","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @AEMPSGOB: Review of therapeutic positioning of afatinib (Giotrif ®) in non-small cell lung cancer http://t.co/ZyKUwClhH6","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":102,"end":124,"url":"http://t.co/ZyKUwClhH6","expanded_url":"http://www.aemps.gob.es/medicamentosUsoHumano/informesPublicos/docs/IPT-afatinib-giotrif.pdf","display_url":"aemps.gob.es/medicamentosUs…"}],"hashtags":{},"annotations":{}},"id":"576012947916468225","created_at":"2015-03-12T13:32:43.000Z","conversation_id":"576012947916468225","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575980680947101696"}],"author_id":"116716199","text":"RT @EU_ECHA: Wish to know more about a chemical substance? Try our improved search function! http://t.co/aExgDGjwas","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":93,"end":115,"url":"http://t.co/aExgDGjwas","expanded_url":"http://bit.ly/1Lwxeh6","display_url":"bit.ly/1Lwxeh6"}],"hashtags":{},"annotations":{}},"id":"576012495963439104","created_at":"2015-03-12T13:30:55.000Z","conversation_id":"576012495963439104","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575972072150708224"}],"author_id":"116716199","text":"RT @edqm_news: A new strategy for #PhEur. General Methods: #European #Pharmacopoeia Commission established a new Working Party http://t.co/…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":34,"end":40,"tag":"PhEur"},{"start":59,"end":68,"tag":"European"},{"start":69,"end":83,"tag":"Pharmacopoeia"}],"annotations":{}},"id":"576011865622491136","created_at":"2015-03-12T13:28:25.000Z","conversation_id":"576011865622491136","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: French medicines agency: 3rd information and exchange day with patient associations http://t.co/WA3MiG5iS6","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":94,"end":116,"url":"http://t.co/WA3MiG5iS6","expanded_url":"https://twitter.com/ansm/status/575967090345144320/photo/1","display_url":"pic.twitter.com/WA3MiG5iS6"}],"hashtags":{},"annotations":{}},"id":"576011587892432897","created_at":"2015-03-12T13:27:18.000Z","conversation_id":"576011587892432897","attachments":{"media_keys":["3_575967089921552384"]}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575949807933636608"}],"author_id":"116716199","text":"RT @EU_eHealth: .@EU_Commission launches €1m #horizonprize for a test to tell if u need #antibiotics or not - http://t.co/jvGqthkKaI http:/…","possibly_sensitive":false,"public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":17,"end":31,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":110,"end":132,"url":"http://t.co/jvGqthkKaI","expanded_url":"http://ow.ly/KetQo","display_url":"ow.ly/KetQo"}],"hashtags":[{"start":45,"end":58,"tag":"horizonprize"},{"start":88,"end":100,"tag":"antibiotics"}],"annotations":{}},"id":"576010862311387136","created_at":"2015-03-12T13:24:25.000Z","conversation_id":"576010862311387136","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published a #guideline on developing #biosimilar #medicines containing #recombinant human #insulin &amp; analogues: http://t.co/HFT0ofB4z7","possibly_sensitive":false,"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":122,"end":144,"url":"http://t.co/HFT0ofB4z7","expanded_url":"http://bit.ly/1C5nDvp","display_url":"bit.ly/1C5nDvp"}],"hashtags":[{"start":18,"end":28,"tag":"guideline"},{"start":43,"end":54,"tag":"biosimilar"},{"start":55,"end":65,"tag":"medicines"},{"start":77,"end":89,"tag":"recombinant"},{"start":96,"end":104,"tag":"insulin"}],"annotations":{}},"id":"575963445784346624","created_at":"2015-03-12T10:16:01.000Z","conversation_id":"575963445784346624","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575947812308926464"}],"author_id":"116716199","text":"RT @EU_ECHA: Are you a civil servant in one of the EU countries? Would you like to work with us as a seconded national expert? http://t.co/…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":{},"hashtags":{},"annotations":{}},"id":"575953173740912640","created_at":"2015-03-12T09:35:11.000Z","conversation_id":"575953173740912640","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575940579365908480"}],"author_id":"116716199","text":"RT @myESMO: FDA approves dinutuximab as part of first-line therapy for paediatric patients with high-risk #neuroblastoma http://t.co/QA9dSa…","possibly_sensitive":false,"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":{},"hashtags":[{"start":106,"end":120,"tag":"neuroblastoma"}],"annotations":[{"start":12,"end":14,"probability":0.8688,"type":"Organization","normalized_text":"FDA"}]},"id":"575952332460023809","created_at":"2015-03-12T09:31:51.000Z","conversation_id":"575952332460023809","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575648131318169600"}],"author_id":"116716199","text":"RT @EFSA_EU: #EFSA NDA panel meet in Brussels on 23-24 April. Register to attend - deadline:1 April http://t.co/rxBGGARxtR","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":100,"end":122,"url":"http://t.co/rxBGGARxtR","expanded_url":"http://bit.ly/1MrpdIY","display_url":"bit.ly/1MrpdIY"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"}],"annotations":[{"start":37,"end":44,"probability":0.9584,"type":"Place","normalized_text":"Brussels"}]},"id":"575706888370790400","created_at":"2015-03-11T17:16:32.000Z","conversation_id":"575706888370790400","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"537208383883845635"}],"author_id":"116716199","text":"RT @EU_Health: #MedicalTreatment in another #EU country: You have the right to choose https://t.co/4UIImG1VH8","possibly_sensitive":false,"public_metrics":{"retweet_count":842,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":86,"end":109,"url":"https://t.co/4UIImG1VH8","expanded_url":"https://cards.twitter.com/cards/oz2fua/8b33","display_url":"cards.twitter.com/cards/oz2fua/8…"}],"hashtags":[{"start":15,"end":32,"tag":"MedicalTreatment"},{"start":44,"end":47,"tag":"EU"}],"annotations":{}},"id":"575705670630117376","created_at":"2015-03-11T17:11:42.000Z","conversation_id":"575705670630117376","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575674862968127489"}],"author_id":"116716199","text":"RT @edqm_news: Next week: Don’t miss the opportunity to hear the latest news on #biologicals directly from Dr Emmanuelle Charton! http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":80,"end":92,"tag":"biologicals"}],"annotations":[{"start":107,"end":127,"probability":0.612,"type":"Person","normalized_text":"Dr Emmanuelle Charton"}]},"id":"575705550194917378","created_at":"2015-03-11T17:11:13.000Z","conversation_id":"575705550194917378","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575661273976823808"}],"author_id":"116716199","text":"RT @WHO: WHO and @WFP join forces to reach zero #Ebola cases http://t.co/9m5knDFfBf http://t.co/RfUpvxjlDB","possibly_sensitive":false,"public_metrics":{"retweet_count":161,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"},{"start":17,"end":21,"username":"WFP","id":"27830610"}],"urls":[{"start":61,"end":83,"url":"http://t.co/9m5knDFfBf","expanded_url":"http://goo.gl/uXKssr","display_url":"goo.gl/uXKssr"},{"start":84,"end":106,"url":"http://t.co/RfUpvxjlDB","expanded_url":"https://twitter.com/WHO/status/575661273976823808/photo/1","display_url":"pic.twitter.com/RfUpvxjlDB"}],"hashtags":[{"start":48,"end":54,"tag":"Ebola"}],"annotations":{}},"id":"575705371865673728","created_at":"2015-03-11T17:10:31.000Z","conversation_id":"575705371865673728","attachments":{"media_keys":["3_575661272454205440"]}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575679721402417152"}],"author_id":"116716199","text":"RT @Uroweb: What is a radical #prostatectomy, and what’s next? Read #EAUPatientInfo to find out: http://t.co/hYyN35CQlC","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"Uroweb","id":"114455333"}],"urls":[{"start":97,"end":119,"url":"http://t.co/hYyN35CQlC","expanded_url":"http://bit.ly/1zDbEiJ","display_url":"bit.ly/1zDbEiJ"}],"hashtags":[{"start":30,"end":44,"tag":"prostatectomy"},{"start":68,"end":83,"tag":"EAUPatientInfo"}],"annotations":{}},"id":"575705145431957504","created_at":"2015-03-11T17:09:37.000Z","conversation_id":"575705145431957504","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575688043786563584"}],"author_id":"116716199","text":"RT @IFAHEurope: #IFAHEurope @EMA_News Infoday taking place tomorrow and Friday. We will be tweeting under #infoday15  - http://t.co/m3M0iHO…","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":28,"end":37,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":16,"end":27,"tag":"IFAHEurope"},{"start":106,"end":116,"tag":"infoday15"}],"annotations":{}},"id":"575704791843762177","created_at":"2015-03-11T17:08:13.000Z","conversation_id":"575704791843762177","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575702849495027712"}],"author_id":"116716199","text":"RT @FDACBER: New draft guidance: Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products http://t.co/LzJ2n4C2IQ","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":110,"end":132,"url":"http://t.co/LzJ2n4C2IQ","expanded_url":"http://go.usa.gov/3avwd","display_url":"go.usa.gov/3avwd"}],"hashtags":{},"annotations":[{"start":61,"end":63,"probability":0.8377,"type":"Organization","normalized_text":"FDA"},{"start":95,"end":108,"probability":0.4874,"type":"Organization","normalized_text":"PDUFA Products"}]},"id":"575704296123187200","created_at":"2015-03-11T17:06:14.000Z","conversation_id":"575704296123187200","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Final #guideline on development of similar #biological #medicines containing #recombinant human #insulin &amp; analogues: http://t.co/HFT0ofB4z7","possibly_sensitive":false,"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":4,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":122,"end":144,"url":"http://t.co/HFT0ofB4z7","expanded_url":"http://bit.ly/1C5nDvp","display_url":"bit.ly/1C5nDvp"}],"hashtags":[{"start":6,"end":16,"tag":"guideline"},{"start":43,"end":54,"tag":"biological"},{"start":55,"end":65,"tag":"medicines"},{"start":77,"end":89,"tag":"recombinant"},{"start":96,"end":104,"tag":"insulin"}],"annotations":{}},"id":"575683479859560448","created_at":"2015-03-11T15:43:31.000Z","conversation_id":"575683479859560448","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published information on how #fees for safety monitoring of medicines will be calculated: http://t.co/LELZgZukkv #pharmacovigilance","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/LELZgZukkv","expanded_url":"http://bit.ly/1wW3BTz","display_url":"bit.ly/1wW3BTz"}],"hashtags":[{"start":35,"end":40,"tag":"fees"},{"start":119,"end":137,"tag":"pharmacovigilance"}],"annotations":{}},"id":"575592093130833920","created_at":"2015-03-11T09:40:23.000Z","conversation_id":"575592093130833920","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the #agenda of this week's #pharmacovigilance committee (PRAC) meeting: http://t.co/47NDgzzt6o","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/47NDgzzt6o","expanded_url":"http://bit.ly/1AemrjH","display_url":"bit.ly/1AemrjH"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":43,"end":61,"tag":"pharmacovigilance"}],"annotations":{}},"id":"575591916240240640","created_at":"2015-03-11T09:39:41.000Z","conversation_id":"575591916240240640","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the #agenda of this week's #pharmacovigilance committee (PRAC) meeting: http://t.co/47NDgzzt6o","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/47NDgzzt6o","expanded_url":"http://bit.ly/1AemrjH","display_url":"bit.ly/1AemrjH"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":43,"end":61,"tag":"pharmacovigilance"}],"annotations":{}},"id":"575351348545351681","created_at":"2015-03-10T17:43:45.000Z","conversation_id":"575351348545351681","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @URPLWMiPB: The Polish medicines agency newsletter on medicines for February 2015 has been published http://t.co/1rLF786aSg","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":104,"end":126,"url":"http://t.co/1rLF786aSg","expanded_url":"http://bit.ly/1E9fwgu","display_url":"bit.ly/1E9fwgu"}],"hashtags":{},"annotations":{}},"id":"575344303091937280","created_at":"2015-03-10T17:15:45.000Z","conversation_id":"575344303091937280","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @GCessak: The Polish medicines agency has published its February newsletter on medicines on its website: http://t.co/3iaj09x3Pe","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":108,"end":130,"url":"http://t.co/3iaj09x3Pe","expanded_url":"http://bit.ly/1BnyVKL","display_url":"bit.ly/1BnyVKL"}],"hashtags":{},"annotations":{}},"id":"575343929245179905","created_at":"2015-03-10T17:14:16.000Z","conversation_id":"575343929245179905","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575336301983043585"}],"author_id":"116716199","text":"RT @ECDC_Flu: The latest #influenza virus characterisation report, examining the 2014–15 season, is now available: http://t.co/QWVfPU1rIz","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":[{"start":115,"end":137,"url":"http://t.co/QWVfPU1rIz","expanded_url":"http://bit.ly/1KRGoIl","display_url":"bit.ly/1KRGoIl"}],"hashtags":[{"start":25,"end":35,"tag":"influenza"}],"annotations":{}},"id":"575343509433151490","created_at":"2015-03-10T17:12:36.000Z","conversation_id":"575343509433151490","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575328154207789057"}],"author_id":"116716199","text":"RT @myCORDIS: #Public #consultation: give your feedback on the #achievements of #FP7 http://t.co/TNJXhb4Yu6 #researcheu please RT","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"urls":[{"start":85,"end":107,"url":"http://t.co/TNJXhb4Yu6","expanded_url":"http://owl.li/K9SKW","display_url":"owl.li/K9SKW"}],"hashtags":[{"start":14,"end":21,"tag":"Public"},{"start":22,"end":35,"tag":"consultation"},{"start":63,"end":76,"tag":"achievements"},{"start":80,"end":84,"tag":"FP7"},{"start":108,"end":119,"tag":"researcheu"}],"annotations":{}},"id":"575333774898110465","created_at":"2015-03-10T16:33:55.000Z","conversation_id":"575333774898110465","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575326399076122624"}],"author_id":"116716199","text":"RT @edqm_news: Just out: the February activity report for the #Certification of #Substances Division (DCEP) is now available! http://t.co/c…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":62,"end":76,"tag":"Certification"},{"start":80,"end":91,"tag":"Substances"}],"annotations":{}},"id":"575333521297924097","created_at":"2015-03-10T16:32:55.000Z","conversation_id":"575333521297924097","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575325888167964673"}],"author_id":"116716199","text":"RT @eurordis: #RareDisease seminar: “Accelerating Access to #Therapeutic Innovation” 27 March, Lyon, France http://t.co/k9CVM1TKf8","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":[{"start":108,"end":130,"url":"http://t.co/k9CVM1TKf8","expanded_url":"http://ow.ly/K0NbX","display_url":"ow.ly/K0NbX"}],"hashtags":[{"start":14,"end":26,"tag":"RareDisease"},{"start":60,"end":72,"tag":"Therapeutic"}],"annotations":[{"start":95,"end":106,"probability":0.4598,"type":"Place","normalized_text":"Lyon, France"}]},"id":"575333502071259136","created_at":"2015-03-10T16:32:50.000Z","conversation_id":"575333502071259136","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575320477914304513"}],"author_id":"116716199","text":"RT @AlzheimerEurope: In the news: @alzheimerssoc research commitment creates network of Doctoral Training Centres http://t.co/06rOzPKwNx","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":34,"end":48,"username":"alzheimerssoc","id":"34267043"}],"urls":[{"start":114,"end":136,"url":"http://t.co/06rOzPKwNx","expanded_url":"http://goo.gl/3l9aKs","display_url":"goo.gl/3l9aKs"}],"hashtags":{},"annotations":[{"start":88,"end":112,"probability":0.6577,"type":"Organization","normalized_text":"Doctoral Training Centres"}]},"id":"575323909777723393","created_at":"2015-03-10T15:54:43.000Z","conversation_id":"575323909777723393","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575320130516819968"}],"author_id":"116716199","text":"RT @EFSA_EU: #traineeships : #EFSA is looking for new #science graduates in #FoodSafety and other areas. Deadline 23/03 http://t.co/Vq2Kmn4…","possibly_sensitive":false,"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":13,"end":26,"tag":"traineeships"},{"start":29,"end":34,"tag":"EFSA"},{"start":54,"end":62,"tag":"science"},{"start":76,"end":87,"tag":"FoodSafety"}],"annotations":{}},"id":"575323733553995777","created_at":"2015-03-10T15:54:01.000Z","conversation_id":"575323733553995777","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575320130122571776"}],"author_id":"116716199","text":"RT @AlzheimerEurope: In the news: @alzassociation publishes report on changing trajectory of #Alzheimer’s disease http://t.co/Irv9T3FiPz ht…","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":34,"end":49,"username":"alzassociation","id":"21121491"}],"urls":[{"start":114,"end":136,"url":"http://t.co/Irv9T3FiPz","expanded_url":"http://goo.gl/c1OC35","display_url":"goo.gl/c1OC35"}],"hashtags":[{"start":93,"end":103,"tag":"Alzheimer"}],"annotations":{}},"id":"575323717603082240","created_at":"2015-03-10T15:53:57.000Z","conversation_id":"575323717603082240","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575317689234755584"}],"author_id":"116716199","text":"RT @IMI_JU: Interested in the training course for patient experts in medicines R&amp;D run by @eupatients? Register by 31 March via http://t.co…","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":94,"end":105,"username":"eupatients","id":"465674067"}],"urls":{},"hashtags":{},"annotations":{}},"id":"575323376417435648","created_at":"2015-03-10T15:52:36.000Z","conversation_id":"575323376417435648","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575317163231350785"}],"author_id":"116716199","text":"RT @AlzheimerEurope: In the news: @IMI_JU launches new patient page on its website http://t.co/GdnzBRdxqo http://t.co/BaB9XQY3w1","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":34,"end":41,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":83,"end":105,"url":"http://t.co/GdnzBRdxqo","expanded_url":"http://goo.gl/cTptxN","display_url":"goo.gl/cTptxN"},{"start":106,"end":128,"url":"http://t.co/BaB9XQY3w1","expanded_url":"https://twitter.com/AlzheimerEurope/status/575317163231350785/photo/1","display_url":"pic.twitter.com/BaB9XQY3w1"}],"hashtags":{},"annotations":{}},"id":"575323354460196864","created_at":"2015-03-10T15:52:31.000Z","conversation_id":"575323354460196864","attachments":{"media_keys":["3_575317162241363969"]}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575315307935461377"}],"author_id":"116716199","text":"RT @AlzheimerEurope: In the news: @NHSChoices sets record straight on “breakthrough” discovery of molecule to prevent @Alzheimer's disease …","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"urls":{},"hashtags":{},"annotations":{}},"id":"575323218493440000","created_at":"2015-03-10T15:51:58.000Z","conversation_id":"575323218493440000","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575314394420224000"}],"author_id":"116716199","text":"RT @Kieran_Research: Understanding Biomarkers of Neurodegeneration: Novel approaches to detecting tau pathology. http://t.co/gya0Hc5ykD #de…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"Kieran_Research","id":"35511598"}],"urls":[{"start":113,"end":135,"url":"http://t.co/gya0Hc5ykD","expanded_url":"http://rdcu.be/cil6","display_url":"rdcu.be/cil6"}],"hashtags":{},"annotations":{}},"id":"575322880684195840","created_at":"2015-03-10T15:50:38.000Z","conversation_id":"575322880684195840","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575314193097867264"}],"author_id":"116716199","text":"RT @Kieran_Research: Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave way for greater understanding …","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"Kieran_Research","id":"35511598"}],"urls":{},"hashtags":{},"annotations":{}},"id":"575322828846841857","created_at":"2015-03-10T15:50:26.000Z","conversation_id":"575322828846841857","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575314008552644608"}],"author_id":"116716199","text":"RT @AlzheimerEurope: In the news: @eupatientsforum announces workshops on Crossborder Healthcare http://t.co/4wq6bXJJaH http://t.co/oanoO8o…","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":34,"end":50,"username":"eupatientsforum","id":"545343465"}],"urls":[{"start":97,"end":119,"url":"http://t.co/4wq6bXJJaH","expanded_url":"http://goo.gl/nZhBDO","display_url":"goo.gl/nZhBDO"}],"hashtags":{},"annotations":{}},"id":"575322749956194305","created_at":"2015-03-10T15:50:07.000Z","conversation_id":"575322749956194305","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @AEMPSGOB: Selection procedure for a physician at the Spanish medicines agency. Deadline 13 March http://t.co/4m0E37NQ8s","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":101,"end":123,"url":"http://t.co/4m0E37NQ8s","expanded_url":"http://bit.ly/1BsYmJE","display_url":"bit.ly/1BsYmJE"}],"hashtags":{},"annotations":{}},"id":"575322697971949568","created_at":"2015-03-10T15:49:54.000Z","conversation_id":"575322697971949568","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575306231084150785"}],"author_id":"116716199","text":"RT @FDAMedia: FDA approves first antibody therapy for high-risk neuroblastoma http://t.co/rnUFzQIQOU","possibly_sensitive":false,"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"urls":[{"start":78,"end":100,"url":"http://t.co/rnUFzQIQOU","expanded_url":"http://go.usa.gov/3aUgG","display_url":"go.usa.gov/3aUgG"}],"hashtags":{},"annotations":[{"start":14,"end":16,"probability":0.9156,"type":"Organization","normalized_text":"FDA"}]},"id":"575309263142318080","created_at":"2015-03-10T14:56:31.000Z","conversation_id":"575309263142318080","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575300315840409600"}],"author_id":"116716199","text":"RT @edqm_news: The 2015 PTS schedules are available and registrations are open for #physicochemical and #biological studies http://t.co/VSq…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":83,"end":99,"tag":"physicochemical"},{"start":104,"end":115,"tag":"biological"}],"annotations":{}},"id":"575302162164674560","created_at":"2015-03-10T14:28:18.000Z","conversation_id":"575302162164674560","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've released information on how #fees for safety monitoring of medicines will be calculated: http://t.co/LELZgZukkv #pharmacovigilance","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/LELZgZukkv","expanded_url":"http://bit.ly/1wW3BTz","display_url":"bit.ly/1wW3BTz"}],"hashtags":[{"start":34,"end":39,"tag":"fees"},{"start":118,"end":136,"tag":"pharmacovigilance"}],"annotations":{}},"id":"575298055731286016","created_at":"2015-03-10T14:11:59.000Z","conversation_id":"575298055731286016","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575296462763982849"}],"author_id":"116716199","text":"RT @FDAanimalhealth: Public Master Files updated with information for P005-042 (lasalocid sodium) &amp; P005-662 (oxytetracycline dihydrate) ht…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":{},"hashtags":{},"annotations":{}},"id":"575297606835945473","created_at":"2015-03-10T14:10:12.000Z","conversation_id":"575297606835945473","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @Aifa_ufficiale: Impact of #medicines on the #environment: state of the art and outlook on a relevant question http://t.co/7w951kJgJZ","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":114,"end":136,"url":"http://t.co/7w951kJgJZ","expanded_url":"http://bit.ly/1MpTjyt","display_url":"bit.ly/1MpTjyt"}],"hashtags":[{"start":30,"end":40,"tag":"medicines"},{"start":48,"end":60,"tag":"environment"}],"annotations":{}},"id":"575288805701349376","created_at":"2015-03-10T13:35:14.000Z","conversation_id":"575288805701349376","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"The #agenda of next week's committee for orphan medicines (COMP) meeting is available: http://t.co/1h1M5grfub","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/1h1M5grfub","expanded_url":"http://bit.ly/1AaHJjd","display_url":"bit.ly/1AaHJjd"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"}],"annotations":{}},"id":"575283721705754624","created_at":"2015-03-10T13:15:02.000Z","conversation_id":"575283721705754624","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"The #agenda of this week's meeting of our committee for #herbal medicines (HMPC) is available: http://t.co/KAACSQiCyA","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/KAACSQiCyA","expanded_url":"http://bit.ly/1KLA9Wl","display_url":"bit.ly/1KLA9Wl"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":56,"end":63,"tag":"herbal"}],"annotations":{}},"id":"575283474787139584","created_at":"2015-03-10T13:14:03.000Z","conversation_id":"575283474787139584","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the EPAR for #Viekirax (#ombitasvir / #paritaprevir / #ritonavir), a new #medicine for #hepatitisC: http://t.co/EPdMb0Tme6","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/EPdMb0Tme6","expanded_url":"http://bit.ly/195AeU8","display_url":"bit.ly/195AeU8"}],"hashtags":[{"start":29,"end":38,"tag":"Viekirax"},{"start":40,"end":51,"tag":"ombitasvir"},{"start":54,"end":67,"tag":"paritaprevir"},{"start":70,"end":80,"tag":"ritonavir"},{"start":89,"end":98,"tag":"medicine"},{"start":103,"end":114,"tag":"hepatitisC"}],"annotations":{}},"id":"575283289851887616","created_at":"2015-03-10T13:13:19.000Z","conversation_id":"575283289851887616","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ZVALatvija: Update published of nearly 5,000 substances used in products: list in Latvian, Latin and English: http://t.co/lhIeWU1S0G","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"ZVALatvija","id":"1576993495"}],"urls":[{"start":114,"end":136,"url":"http://t.co/lhIeWU1S0G","expanded_url":"http://bit.ly/1MpPI3y","display_url":"bit.ly/1MpPI3y"}],"hashtags":{},"annotations":{}},"id":"575282412516675584","created_at":"2015-03-10T13:09:50.000Z","conversation_id":"575282412516675584","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575278439214809088"}],"author_id":"116716199","text":"RT @EU_H2020: Why a #HorizonPrize for better use of #antibiotics? Find out more in this infographic http://t.co/iinUXcxgTg #H2020 http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"urls":[{"start":100,"end":122,"url":"http://t.co/iinUXcxgTg","expanded_url":"http://europa.eu/!wQ36Um","display_url":"europa.eu/!wQ36Um"}],"hashtags":[{"start":20,"end":33,"tag":"HorizonPrize"},{"start":52,"end":64,"tag":"antibiotics"},{"start":123,"end":129,"tag":"H2020"}],"annotations":{}},"id":"575281879961702400","created_at":"2015-03-10T13:07:43.000Z","conversation_id":"575281879961702400","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575278439198015488"}],"author_id":"116716199","text":"RT @innovationunion: Why a #HorizonPrize for better use of #antibiotics? Find out more in this infographic http://t.co/dmjD8cREl2 #H2020 ht…","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":107,"end":129,"url":"http://t.co/dmjD8cREl2","expanded_url":"http://europa.eu/!wQ36Um","display_url":"europa.eu/!wQ36Um"}],"hashtags":[{"start":27,"end":40,"tag":"HorizonPrize"},{"start":59,"end":71,"tag":"antibiotics"},{"start":130,"end":136,"tag":"H2020"}],"annotations":{}},"id":"575281867815002112","created_at":"2015-03-10T13:07:40.000Z","conversation_id":"575281867815002112","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575248063595417600"}],"author_id":"116716199","text":"RT @IMI_JU: Deadline this Fri: GetReal consultation on use of real world data in drug dvpt &amp; clinical effectiveness assmt http://t.co/G8Jam…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"hashtags":{},"annotations":{}},"id":"575280260624875520","created_at":"2015-03-10T13:01:16.000Z","conversation_id":"575280260624875520","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575236687569272833"}],"author_id":"116716199","text":"RT @EU_H2020: What kind of #research does the #ERC fund? https://t.co/i8nx3DXDwf @ERC_Research #H2020","possibly_sensitive":false,"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"},{"start":81,"end":94,"username":"ERC_Research","id":"467551928"}],"urls":[{"start":57,"end":80,"url":"https://t.co/i8nx3DXDwf","expanded_url":"https://www.youtube.com/watch?v=ZqtHxeuYnsk","display_url":"youtube.com/watch?v=ZqtHxe…"}],"hashtags":[{"start":27,"end":36,"tag":"research"},{"start":46,"end":50,"tag":"ERC"},{"start":95,"end":101,"tag":"H2020"}],"annotations":{}},"id":"575279382987677696","created_at":"2015-03-10T12:57:47.000Z","conversation_id":"575279382987677696","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575236687330213888"}],"author_id":"116716199","text":"RT @innovationunion: What kind of #research does the #ERC fund? https://t.co/mfGQxXTrki @ERC_Research #H2020","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"},{"start":88,"end":101,"username":"ERC_Research","id":"467551928"}],"urls":[{"start":64,"end":87,"url":"https://t.co/mfGQxXTrki","expanded_url":"https://www.youtube.com/watch?v=ZqtHxeuYnsk","display_url":"youtube.com/watch?v=ZqtHxe…"}],"hashtags":[{"start":34,"end":43,"tag":"research"},{"start":53,"end":57,"tag":"ERC"},{"start":102,"end":108,"tag":"H2020"}],"annotations":{}},"id":"575279367951093760","created_at":"2015-03-10T12:57:44.000Z","conversation_id":"575279367951093760","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: The French medicines agency publishes an update on the February #CHMP meeting: 3 new medicinces recommended http://t.co/wrL7C6m0HN","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":118,"end":140,"url":"http://t.co/wrL7C6m0HN","expanded_url":"http://bit.ly/1MpNG3p","display_url":"bit.ly/1MpNG3p"}],"hashtags":[{"start":74,"end":79,"tag":"CHMP"}],"annotations":{}},"id":"575279241224437760","created_at":"2015-03-10T12:57:13.000Z","conversation_id":"575279241224437760","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @URPLWMiPB: Read the package leaflet of medicines. The leaflet is your safety #medicinesafety http://t.co/qfoABkHsAb","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":97,"end":119,"url":"http://t.co/qfoABkHsAb","expanded_url":"http://bit.ly/1C1wFtl","display_url":"bit.ly/1C1wFtl"}],"hashtags":[{"start":81,"end":96,"tag":"medicinesafety"}],"annotations":{}},"id":"575278772049559552","created_at":"2015-03-10T12:55:22.000Z","conversation_id":"575278772049559552","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575233653892059136"}],"author_id":"116716199","text":"RT @NICEcomms: An Evidence Update on feverish illness in children is now available: http://t.co/n7G3tY0Vk2","possibly_sensitive":false,"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":84,"end":106,"url":"http://t.co/n7G3tY0Vk2","expanded_url":"http://www.nice.org.uk/media/default/About/what-we-do/Evidence%20Services/Evidence-Updates-list.pdf","display_url":"nice.org.uk/media/default/…"}],"hashtags":{},"annotations":{}},"id":"575277495454466048","created_at":"2015-03-10T12:50:17.000Z","conversation_id":"575277495454466048","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575231395733315584"}],"author_id":"116716199","text":"RT @egabiosimilars: Biosimilar products approved by the FDA meet the agency’s rigorous safety, efficacy and quality standards http://t.co/m…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":{},"hashtags":{},"annotations":[{"start":56,"end":58,"probability":0.9659,"type":"Organization","normalized_text":"FDA"}]},"id":"575277366798389249","created_at":"2015-03-10T12:49:47.000Z","conversation_id":"575277366798389249","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575226600343625728"}],"author_id":"116716199","text":"RT @WHO: The panel will present a first progress report on its work to the 68th World Health Assembly in May 2015 http://t.co/Qap6n103Zh #W…","possibly_sensitive":false,"public_metrics":{"retweet_count":47,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":114,"end":136,"url":"http://t.co/Qap6n103Zh","expanded_url":"http://goo.gl/B5vJ97","display_url":"goo.gl/B5vJ97"}],"hashtags":{},"annotations":[{"start":75,"end":100,"probability":0.574,"type":"Other","normalized_text":"68th World Health Assembly"}]},"id":"575277130080256000","created_at":"2015-03-10T12:48:50.000Z","conversation_id":"575277130080256000","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575226453224243200"}],"author_id":"116716199","text":"RT @WHO: WHO Dr Chan has commissioned a panel of independent experts to assess all aspects of WHO’s #Ebola response http://t.co/Qap6n103Zh","possibly_sensitive":false,"public_metrics":{"retweet_count":78,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":116,"end":138,"url":"http://t.co/Qap6n103Zh","expanded_url":"http://goo.gl/B5vJ97","display_url":"goo.gl/B5vJ97"}],"hashtags":[{"start":100,"end":106,"tag":"Ebola"}],"annotations":[{"start":13,"end":19,"probability":0.9911,"type":"Person","normalized_text":"Dr Chan"}]},"id":"575277114028658688","created_at":"2015-03-10T12:48:46.000Z","conversation_id":"575277114028658688","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575219843433152512"}],"author_id":"116716199","text":"RT @EURLex: #PublicHealth: refusal of authorisation for certain #health claims on foods referring to #children's development - http://t.co/…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"urls":{},"hashtags":[{"start":12,"end":25,"tag":"PublicHealth"},{"start":64,"end":71,"tag":"health"},{"start":101,"end":110,"tag":"children"}],"annotations":{}},"id":"575276182209454080","created_at":"2015-03-10T12:45:04.000Z","conversation_id":"575276182209454080","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575219125179584513"}],"author_id":"116716199","text":"RT @myESMO: FDA approves 1st biosimilar product in US: filgrastim-sndz intended for patients who receive myelosuppressive chemo http://t.co…","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":{},"hashtags":{},"annotations":[{"start":12,"end":14,"probability":0.9554,"type":"Organization","normalized_text":"FDA"},{"start":51,"end":52,"probability":0.8147,"type":"Place","normalized_text":"US"}]},"id":"575275659741818881","created_at":"2015-03-10T12:43:00.000Z","conversation_id":"575275659741818881","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"575212910764556288"}],"author_id":"116716199","text":"RT @EFSA_EU: Still 3 days to register to #EFSA Management Board meeting in Parma on 19 March http://t.co/mj487BZ5dg","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":93,"end":115,"url":"http://t.co/mj487BZ5dg","expanded_url":"http://bit.ly/1wLGM54","display_url":"bit.ly/1wLGM54"}],"hashtags":[{"start":41,"end":46,"tag":"EFSA"}],"annotations":[{"start":75,"end":79,"probability":0.8179,"type":"Place","normalized_text":"Parma"}]},"id":"575275527759622144","created_at":"2015-03-10T12:42:28.000Z","conversation_id":"575275527759622144","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"575075156994957314"}],"author_id":"116716199","text":"@fararod @AEMPSGOB Please keep an eye on the medicine page or sign up for its RSS feed: http://t.co/nAiQiehhGO","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":8,"username":"fararod","id":"525798275"},{"start":9,"end":18,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":88,"end":110,"url":"http://t.co/nAiQiehhGO","expanded_url":"http://bit.ly/1Exa3CG","display_url":"bit.ly/1Exa3CG"}],"hashtags":{},"annotations":{}},"id":"575271212093435907","created_at":"2015-03-10T12:25:19.000Z","conversation_id":"575075156994957314","attachments":{"media_keys":{}},"in_reply_to_user_id":"525798275"},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the assessment report for #Viekirax (ombitasvir/paritaprevi/ritonavir), a #medicine for #hepatitis C: http://t.co/EPdMb0Tme6","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/EPdMb0Tme6","expanded_url":"http://bit.ly/195AeU8","display_url":"bit.ly/195AeU8"}],"hashtags":[{"start":42,"end":51,"tag":"Viekirax"},{"start":90,"end":99,"tag":"medicine"},{"start":104,"end":114,"tag":"hepatitis"}],"annotations":{}},"id":"574980636072673280","created_at":"2015-03-09T17:10:40.000Z","conversation_id":"574980636072673280","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the #agenda of this week's meeting of our committee for #herbal medicines (HMPC): http://t.co/KAACSQiCyA","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/KAACSQiCyA","expanded_url":"http://bit.ly/1KLA9Wl","display_url":"bit.ly/1KLA9Wl"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":72,"end":79,"tag":"herbal"}],"annotations":{}},"id":"574961264985833472","created_at":"2015-03-09T15:53:42.000Z","conversation_id":"574961264985833472","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the #agenda of our committee for orphan medicines (COMP) next week: http://t.co/1h1M5grfub","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/1h1M5grfub","expanded_url":"http://bit.ly/1AaHJjd","display_url":"bit.ly/1AaHJjd"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"}],"annotations":{}},"id":"574960454742732801","created_at":"2015-03-09T15:50:29.000Z","conversation_id":"574960454742732801","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"574948213901410304"}],"author_id":"116716199","text":"RT @FDA_Drug_Info: Public Workshop - Complexities in Personalized Medicine: Harmonizing Companion Diagnostics, March 24, 2015. http://t.co/…","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"hashtags":{},"annotations":{}},"id":"574949505667301376","created_at":"2015-03-09T15:06:58.000Z","conversation_id":"574949505667301376","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"574948925540548608"}],"author_id":"116716199","text":"RT @myCORDIS: #CORDISExpress: Tackling #diseases with #vaccines http://t.co/2quMbQBlR2","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"urls":[{"start":64,"end":86,"url":"http://t.co/2quMbQBlR2","expanded_url":"http://cordis.europa.eu/news/rcn/122486_en.html?WT.mc_id=Twitter_myCORDIS","display_url":"cordis.europa.eu/news/rcn/12248…"}],"hashtags":[{"start":14,"end":28,"tag":"CORDISExpress"},{"start":39,"end":48,"tag":"diseases"},{"start":54,"end":63,"tag":"vaccines"}],"annotations":{}},"id":"574949488105799680","created_at":"2015-03-09T15:06:54.000Z","conversation_id":"574949488105799680","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: Last chance to register for #ANSM information day for #patient associations: http://t.co/x2dfDOCLhi","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":87,"end":109,"url":"http://t.co/x2dfDOCLhi","expanded_url":"http://bit.ly/1MlfWlD","display_url":"bit.ly/1MlfWlD"}],"hashtags":[{"start":38,"end":43,"tag":"ANSM"},{"start":64,"end":72,"tag":"patient"}],"annotations":{}},"id":"574947626107412480","created_at":"2015-03-09T14:59:30.000Z","conversation_id":"574947626107412480","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"574887815231725569"}],"author_id":"116716199","text":"RT @EU_OSHA: 20 million workers in the EU experienced a work-related #health #problem in recent years. Find out more on #OSHwiki http://t.c…","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EU_OSHA","id":"23600999"}],"urls":{},"hashtags":[{"start":69,"end":76,"tag":"health"},{"start":77,"end":85,"tag":"problem"},{"start":120,"end":128,"tag":"OSHwiki"}],"annotations":{}},"id":"574947235957506049","created_at":"2015-03-09T14:57:57.000Z","conversation_id":"574947235957506049","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"574892192071819265"}],"author_id":"116716199","text":"RT @eupatientsforum: Parents of babies born with cleft can now refer to guidelines on early care thanks to the European Cleft Organisation …","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"urls":{},"hashtags":{},"annotations":{}},"id":"574947145972891648","created_at":"2015-03-09T14:57:36.000Z","conversation_id":"574947145972891648","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"574908484581486592"}],"author_id":"116716199","text":"RT @edqm_news: Do you know what the most used medicines in the world are? Find the answer and much more in #EDQM brochure http://t.co/lhYPj…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":107,"end":112,"tag":"EDQM"}],"annotations":{}},"id":"574946930335309825","created_at":"2015-03-09T14:56:44.000Z","conversation_id":"574946930335309825","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"574913532032086016"}],"author_id":"116716199","text":"RT @myESMO: Abstract submission d/line for World Congress on Gastrointestinal Cancer 2015 #worldGI is today http://t.co/rgduNdRl9e","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":108,"end":130,"url":"http://t.co/rgduNdRl9e","expanded_url":"http://ow.ly/K62jp","display_url":"ow.ly/K62jp"}],"hashtags":[{"start":90,"end":98,"tag":"worldGI"}],"annotations":[{"start":61,"end":83,"probability":0.623,"type":"Other","normalized_text":"Gastrointestinal Cancer"}]},"id":"574946884911038464","created_at":"2015-03-09T14:56:34.000Z","conversation_id":"574946884911038464","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"574935789248905217"}],"author_id":"116716199","text":"RT @edqm_news: Want to receive e-mail alerts when a #Pharmeuropa issue is complete? Register today and access all texts for comments http:/…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":52,"end":64,"tag":"Pharmeuropa"}],"annotations":{}},"id":"574946607034204160","created_at":"2015-03-09T14:55:27.000Z","conversation_id":"574946607034204160","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"574936835627094016"}],"author_id":"116716199","text":"RT @EFSA_EU: #PublicConsultation on guidance on health claims for #gut and #immune function  http://t.co/342L6vOI5M","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":93,"end":115,"url":"http://t.co/342L6vOI5M","expanded_url":"http://bit.ly/1Ml7tz7","display_url":"bit.ly/1Ml7tz7"}],"hashtags":[{"start":13,"end":32,"tag":"PublicConsultation"},{"start":66,"end":70,"tag":"gut"},{"start":75,"end":82,"tag":"immune"}],"annotations":{}},"id":"574946581746741248","created_at":"2015-03-09T14:55:21.000Z","conversation_id":"574946581746741248","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"574943222641913856"}],"author_id":"116716199","text":"RT @eu_echo: #Ebola outbreak: new cases reported in #SierraLeone and #Guinea, no new in #Liberia in past week. See map for more. http://t.c…","possibly_sensitive":false,"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"eu_echo","id":"470099591"}],"urls":{},"hashtags":[{"start":13,"end":19,"tag":"Ebola"},{"start":52,"end":64,"tag":"SierraLeone"},{"start":69,"end":76,"tag":"Guinea"},{"start":88,"end":96,"tag":"Liberia"}],"annotations":{}},"id":"574946469834326016","created_at":"2015-03-09T14:54:55.000Z","conversation_id":"574946469834326016","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"574943797450260480"}],"author_id":"116716199","text":"RT @EUEnvironment: #Cardiovascular disease and #cancers are the biggest cause of mortality worldwide. #SOER http://t.co/ElSeiPikvi http://t…","possibly_sensitive":false,"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"EUEnvironment","id":"22362552"}],"urls":[{"start":108,"end":130,"url":"http://t.co/ElSeiPikvi","expanded_url":"http://goo.gl/FzvztQ","display_url":"goo.gl/FzvztQ"}],"hashtags":[{"start":19,"end":34,"tag":"Cardiovascular"},{"start":47,"end":55,"tag":"cancers"},{"start":102,"end":107,"tag":"SOER"}],"annotations":{}},"id":"574946421687853056","created_at":"2015-03-09T14:54:43.000Z","conversation_id":"574946421687853056","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One week to answer call for scientific data for review of #herbal monograph on #Althaea officinalis L., radix: http://t.co/QQaGNKdRBt","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/QQaGNKdRBt","expanded_url":"http://bit.ly/16nYoaU","display_url":"bit.ly/16nYoaU"}],"hashtags":[{"start":58,"end":65,"tag":"herbal"},{"start":79,"end":87,"tag":"Althaea"}],"annotations":{}},"id":"574871754881040384","created_at":"2015-03-09T09:58:01.000Z","conversation_id":"574871754881040384","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One week to answer call for scientific data for review of #herbal monograph on #Salvia officinalis L., folium: http://t.co/p30cmPPkZB","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/p30cmPPkZB","expanded_url":"http://bit.ly/13610b9","display_url":"bit.ly/13610b9"}],"hashtags":[{"start":58,"end":65,"tag":"herbal"},{"start":79,"end":86,"tag":"Salvia"}],"annotations":{}},"id":"574871513377169408","created_at":"2015-03-09T09:57:04.000Z","conversation_id":"574871513377169408","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One week to answer call for scientific data for review of #herbal monograph on #Centaurium erythraea Rafn., herba: http://t.co/D0xiiOsWWC","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/D0xiiOsWWC","expanded_url":"http://bit.ly/1w9nJiz","display_url":"bit.ly/1w9nJiz"}],"hashtags":[{"start":58,"end":65,"tag":"herbal"},{"start":79,"end":90,"tag":"Centaurium"}],"annotations":{}},"id":"574871155498164227","created_at":"2015-03-09T09:55:38.000Z","conversation_id":"574871155498164227","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One more week to comment on draft #herbal monograph on #Serenoa repens (W. Bartram) Small, fructus: http://t.co/n2G6WKdLD5 #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/n2G6WKdLD5","expanded_url":"http://bit.ly/1LQk6nl","display_url":"bit.ly/1LQk6nl"}],"hashtags":[{"start":34,"end":41,"tag":"herbal"},{"start":55,"end":63,"tag":"Serenoa"},{"start":123,"end":136,"tag":"consultation"}],"annotations":{}},"id":"574870777725599744","created_at":"2015-03-09T09:54:08.000Z","conversation_id":"574870777725599744","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Our #veterinary #medicines committee (CVMP) meets this week. Highlights out this Friday: http://t.co/4ktG2SVrbt","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/4ktG2SVrbt","expanded_url":"http://bit.ly/1DZUil7","display_url":"bit.ly/1DZUil7"}],"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":16,"end":26,"tag":"medicines"}],"annotations":{}},"id":"574870458576826368","created_at":"2015-03-09T09:52:52.000Z","conversation_id":"574870458576826368","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Our #pharmacovigilance committee (PRAC) meets this week. Highlights out this Friday: http://t.co/uw9klAVGpX","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/uw9klAVGpX","expanded_url":"http://bit.ly/1x05TeO","display_url":"bit.ly/1x05TeO"}],"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}],"annotations":{}},"id":"574870195837276160","created_at":"2015-03-09T09:51:49.000Z","conversation_id":"574870195837276160","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One more week to comment on draft #herbal monograph on #Carum carvi L. aetheroleum: http://t.co/KafAw4xmgW #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/KafAw4xmgW","expanded_url":"http://bit.ly/1CAjNbo","display_url":"bit.ly/1CAjNbo"}],"hashtags":[{"start":34,"end":41,"tag":"herbal"},{"start":55,"end":61,"tag":"Carum"},{"start":107,"end":120,"tag":"consultation"}],"annotations":{}},"id":"574869550736535552","created_at":"2015-03-09T09:49:16.000Z","conversation_id":"574869550736535552","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One more week to comment on draft #herbal monograph on #Carum carvi L., fructus: http://t.co/HsqgSkn4jK #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/HsqgSkn4jK","expanded_url":"http://bit.ly/1zeto42","display_url":"bit.ly/1zeto42"}],"hashtags":[{"start":34,"end":41,"tag":"herbal"},{"start":55,"end":61,"tag":"Carum"},{"start":104,"end":117,"tag":"consultation"}],"annotations":{}},"id":"574869217830400000","created_at":"2015-03-09T09:47:56.000Z","conversation_id":"574869217830400000","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One week left to answer call for scientific data for review of #herbal monograph on #Fragaria vesca L., folium: http://t.co/9XxIr3X8Oa","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/9XxIr3X8Oa","expanded_url":"http://bit.ly/1yRFCzv","display_url":"bit.ly/1yRFCzv"}],"hashtags":[{"start":63,"end":70,"tag":"herbal"},{"start":84,"end":93,"tag":"Fragaria"}],"annotations":{}},"id":"574868860366626816","created_at":"2015-03-09T09:46:31.000Z","conversation_id":"574868860366626816","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"574834693209722880"}],"author_id":"116716199","text":"RT @EU_Health: 09-10.03 #Bruxelles: #EU Summit on #Innovation for Active &amp; Healthy #Ageing http://t.co/FfgeS9GlPc #AgeingSummit http://t.co…","possibly_sensitive":false,"public_metrics":{"retweet_count":63,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":95,"end":117,"url":"http://t.co/FfgeS9GlPc","expanded_url":"http://europa.eu/!NB94rB","display_url":"europa.eu/!NB94rB"}],"hashtags":[{"start":24,"end":34,"tag":"Bruxelles"},{"start":36,"end":39,"tag":"EU"},{"start":50,"end":61,"tag":"Innovation"},{"start":87,"end":94,"tag":"Ageing"},{"start":118,"end":131,"tag":"AgeingSummit"}],"annotations":{}},"id":"574864124322181122","created_at":"2015-03-09T09:27:42.000Z","conversation_id":"574864124322181122","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"574842412478119936"}],"author_id":"116716199","text":"RT @eurordis: DEBRA Int. calls for research proposals on clinical research/ trials for #epidermolysisbullosa. Deadline: 1 April http://t.co…","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"hashtags":[{"start":87,"end":108,"tag":"epidermolysisbullosa"}],"annotations":[{"start":14,"end":22,"probability":0.5436,"type":"Person","normalized_text":"DEBRA Int"}]},"id":"574864059654406144","created_at":"2015-03-09T09:27:26.000Z","conversation_id":"574864059654406144","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"574851294080401408"}],"author_id":"116716199","text":"RT @edqm_news: Did you read about our upcoming webinar on #biologicals, provided by Dr Emmanuelle Charton? Join us on 19 March 2015! http:/…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":58,"end":70,"tag":"biologicals"}],"annotations":[{"start":84,"end":104,"probability":0.9273,"type":"Person","normalized_text":"Dr Emmanuelle Charton"}]},"id":"574863923431743488","created_at":"2015-03-09T09:26:54.000Z","conversation_id":"574863923431743488","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: Submission of applications to vary marketing authorisations for #statin-containing #medicines by 18/04/2015 http://t.co/iiXJinxPfk","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":118,"end":140,"url":"http://t.co/iiXJinxPfk","expanded_url":"http://bit.ly/1EmuuSX","display_url":"bit.ly/1EmuuSX"}],"hashtags":[{"start":74,"end":81,"tag":"statin"},{"start":93,"end":103,"tag":"medicines"}],"annotations":{}},"id":"573904051835904000","created_at":"2015-03-06T17:52:43.000Z","conversation_id":"573904051835904000","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573901482141073408"}],"author_id":"116716199","text":"RT @EUlondonrep: Our weekly round-up now online: http://t.co/Abta8JJnPo #EbolaResponse @TimmermansEU #EnergyUnion @simonjhix","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":87,"end":100,"username":"TimmermansEU","id":"1391776140"},{"start":114,"end":124,"username":"simonjhix","id":"493370166"}],"urls":[{"start":49,"end":71,"url":"http://t.co/Abta8JJnPo","expanded_url":"http://ec.europa.eu/unitedkingdom/press/frontpage/2015/28_en.htm","display_url":"ec.europa.eu/unitedkingdom/…"}],"hashtags":[{"start":72,"end":86,"tag":"EbolaResponse"},{"start":101,"end":113,"tag":"EnergyUnion"}],"annotations":{}},"id":"573901745685950465","created_at":"2015-03-06T17:43:33.000Z","conversation_id":"573901745685950465","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573898976031719424"}],"author_id":"116716199","text":"RT @innovationunion: Why a #HorizonPrize on better use of #antibiotics? \nFind out more in this infographic http://t.co/dmjD8d9fcA #H2020 #A…","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":107,"end":129,"url":"http://t.co/dmjD8d9fcA","expanded_url":"http://europa.eu/!wQ36Um","display_url":"europa.eu/!wQ36Um"}],"hashtags":[{"start":27,"end":40,"tag":"HorizonPrize"},{"start":58,"end":70,"tag":"antibiotics"},{"start":130,"end":136,"tag":"H2020"}],"annotations":{}},"id":"573899614744670208","created_at":"2015-03-06T17:35:05.000Z","conversation_id":"573899614744670208","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573898971971645440"}],"author_id":"116716199","text":"RT @EU_H2020: Why a #HorizonPrize on better use of #antibiotics? \nFind out more in this infographic http://t.co/iinUXcfFuG #H2020 #AMR","possibly_sensitive":false,"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"urls":[{"start":100,"end":122,"url":"http://t.co/iinUXcfFuG","expanded_url":"http://europa.eu/!wQ36Um","display_url":"europa.eu/!wQ36Um"}],"hashtags":[{"start":20,"end":33,"tag":"HorizonPrize"},{"start":51,"end":63,"tag":"antibiotics"},{"start":123,"end":129,"tag":"H2020"},{"start":130,"end":134,"tag":"AMR"}],"annotations":{}},"id":"573899604057550848","created_at":"2015-03-06T17:35:02.000Z","conversation_id":"573899604057550848","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"#Consultation on #guidelines aiming to reduce antimicrobial #resistance in animals &amp; prevent transmission to humans: http://t.co/atR2IoLCNd","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":5,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":121,"end":143,"url":"http://t.co/atR2IoLCNd","expanded_url":"http://bit.ly/1DZMIac","display_url":"bit.ly/1DZMIac"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":17,"end":28,"tag":"guidelines"},{"start":60,"end":71,"tag":"resistance"}],"annotations":{}},"id":"573893511839358976","created_at":"2015-03-06T17:10:50.000Z","conversation_id":"573893511839358976","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: Submission of applications to vary marketing authorisations for #statin-containing #medicines by 18/04/2015 http://t.co/0FlkOvnMGa","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":118,"end":140,"url":"http://t.co/0FlkOvnMGa","expanded_url":"http://bit.ly/1zViIHx","display_url":"bit.ly/1zViIHx"}],"hashtags":[{"start":74,"end":81,"tag":"statin"},{"start":93,"end":103,"tag":"medicines"}],"annotations":{}},"id":"573893012482310144","created_at":"2015-03-06T17:08:51.000Z","conversation_id":"573893012482310144","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"The EPAR for #Xydalba (#dalbavancin), a #medicine for acute bacterial skin #infections, is now available: http://t.co/9YAXAuTZE4","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":4,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/9YAXAuTZE4","expanded_url":"http://bit.ly/1DYOgkH","display_url":"bit.ly/1DYOgkH"}],"hashtags":[{"start":13,"end":21,"tag":"Xydalba"},{"start":23,"end":35,"tag":"dalbavancin"},{"start":40,"end":49,"tag":"medicine"},{"start":75,"end":86,"tag":"infections"}],"annotations":{}},"id":"573892108861489153","created_at":"2015-03-06T17:05:15.000Z","conversation_id":"573892108861489153","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573882616971194368"}],"author_id":"116716199","text":"RT @MHRAgovuk: See our #ThinkPatientSafety Storify. It includes coverage of the #HumanFactors event in association with @NHSEngland https:/…","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"},{"start":120,"end":131,"username":"NHSEngland","id":"551426814"}],"urls":{},"hashtags":[{"start":23,"end":42,"tag":"ThinkPatientSafety"},{"start":80,"end":93,"tag":"HumanFactors"}],"annotations":{}},"id":"573888355143909376","created_at":"2015-03-06T16:50:20.000Z","conversation_id":"573888355143909376","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573881859832180737"}],"author_id":"116716199","text":"RT @IMI_JU: Training on trials: #Patients taught the language of #drug #development - @NatureMedicine article on @eupatients http://t.co/p1…","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":86,"end":101,"username":"NatureMedicine","id":"26832834"},{"start":113,"end":124,"username":"eupatients","id":"465674067"}],"urls":{},"hashtags":[{"start":32,"end":41,"tag":"Patients"},{"start":65,"end":70,"tag":"drug"},{"start":71,"end":83,"tag":"development"}],"annotations":{}},"id":"573888291877056513","created_at":"2015-03-06T16:50:05.000Z","conversation_id":"573888291877056513","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573879505200218112"}],"author_id":"116716199","text":"RT @DrugInfoAssn: Today the first #biosimilar product was approved by the @US_FDA in the US #Zarxio http://t.co/YpXw4VhXom http://t.co/4ttU…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":74,"end":81,"username":"US_FDA","id":"208120290"}],"urls":[{"start":100,"end":122,"url":"http://t.co/YpXw4VhXom","expanded_url":"http://buff.ly/1GqI1JY","display_url":"buff.ly/1GqI1JY"}],"hashtags":[{"start":34,"end":45,"tag":"biosimilar"},{"start":92,"end":99,"tag":"Zarxio"}],"annotations":[{"start":89,"end":90,"probability":0.728,"type":"Place","normalized_text":"US"}]},"id":"573888228194934784","created_at":"2015-03-06T16:49:50.000Z","conversation_id":"573888228194934784","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @Aifa_ufficiale: Monitoring and assessment of #medicines - results of the European project PROTECT http://t.co/Lwi9f78b9B","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":102,"end":124,"url":"http://t.co/Lwi9f78b9B","expanded_url":"http://bit.ly/1zVcoja","display_url":"bit.ly/1zVcoja"}],"hashtags":[{"start":49,"end":59,"tag":"medicines"}],"annotations":{}},"id":"573887730477826049","created_at":"2015-03-06T16:47:51.000Z","conversation_id":"573887730477826049","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573868602538917889"}],"author_id":"116716199","text":"RT @FDACBER: #FDA approves first biosimilar product. http://t.co/jbKDdp1Fd9 Learn more about #biosimilars. http://t.co/nraAOInZgr","possibly_sensitive":false,"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":53,"end":75,"url":"http://t.co/jbKDdp1Fd9","expanded_url":"http://go.usa.gov/3aqKe","display_url":"go.usa.gov/3aqKe"},{"start":107,"end":129,"url":"http://t.co/nraAOInZgr","expanded_url":"http://go.usa.gov/3aqKY","display_url":"go.usa.gov/3aqKY"}],"hashtags":[{"start":13,"end":17,"tag":"FDA"},{"start":93,"end":105,"tag":"biosimilars"}],"annotations":{}},"id":"573886380411084801","created_at":"2015-03-06T16:42:30.000Z","conversation_id":"573886380411084801","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573868126951116801"}],"author_id":"116716199","text":"RT @eupatientsforum: #eupati2015 is accepting applications for the 2nd cycle of the Expert Training Course until 31 March! http://t.co/R5Jq…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"urls":{},"hashtags":[{"start":21,"end":32,"tag":"eupati2015"}],"annotations":[{"start":84,"end":105,"probability":0.4488,"type":"Other","normalized_text":"Expert Training Course"}]},"id":"573868334292340736","created_at":"2015-03-06T15:30:47.000Z","conversation_id":"573868334292340736","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573864820732268544"}],"author_id":"116716199","text":"RT @egabiosimilars: The first US biosimilar medicine is approved for the same indications as its reference product http://t.co/mys6manp5O v…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/mys6manp5O","expanded_url":"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm436648.htm","display_url":"fda.gov/NewsEvents/New…"}],"hashtags":{},"annotations":[{"start":30,"end":31,"probability":0.5324,"type":"Place","normalized_text":"US"}]},"id":"573867701954871297","created_at":"2015-03-06T15:28:16.000Z","conversation_id":"573867701954871297","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573859205028913152"}],"author_id":"116716199","text":"RT @FDA_Drug_Info: FDA approves first biosimilar product in the United States. http://t.co/zHiuccje5H http://t.co/QBkiYpgtCd","possibly_sensitive":false,"public_metrics":{"retweet_count":78,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":79,"end":101,"url":"http://t.co/zHiuccje5H","expanded_url":"http://go.usa.gov/3aqgQ","display_url":"go.usa.gov/3aqgQ"},{"start":102,"end":124,"url":"http://t.co/QBkiYpgtCd","expanded_url":"https://twitter.com/FDA_Drug_Info/status/573859205028913152/photo/1","display_url":"pic.twitter.com/QBkiYpgtCd"}],"hashtags":{},"annotations":[{"start":19,"end":21,"probability":0.9799,"type":"Organization","normalized_text":"FDA"},{"start":64,"end":76,"probability":0.9185,"type":"Place","normalized_text":"United States"}]},"id":"573867507305553921","created_at":"2015-03-06T15:27:30.000Z","conversation_id":"573867507305553921","attachments":{"media_keys":["3_573859204601147392"]}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573855133416562688"}],"author_id":"116716199","text":"RT @EuropaBio: New #trade #blog #EU action 4 #rarediseases #ciruclareconomy &amp; #industrialbiotech this &amp; more news in @EuropaBio new…https:/…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"},{"start":125,"end":135,"username":"EuropaBio","id":"19642657"}],"urls":{},"hashtags":[{"start":19,"end":25,"tag":"trade"},{"start":26,"end":31,"tag":"blog"},{"start":32,"end":35,"tag":"EU"},{"start":45,"end":58,"tag":"rarediseases"},{"start":59,"end":75,"tag":"ciruclareconomy"},{"start":82,"end":100,"tag":"industrialbiotech"}],"annotations":{}},"id":"573867168888061952","created_at":"2015-03-06T15:26:09.000Z","conversation_id":"573867168888061952","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573852640490168320"}],"author_id":"116716199","text":"RT @MHRApress: New learning module on corticosteroids side effects launched today https://t.co/u0k7W5ttrS","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":[{"start":82,"end":105,"url":"https://t.co/u0k7W5ttrS","expanded_url":"https://www.gov.uk/government/news/regulator-launches-learning-module-on-steroids","display_url":"gov.uk/government/new…"}],"hashtags":{},"annotations":{}},"id":"573866946585837568","created_at":"2015-03-06T15:25:16.000Z","conversation_id":"573866946585837568","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573851282177400832"}],"author_id":"116716199","text":"RT @BushbyKate: Online catalogue for #raredisease biobanks a new feature of @ConnectRD platform #rdpalma http://t.co/ITL13awNMZ","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"BushbyKate","id":"1216228962"},{"start":76,"end":86,"username":"ConnectRD","id":"1227295489"}],"urls":[{"start":105,"end":127,"url":"http://t.co/ITL13awNMZ","expanded_url":"http://rd-connect.eu/news/rare-disease-biobanks-are-invited-to-publish-their-collection-the-rd-connect-catalogue/","display_url":"rd-connect.eu/news/rare-dise…"}],"hashtags":[{"start":37,"end":49,"tag":"raredisease"},{"start":96,"end":104,"tag":"rdpalma"}],"annotations":{}},"id":"573866879930003457","created_at":"2015-03-06T15:25:00.000Z","conversation_id":"573866879930003457","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573851154230153216"}],"author_id":"116716199","text":"RT @US_FDA: What will biosimilars mean for patients? http://t.co/sowNvMXgAw","possibly_sensitive":false,"public_metrics":{"retweet_count":56,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":53,"end":75,"url":"http://t.co/sowNvMXgAw","expanded_url":"http://go.usa.gov/3xhzP","display_url":"go.usa.gov/3xhzP"}],"hashtags":{},"annotations":{}},"id":"573865099674447872","created_at":"2015-03-06T15:17:56.000Z","conversation_id":"573865099674447872","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573848117365325824"}],"author_id":"116716199","text":"RT @FDAanimalhealth: The #FDA Issues Final Guidances for Animal Drug Depletion Studies http://t.co/hEzhtQCf4k","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":87,"end":109,"url":"http://t.co/hEzhtQCf4k","expanded_url":"http://1.usa.gov/1BaM75y","display_url":"1.usa.gov/1BaM75y"}],"hashtags":[{"start":25,"end":29,"tag":"FDA"}],"annotations":{}},"id":"573864962965270528","created_at":"2015-03-06T15:17:23.000Z","conversation_id":"573864962965270528","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573847020408020992"}],"author_id":"116716199","text":"RT @AnneGlover_EU: Summaries of scientific opinions from Health and Food Safety Scientific Committees can be found at http://t.co/Qkus1d9ii…","possibly_sensitive":false,"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"AnneGlover_EU","id":"569921322"}],"urls":{},"hashtags":{},"annotations":[{"start":57,"end":100,"probability":0.6477,"type":"Organization","normalized_text":"Health and Food Safety Scientific Committees"}]},"id":"573864881365082112","created_at":"2015-03-06T15:17:04.000Z","conversation_id":"573864881365082112","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573846364746084352"}],"author_id":"116716199","text":"RT @US_FDA: FDA approves first biosimilar product in the United States. http://t.co/3qrCPo7ijZ","possibly_sensitive":false,"public_metrics":{"retweet_count":95,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":72,"end":94,"url":"http://t.co/3qrCPo7ijZ","expanded_url":"http://go.usa.gov/3xhfh","display_url":"go.usa.gov/3xhfh"}],"hashtags":{},"annotations":[{"start":12,"end":14,"probability":0.9794,"type":"Organization","normalized_text":"FDA"},{"start":57,"end":69,"probability":0.9343,"type":"Place","normalized_text":"United States"}]},"id":"573864793746051072","created_at":"2015-03-06T15:16:43.000Z","conversation_id":"573864793746051072","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @luca__pani: PROTECT: closing symposium discusses results of European project on monitoring medicine assessment http://t.co/BloBIYjTeo","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"urls":[{"start":115,"end":137,"url":"http://t.co/BloBIYjTeo","expanded_url":"http://bit.ly/1x0eqyp","display_url":"bit.ly/1x0eqyp"}],"hashtags":{},"annotations":{}},"id":"573846299604353024","created_at":"2015-03-06T14:03:14.000Z","conversation_id":"573846299604353024","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573843692139757568"}],"author_id":"116716199","text":"RT @Eurovaccine: Current practices in #immunisation policymaking in #Europe http://t.co/lRKg97isE0","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":76,"end":98,"url":"http://t.co/lRKg97isE0","expanded_url":"http://bit.ly/1H61Ljl","display_url":"bit.ly/1H61Ljl"}],"hashtags":[{"start":38,"end":51,"tag":"immunisation"},{"start":68,"end":75,"tag":"Europe"}],"annotations":{}},"id":"573845987212550144","created_at":"2015-03-06T14:01:59.000Z","conversation_id":"573845987212550144","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573842553994362880"}],"author_id":"116716199","text":"RT @EFSA_EU: Register to attend #EFSA #ManagementBoard meeting -  Parma, 19 March http://t.co/mj487BZ5dg","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":82,"end":104,"url":"http://t.co/mj487BZ5dg","expanded_url":"http://bit.ly/1wLGM54","display_url":"bit.ly/1wLGM54"}],"hashtags":[{"start":32,"end":37,"tag":"EFSA"},{"start":38,"end":54,"tag":"ManagementBoard"}],"annotations":{}},"id":"573845881205755904","created_at":"2015-03-06T14:01:34.000Z","conversation_id":"573845881205755904","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573834151092174848"}],"author_id":"116716199","text":"RT @EMCDDA: The latest issue of our best practice email newsletter on pregnancy and drug use just published: http://t.co/BS3EL2OBGD","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":109,"end":131,"url":"http://t.co/BS3EL2OBGD","expanded_url":"http://eepurl.com/7PuOX","display_url":"eepurl.com/7PuOX"}],"hashtags":{},"annotations":{}},"id":"573845069712719872","created_at":"2015-03-06T13:58:20.000Z","conversation_id":"573845069712719872","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573828654167388160"}],"author_id":"116716199","text":"RT @egabiosimilars: The EU INN naming policy supports safe use of biosimilar medicines #biosimilars #pharma #news","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":{},"hashtags":[{"start":87,"end":99,"tag":"biosimilars"},{"start":100,"end":107,"tag":"pharma"},{"start":108,"end":113,"tag":"news"}],"annotations":[{"start":24,"end":29,"probability":0.5664,"type":"Organization","normalized_text":"EU INN"}]},"id":"573844684092620800","created_at":"2015-03-06T13:56:48.000Z","conversation_id":"573844684092620800","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One week to answer our call for data to review monograph on #Althaea officinalis L., radix: http://t.co/QQaGNKdRBt  #consultation #herbal","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/QQaGNKdRBt","expanded_url":"http://bit.ly/16nYoaU","display_url":"bit.ly/16nYoaU"}],"hashtags":[{"start":60,"end":68,"tag":"Althaea"},{"start":116,"end":129,"tag":"consultation"},{"start":130,"end":137,"tag":"herbal"}],"annotations":{}},"id":"573825061267902464","created_at":"2015-03-06T12:38:50.000Z","conversation_id":"573825061267902464","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One week to answer our call for data to review monograph on #Salvia officinalis L., folium: http://t.co/p30cmPPkZB  #consultation #herbal","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/p30cmPPkZB","expanded_url":"http://bit.ly/13610b9","display_url":"bit.ly/13610b9"}],"hashtags":[{"start":60,"end":67,"tag":"Salvia"},{"start":116,"end":129,"tag":"consultation"},{"start":130,"end":137,"tag":"herbal"}],"annotations":{}},"id":"573824902849040384","created_at":"2015-03-06T12:38:12.000Z","conversation_id":"573824902849040384","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One week to answer our call for data to review monograph on #Centaurium erythraea Rafn., herba: http://t.co/D0xiiOsWWC  #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/D0xiiOsWWC","expanded_url":"http://bit.ly/1w9nJiz","display_url":"bit.ly/1w9nJiz"}],"hashtags":[{"start":60,"end":71,"tag":"Centaurium"},{"start":120,"end":133,"tag":"consultation"}],"annotations":{}},"id":"573824415105945601","created_at":"2015-03-06T12:36:16.000Z","conversation_id":"573824415105945601","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One week to comment on draft #herbal monograph on #Serenoa repens, fructus (saw #palmetto fruit): http://t.co/n2G6WKdLD5  #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/n2G6WKdLD5","expanded_url":"http://bit.ly/1LQk6nl","display_url":"bit.ly/1LQk6nl"}],"hashtags":[{"start":29,"end":36,"tag":"herbal"},{"start":50,"end":58,"tag":"Serenoa"},{"start":80,"end":89,"tag":"palmetto"},{"start":122,"end":135,"tag":"consultation"}],"annotations":{}},"id":"573824199015464961","created_at":"2015-03-06T12:35:24.000Z","conversation_id":"573824199015464961","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One weeks to comment on draft #herbal monograph on #Carum carvi L., fructus (#caraway fruit): http://t.co/HsqgSkn4jK  #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/HsqgSkn4jK","expanded_url":"http://bit.ly/1zeto42","display_url":"bit.ly/1zeto42"}],"hashtags":[{"start":30,"end":37,"tag":"herbal"},{"start":51,"end":57,"tag":"Carum"},{"start":77,"end":85,"tag":"caraway"},{"start":118,"end":131,"tag":"consultation"}],"annotations":{}},"id":"573823880969740288","created_at":"2015-03-06T12:34:09.000Z","conversation_id":"573823880969740288","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One week to comment on draft #herbal monograph on #Carum carvi L. aetheroleum (#caraway oil): http://t.co/KafAw4xmgW #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/KafAw4xmgW","expanded_url":"http://bit.ly/1CAjNbo","display_url":"bit.ly/1CAjNbo"}],"hashtags":[{"start":29,"end":36,"tag":"herbal"},{"start":50,"end":56,"tag":"Carum"},{"start":79,"end":87,"tag":"caraway"},{"start":117,"end":130,"tag":"consultation"}],"annotations":{}},"id":"573823443642286081","created_at":"2015-03-06T12:32:24.000Z","conversation_id":"573823443642286081","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"One week to answer our call for scientific data to review the monograph on #Fragaria vesca L., folium: http://t.co/9XxIr3X8Oa  #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/9XxIr3X8Oa","expanded_url":"http://bit.ly/1yRFCzv","display_url":"bit.ly/1yRFCzv"}],"hashtags":[{"start":75,"end":84,"tag":"Fragaria"},{"start":127,"end":140,"tag":"consultation"}],"annotations":{}},"id":"573823085431898113","created_at":"2015-03-06T12:30:59.000Z","conversation_id":"573823085431898113","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Our #veterinary medicine committee (CVMP) meets next week. Highlights out on Friday: http://t.co/4ktG2SVrbt","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/4ktG2SVrbt","expanded_url":"http://bit.ly/1DZUil7","display_url":"bit.ly/1DZUil7"}],"hashtags":[{"start":4,"end":15,"tag":"veterinary"}],"annotations":{}},"id":"573822463970312192","created_at":"2015-03-06T12:28:31.000Z","conversation_id":"573822463970312192","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Our #pharmacovigilance committee (PRAC) meets next week. Highlights out on Friday: http://t.co/uw9klAVGpX","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":83,"end":105,"url":"http://t.co/uw9klAVGpX","expanded_url":"http://bit.ly/1x05TeO","display_url":"bit.ly/1x05TeO"}],"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}],"annotations":{}},"id":"573822249003802624","created_at":"2015-03-06T12:27:39.000Z","conversation_id":"573822249003802624","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573816779480432640"}],"author_id":"116716199","text":"RT @IAPOtweets: Our members and others from across the world helped make Rare Disease Day a big success: http://t.co/bgMjHLceEa http://t.co…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":105,"end":127,"url":"http://t.co/bgMjHLceEa","expanded_url":"http://bit.ly/1MbpfVs","display_url":"bit.ly/1MbpfVs"}],"hashtags":{},"annotations":[{"start":73,"end":88,"probability":0.6859,"type":"Other","normalized_text":"Rare Disease Day"}]},"id":"573821756206510081","created_at":"2015-03-06T12:25:42.000Z","conversation_id":"573821756206510081","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573815527220645888"}],"author_id":"116716199","text":"RT @IDFEuropeBxl: Why patients need to engage in medicines R&amp;D? Great piece on @eupatients via @NatureMedicine http://t.co/x6BtyWNasO","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"IDFEuropeBXL","id":"848831221"},{"start":83,"end":94,"username":"eupatients","id":"465674067"},{"start":99,"end":114,"username":"NatureMedicine","id":"26832834"}],"urls":[{"start":115,"end":137,"url":"http://t.co/x6BtyWNasO","expanded_url":"http://goo.gl/6OUuy2","display_url":"goo.gl/6OUuy2"}],"hashtags":{},"annotations":{}},"id":"573821389863415808","created_at":"2015-03-06T12:24:15.000Z","conversation_id":"573821389863415808","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573797264432435200"}],"author_id":"116716199","text":"RT @NICEcomms: Consultation is now open for the draft update of our #coeliac disease guidelines http://t.co/D6sFzrWhjZ","possibly_sensitive":false,"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":96,"end":118,"url":"http://t.co/D6sFzrWhjZ","expanded_url":"http://www.nice.org.uk/guidance/indevelopment/gid-cgwave0653/consultation","display_url":"nice.org.uk/guidance/indev…"}],"hashtags":[{"start":68,"end":76,"tag":"coeliac"}],"annotations":{}},"id":"573820411248427008","created_at":"2015-03-06T12:20:21.000Z","conversation_id":"573820411248427008","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573791754350108672"}],"author_id":"116716199","text":"RT @egabiosimilars: EGA introduces its Code of Conduct for the European #generic and #biosimilar #medicines industries http://t.co/XZD5XZMD…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":{},"hashtags":[{"start":72,"end":80,"tag":"generic"},{"start":85,"end":96,"tag":"biosimilar"},{"start":97,"end":107,"tag":"medicines"}],"annotations":[{"start":20,"end":22,"probability":0.6854,"type":"Organization","normalized_text":"EGA"}]},"id":"573820196575535104","created_at":"2015-03-06T12:19:30.000Z","conversation_id":"573820196575535104","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573791632199413762"}],"author_id":"116716199","text":"RT @egagenerics: EGA introduces its Code of Conduct for the European #generic and #biosimilar #medicines industries http://t.co/D5fsPIyuX7 …","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":116,"end":138,"url":"http://t.co/D5fsPIyuX7","expanded_url":"http://www.egagenerics.com/index.php/press-room/press-releases/94-2015/393-ega-introduces-its-code-of-conduct-for-the-european-generic-and-biosimilar-medicines-industries","display_url":"egagenerics.com/index.php/pres…"}],"hashtags":[{"start":69,"end":77,"tag":"generic"},{"start":82,"end":93,"tag":"biosimilar"},{"start":94,"end":104,"tag":"medicines"}],"annotations":[{"start":17,"end":19,"probability":0.6854,"type":"Organization","normalized_text":"EGA"}]},"id":"573820175755046913","created_at":"2015-03-06T12:19:25.000Z","conversation_id":"573820175755046913","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573778043380064256"}],"author_id":"116716199","text":"RT @myESMO: FDA expands approved use of nivolumab to squamous #NSCLC http://t.co/ed8rSjb4JI","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":69,"end":91,"url":"http://t.co/ed8rSjb4JI","expanded_url":"http://ow.ly/K0dLC","display_url":"ow.ly/K0dLC"}],"hashtags":[{"start":62,"end":68,"tag":"NSCLC"}],"annotations":[{"start":12,"end":14,"probability":0.9332,"type":"Organization","normalized_text":"FDA"}]},"id":"573819547486056448","created_at":"2015-03-06T12:16:55.000Z","conversation_id":"573819547486056448","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573763223490543617"}],"author_id":"116716199","text":"RT @EPHA_EU: European Medicines Agency (@EMA_News) - Draft Proposal on Transparency Addendum: http://t.co/TyMUzxdf2y #ClinicalTrial #EMA | …","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":40,"end":49,"username":"EMA_News","id":"116716199"}],"urls":[{"start":94,"end":116,"url":"http://t.co/TyMUzxdf2y","expanded_url":"http://bit.ly/17XuElC","display_url":"bit.ly/17XuElC"}],"hashtags":[{"start":117,"end":131,"tag":"ClinicalTrial"},{"start":132,"end":136,"tag":"EMA"}],"annotations":[{"start":13,"end":37,"probability":0.36,"type":"Organization","normalized_text":"European Medicines Agency"}]},"id":"573816214314614786","created_at":"2015-03-06T12:03:41.000Z","conversation_id":"573816214314614786","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573531336327168002"}],"author_id":"116716199","text":"RT @egabiosimilars: Find out @EMA_News questions and answers on biosimilar #medicines here: http://t.co/QTleC5Wmjh #biosimilars #informatio…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":29,"end":38,"username":"EMA_News","id":"116716199"}],"urls":[{"start":92,"end":114,"url":"http://t.co/QTleC5Wmjh","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/12/WC500020062.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":[{"start":75,"end":85,"tag":"medicines"},{"start":115,"end":127,"tag":"biosimilars"}],"annotations":{}},"id":"573815765884764161","created_at":"2015-03-06T12:01:54.000Z","conversation_id":"573815765884764161","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573422621934682112"}],"author_id":"116716199","text":"RT @laurentlouette: Technical but interesting info session on biosimilars at @EMA_News","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"laurentlouette","id":"207525510"},{"start":77,"end":86,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{}},"id":"573815598829867008","created_at":"2015-03-06T12:01:14.000Z","conversation_id":"573815598829867008","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573151514803482624"}],"author_id":"116716199","text":"RT @JeanGeorgesAE: Interesting updates on @EMA_News and @IMI_JU projects PROTECT and WEB-RADR http://t.co/pZcRCp4M32 and http://t.co/eFgLq7…","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":42,"end":51,"username":"EMA_News","id":"116716199"},{"start":56,"end":63,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":94,"end":116,"url":"http://t.co/pZcRCp4M32","expanded_url":"http://web-radr.eu","display_url":"web-radr.eu"}],"hashtags":{},"annotations":{}},"id":"573815224974774272","created_at":"2015-03-06T11:59:45.000Z","conversation_id":"573815224974774272","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Use of #antimicrobials in animals - public #consultation on two #guidelines: http://t.co/atR2IoLCNd","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/atR2IoLCNd","expanded_url":"http://bit.ly/1DZMIac","display_url":"bit.ly/1DZMIac"}],"hashtags":[{"start":7,"end":22,"tag":"antimicrobials"},{"start":43,"end":56,"tag":"consultation"},{"start":64,"end":75,"tag":"guidelines"}],"annotations":{}},"id":"573796324203757568","created_at":"2015-03-06T10:44:38.000Z","conversation_id":"573796324203757568","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573522103695179776"}],"author_id":"116716199","text":"RT @US_FDA: Read the newest Patient Network Newsletter for all the most recent happenings from the FDA. http://t.co/kBtTOkUb8d","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":104,"end":126,"url":"http://t.co/kBtTOkUb8d","expanded_url":"http://go.usa.gov/3xepC","display_url":"go.usa.gov/3xepC"}],"hashtags":{},"annotations":[{"start":99,"end":101,"probability":0.8229,"type":"Organization","normalized_text":"FDA"}]},"id":"573550057598791680","created_at":"2015-03-05T18:26:04.000Z","conversation_id":"573550057598791680","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573532619826143232"}],"author_id":"116716199","text":"RT @EFSA_EU: Subscribe to #EFSA #newsletter ! This week #EFSAExpo2015 event, data warehouse and much more http://t.co/X3cnWNEqAH http://t.c…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":106,"end":128,"url":"http://t.co/X3cnWNEqAH","expanded_url":"http://bit.ly/1gBYrmo","display_url":"bit.ly/1gBYrmo"}],"hashtags":[{"start":26,"end":31,"tag":"EFSA"},{"start":32,"end":43,"tag":"newsletter"},{"start":56,"end":69,"tag":"EFSAExpo2015"}],"annotations":{}},"id":"573549969036152832","created_at":"2015-03-05T18:25:43.000Z","conversation_id":"573549969036152832","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573536015836573696"}],"author_id":"116716199","text":"RT @ESEndocrinology: This morning at #ENDO2015: #Acromegaly genetics to management. Read a study on disease control in EJE \nhttp://t.co/DoX…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":{},"hashtags":[{"start":37,"end":46,"tag":"ENDO2015"},{"start":48,"end":59,"tag":"Acromegaly"}],"annotations":{}},"id":"573549898739679233","created_at":"2015-03-05T18:25:26.000Z","conversation_id":"573549898739679233","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the assessment report for #Xydalba (#dalbavancin), a #medicine for acute  bacterial skin #infections: http://t.co/9YAXAuTZE4","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/9YAXAuTZE4","expanded_url":"http://bit.ly/1DYOgkH","display_url":"bit.ly/1DYOgkH"}],"hashtags":[{"start":42,"end":50,"tag":"Xydalba"},{"start":52,"end":64,"tag":"dalbavancin"},{"start":69,"end":78,"tag":"medicine"},{"start":105,"end":116,"tag":"infections"}],"annotations":{}},"id":"573544925427539968","created_at":"2015-03-05T18:05:40.000Z","conversation_id":"573544925427539968","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573432292191924225"}],"author_id":"116716199","text":"RT @eupatientsforum: We need your your input on the state of implementation of the #CrossBorder #Healthcare Directive in your country: http…","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"urls":{},"hashtags":[{"start":83,"end":95,"tag":"CrossBorder"},{"start":96,"end":107,"tag":"Healthcare"}],"annotations":{}},"id":"573446354221056000","created_at":"2015-03-05T11:33:59.000Z","conversation_id":"573446354221056000","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573433517041963008"}],"author_id":"116716199","text":"RT @Uroweb: #EAUPatientInfo has some tips to deal with urinary #incontinence at work. Read more: http://t.co/8HvvYPFwUO","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"Uroweb","id":"114455333"}],"urls":[{"start":97,"end":119,"url":"http://t.co/8HvvYPFwUO","expanded_url":"http://bit.ly/1xVcoSc","display_url":"bit.ly/1xVcoSc"}],"hashtags":[{"start":12,"end":27,"tag":"EAUPatientInfo"},{"start":63,"end":76,"tag":"incontinence"}],"annotations":{}},"id":"573446251586453504","created_at":"2015-03-05T11:33:35.000Z","conversation_id":"573446251586453504","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573439068740157441"}],"author_id":"116716199","text":"RT @eu_echo: Provision of mobile labs constitute a key part of the #EU #EbolaResponse - take a video tour of one in #Guinea: http://t.co/7C…","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"eu_echo","id":"470099591"}],"urls":{},"hashtags":[{"start":67,"end":70,"tag":"EU"},{"start":71,"end":85,"tag":"EbolaResponse"},{"start":116,"end":123,"tag":"Guinea"}],"annotations":{}},"id":"573446032568291328","created_at":"2015-03-05T11:32:42.000Z","conversation_id":"573446032568291328","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573443612257697793"}],"author_id":"116716199","text":"RT @PrimaryCare4um: @ WHO_Europe @OBSHealth #Iceland HiT - prioritize #primarycare as patients' first port of call  http://t.co/cQTMX53c0X","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":33,"end":43,"username":"OBShealth","id":"254489771"}],"urls":[{"start":116,"end":138,"url":"http://t.co/cQTMX53c0X","expanded_url":"http://bit.ly/1CAyoa2","display_url":"bit.ly/1CAyoa2","status":404,"unwound_url":"https://www.euro.who.int/en/about-us/partners/observatory/publications/health-system-reviews-hits/full-list-of-country-hits/iceland-hit-2014"}],"hashtags":[{"start":44,"end":52,"tag":"Iceland"},{"start":70,"end":82,"tag":"primarycare"}],"annotations":[{"start":26,"end":31,"probability":0.6448,"type":"Place","normalized_text":"Europe"}]},"id":"573445712261844992","created_at":"2015-03-05T11:31:26.000Z","conversation_id":"573445712261844992","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573414345507516416"}],"author_id":"116716199","text":"RT @Kieran_Research: At a very interesting meeting at @EMA_News on \"biosimilars\" - new version of an existing biological product with poten…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"Kieran_Research","id":"35511598"},{"start":54,"end":63,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{}},"id":"573444751409696768","created_at":"2015-03-05T11:27:37.000Z","conversation_id":"573444751409696768","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"573201420104667136"}],"author_id":"116716199","text":"@TheLeeWilliams The recording will be published in the coming weeks: http://t.co/o9gp5fv3zy. Please check 'What's new' for updates.","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":69,"end":91,"url":"http://t.co/o9gp5fv3zy","expanded_url":"http://bit.ly/1DkJpda","display_url":"bit.ly/1DkJpda"}],"hashtags":{},"annotations":{}},"id":"573422506398392320","created_at":"2015-03-05T09:59:13.000Z","conversation_id":"573201420104667136","attachments":{"media_keys":{}},"in_reply_to_user_id":"3722601"},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the #minutes of our human medicines committee (CHMP) meeting in January: http://t.co/uK3mDP2Wxn","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/uK3mDP2Wxn","expanded_url":"http://bit.ly/1DNKSqb","display_url":"bit.ly/1DNKSqb"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"}],"annotations":{}},"id":"573408321081905152","created_at":"2015-03-05T09:02:51.000Z","conversation_id":"573408321081905152","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We're recruiting an internal #auditor. Apply by 4 April: http://t.co/y3wjiSblW9 #recruitment","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":57,"end":79,"url":"http://t.co/y3wjiSblW9","expanded_url":"http://bit.ly/1F97qUu","display_url":"bit.ly/1F97qUu"}],"hashtags":[{"start":29,"end":37,"tag":"auditor"},{"start":80,"end":92,"tag":"recruitment"}],"annotations":{}},"id":"573408206732599296","created_at":"2015-03-05T09:02:24.000Z","conversation_id":"573408206732599296","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We're recruiting a #planning officer. Apply by 4 April: http://t.co/rAQID2ug1t #recruitment","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":56,"end":78,"url":"http://t.co/rAQID2ug1t","expanded_url":"http://bit.ly/1EMZGtn","display_url":"bit.ly/1EMZGtn"}],"hashtags":[{"start":19,"end":28,"tag":"planning"},{"start":79,"end":91,"tag":"recruitment"}],"annotations":{}},"id":"573408032316645376","created_at":"2015-03-05T09:01:42.000Z","conversation_id":"573408032316645376","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573154974999449600"}],"author_id":"116716199","text":"RT @my_ueg: Discussion &amp; answer for the last #elearning Case of the Month by @Bjorn_Rembacken now available http://t.co/M2uC9XxcID","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"my_ueg","id":"487344065"},{"start":81,"end":97,"username":"Bjorn_Rembacken","id":"207417799"}],"urls":[{"start":112,"end":134,"url":"http://t.co/M2uC9XxcID","expanded_url":"http://ow.ly/JSnZi","display_url":"ow.ly/JSnZi"}],"hashtags":[{"start":49,"end":59,"tag":"elearning"}],"annotations":{}},"id":"573185714764038144","created_at":"2015-03-04T18:18:18.000Z","conversation_id":"573185714764038144","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573157208667643904"}],"author_id":"116716199","text":"RT @EFSA_EU: Data warehouse access rules are an important milestone in #EFSA transformation to an open #science organisation http://t.co/i1…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":71,"end":76,"tag":"EFSA"},{"start":103,"end":111,"tag":"science"}],"annotations":{}},"id":"573185672200241152","created_at":"2015-03-04T18:18:08.000Z","conversation_id":"573185672200241152","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573161497825808385"}],"author_id":"116716199","text":"RT @IAPOtweets: Global patients congress, rare diseases and picnics: March news is out now http://t.co/CLqm1odQbv  #iaponews http://t.co/K9…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":91,"end":113,"url":"http://t.co/CLqm1odQbv","expanded_url":"http://bit.ly/1DTyebO","display_url":"bit.ly/1DTyebO"}],"hashtags":[{"start":115,"end":124,"tag":"iaponews"}],"annotations":{}},"id":"573185644639457280","created_at":"2015-03-04T18:18:01.000Z","conversation_id":"573185644639457280","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573177818886103041"}],"author_id":"116716199","text":"RT @eurordis: ‘How to enable meaningful patient contribution to ethical review?’ @eupatients webinar, 17:00, 5 March http://t.co/ortCjKeLr4…","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":81,"end":92,"username":"eupatients","id":"465674067"}],"urls":[{"start":117,"end":139,"url":"http://t.co/ortCjKeLr4","expanded_url":"http://ow.ly/JFKIh","display_url":"ow.ly/JFKIh"}],"hashtags":{},"annotations":{}},"id":"573185507276005376","created_at":"2015-03-04T18:17:28.000Z","conversation_id":"573185507276005376","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573145556287156225"}],"author_id":"116716199","text":"RT @EU_Careers: Do you have what it takes to be an auditor for the EU? Apply from 26/03 to 28/04. More info: http://t.co/J2OcgGKXpA  #workf…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"EU_Careers","id":"81119708"}],"urls":[{"start":109,"end":131,"url":"http://t.co/J2OcgGKXpA","expanded_url":"http://bit.ly/EUaudit","display_url":"bit.ly/EUaudit"}],"hashtags":{},"annotations":{}},"id":"573150971272036352","created_at":"2015-03-04T16:00:14.000Z","conversation_id":"573150971272036352","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573142195810766848"}],"author_id":"116716199","text":"RT @FDAWomen: New FDA Drug Safety Communication - do not share multi-dose #diabetes pen devices among patients: http://t.co/vuQ8qdIhs4 via …","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":[{"start":112,"end":134,"url":"http://t.co/vuQ8qdIhs4","expanded_url":"http://go.usa.gov/3cPEV","display_url":"go.usa.gov/3cPEV"}],"hashtags":[{"start":74,"end":83,"tag":"diabetes"}],"annotations":{}},"id":"573143443372961792","created_at":"2015-03-04T15:30:20.000Z","conversation_id":"573143443372961792","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573127129078108160"}],"author_id":"116716199","text":"RT @DrugInfoAssn: The @US_FDA is requiring warning labels about health risks to be added to #testosterone products http://t.co/q2VPA7l4xN","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":22,"end":29,"username":"US_FDA","id":"208120290"}],"urls":[{"start":115,"end":137,"url":"http://t.co/q2VPA7l4xN","expanded_url":"http://ow.ly/JV3fw","display_url":"ow.ly/JV3fw"}],"hashtags":[{"start":92,"end":105,"tag":"testosterone"}],"annotations":{}},"id":"573129810886725632","created_at":"2015-03-04T14:36:09.000Z","conversation_id":"573129810886725632","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573124727398666240"}],"author_id":"116716199","text":"RT @EFSA_EU: 'Our scientific data warehouse project will contribute to scientific progress' says #EFSA ED http://t.co/JUalo6CJuZ http://t.c…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":106,"end":128,"url":"http://t.co/JUalo6CJuZ","expanded_url":"http://bit.ly/1B6rlCY","display_url":"bit.ly/1B6rlCY"}],"hashtags":[{"start":97,"end":102,"tag":"EFSA"}],"annotations":{}},"id":"573129270802968576","created_at":"2015-03-04T14:34:01.000Z","conversation_id":"573129270802968576","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the #minutes of the January meeting of our human medicines committee (CHMP): http://t.co/uK3mDP2Wxn","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/uK3mDP2Wxn","expanded_url":"http://bit.ly/1DNKSqb","display_url":"bit.ly/1DNKSqb"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"}],"annotations":{}},"id":"573122159578624000","created_at":"2015-03-04T14:05:45.000Z","conversation_id":"573122159578624000","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We're looking to hire an internal #auditor: http://t.co/y3wjiSblW9 #recruitment","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":44,"end":66,"url":"http://t.co/y3wjiSblW9","expanded_url":"http://bit.ly/1F97qUu","display_url":"bit.ly/1F97qUu"}],"hashtags":[{"start":34,"end":42,"tag":"auditor"},{"start":67,"end":79,"tag":"recruitment"}],"annotations":{}},"id":"573121625513697280","created_at":"2015-03-04T14:03:38.000Z","conversation_id":"573121625513697280","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We're looking to hire a #planning officer: http://t.co/rAQID2ug1t #recruitment","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":43,"end":65,"url":"http://t.co/rAQID2ug1t","expanded_url":"http://bit.ly/1EMZGtn","display_url":"bit.ly/1EMZGtn"}],"hashtags":[{"start":24,"end":33,"tag":"planning"},{"start":66,"end":78,"tag":"recruitment"}],"annotations":{}},"id":"573120287035797504","created_at":"2015-03-04T13:58:19.000Z","conversation_id":"573120287035797504","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573118069981245440"}],"author_id":"116716199","text":"RT @eu_echo: The statement of the co-chairs of yesterday's #EU #Ebola conference: http://t.co/7nQFIyiVPS #EbolaResponse http://t.co/VYil7XC…","possibly_sensitive":false,"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"eu_echo","id":"470099591"}],"urls":[{"start":82,"end":104,"url":"http://t.co/7nQFIyiVPS","expanded_url":"http://bit.ly/1M6Peip","display_url":"bit.ly/1M6Peip"}],"hashtags":[{"start":59,"end":62,"tag":"EU"},{"start":63,"end":69,"tag":"Ebola"},{"start":105,"end":119,"tag":"EbolaResponse"}],"annotations":{}},"id":"573118780722819073","created_at":"2015-03-04T13:52:20.000Z","conversation_id":"573118780722819073","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573117494296227840"}],"author_id":"116716199","text":"RT @IMI_JU: Starting now at #EP - #EbolaSTOA workshop feat. IMI. Watch live at http://t.co/cBhPMjyFO2 More on IMI’s #Ebola work: http://t.c…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":79,"end":101,"url":"http://t.co/cBhPMjyFO2","expanded_url":"http://bit.ly/1aLjoKS","display_url":"bit.ly/1aLjoKS"}],"hashtags":[{"start":28,"end":31,"tag":"EP"},{"start":34,"end":44,"tag":"EbolaSTOA"},{"start":116,"end":122,"tag":"Ebola"}],"annotations":{}},"id":"573118745180307456","created_at":"2015-03-04T13:52:11.000Z","conversation_id":"573118745180307456","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573114500678881280"}],"author_id":"116716199","text":"RT @FDA_MCMi: Science Board to the FDA also meets today 8:30 am - 4 pm ET w/ webcast: http://t.co/YbvrlYQSKu","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":86,"end":108,"url":"http://t.co/YbvrlYQSKu","expanded_url":"http://ht.ly/JUOD0","display_url":"ht.ly/JUOD0"}],"hashtags":{},"annotations":[{"start":35,"end":37,"probability":0.6126,"type":"Organization","normalized_text":"FDA"}]},"id":"573118429009461249","created_at":"2015-03-04T13:50:56.000Z","conversation_id":"573118429009461249","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573113372075536384"}],"author_id":"116716199","text":"RT @EP_Industry: Workshop on #Ebola starts now w/@MSF @WHO @ECDC_EU: Live: http://t.co/XfZDZJp1y8 @EP_Industry @PaulRuebig @vickyford @Char…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":15,"username":"EP_Industry","id":"951326846"},{"start":49,"end":53,"username":"MSF","id":"2195671183"},{"start":54,"end":58,"username":"WHO","id":"14499829"},{"start":59,"end":67,"username":"ECDC_EU","id":"204752573"},{"start":98,"end":110,"username":"EP_Industry","id":"951326846"},{"start":111,"end":122,"username":"PaulRuebig","id":"306115656"},{"start":123,"end":133,"username":"vickyford","id":"14691032"}],"urls":[{"start":75,"end":97,"url":"http://t.co/XfZDZJp1y8","expanded_url":"http://ow.ly/JRCOn","display_url":"ow.ly/JRCOn"}],"hashtags":[{"start":29,"end":35,"tag":"Ebola"}],"annotations":{}},"id":"573118230744727552","created_at":"2015-03-04T13:50:08.000Z","conversation_id":"573118230744727552","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573113333638934528"}],"author_id":"116716199","text":"RT @FDA_MCMi: Vaccines &amp; Related Biological Products Advisory Committee meets today on 2015-16 influenza vaccines: http://t.co/p6QH0fH5Yx (…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":119,"end":141,"url":"http://t.co/p6QH0fH5Yx","expanded_url":"http://ht.ly/JUOqI","display_url":"ht.ly/JUOqI"}],"hashtags":{},"annotations":{}},"id":"573118204534497280","created_at":"2015-03-04T13:50:02.000Z","conversation_id":"573118204534497280","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573113272360038400"}],"author_id":"116716199","text":"RT @FDACBER: Vaccines &amp; Related Biological Products Advisory Committee Meeting is today from 8:30am – 3pm. Watch the live webcast. http://t…","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":{},"hashtags":{},"annotations":{}},"id":"573118180517928961","created_at":"2015-03-04T13:49:56.000Z","conversation_id":"573118180517928961","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @AEMPSGOB: Report on therapeutic positioning of regorafenib (Stivarga ®) in colorectal cancer http://t.co/kLN3o3MCxv","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":97,"end":119,"url":"http://t.co/kLN3o3MCxv","expanded_url":"http://bit.ly/1zXUgpV","display_url":"bit.ly/1zXUgpV"}],"hashtags":{},"annotations":{}},"id":"573117853869719552","created_at":"2015-03-04T13:48:39.000Z","conversation_id":"573117853869719552","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573106198351912960"}],"author_id":"116716199","text":"RT @EURLex: #recruitment: @EMA_News selection procedure for Internal Audit Officer and Planning Officer in Corp Governance Dept – http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":26,"end":35,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":12,"end":24,"tag":"recruitment"}],"annotations":{}},"id":"573117665851641859","created_at":"2015-03-04T13:47:54.000Z","conversation_id":"573117665851641859","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573105907233644545"}],"author_id":"116716199","text":"RT @europarlAV: #Ebola: the way forward; statements by #Johnson Sirleaf and #Chambas, VIDEO http://t.co/fKg8rZ7jfr #ACP-EU","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"europarlAV","id":"570018183"}],"urls":[{"start":92,"end":114,"url":"http://t.co/fKg8rZ7jfr","expanded_url":"http://ow.ly/JT4yT","display_url":"ow.ly/JT4yT"}],"hashtags":[{"start":16,"end":22,"tag":"Ebola"},{"start":55,"end":63,"tag":"Johnson"},{"start":76,"end":84,"tag":"Chambas"},{"start":115,"end":119,"tag":"ACP"}],"annotations":{}},"id":"573117643131121664","created_at":"2015-03-04T13:47:48.000Z","conversation_id":"573117643131121664","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573099111198674944"}],"author_id":"116716199","text":"RT @EU_ECHA: New public consultation on the identification of substances of very high concern. Contribute by 16 April http://t.co/fzNmjvZRv9","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":118,"end":140,"url":"http://t.co/fzNmjvZRv9","expanded_url":"http://bit.ly/1s9sx3T","display_url":"bit.ly/1s9sx3T"}],"hashtags":{},"annotations":{}},"id":"573117516379250688","created_at":"2015-03-04T13:47:18.000Z","conversation_id":"573117516379250688","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573098066586292224"}],"author_id":"116716199","text":"RT @H2020SME: Already 138 members in our Twitter list of #H2020 #SMEinstrument beneficiaries! http://t.co/mTyCipPQ3c @EU_H2020","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"H2020SME","id":"874591855626858496"},{"start":117,"end":126,"username":"EU_H2020","id":"920249612329504768"}],"urls":[{"start":94,"end":116,"url":"http://t.co/mTyCipPQ3c","expanded_url":"http://ow.ly/JULul","display_url":"ow.ly/JULul"}],"hashtags":[{"start":57,"end":63,"tag":"H2020"},{"start":64,"end":78,"tag":"SMEinstrument"}],"annotations":[{"start":41,"end":47,"probability":0.4822,"type":"Product","normalized_text":"Twitter"}]},"id":"573117483701440512","created_at":"2015-03-04T13:47:10.000Z","conversation_id":"573117483701440512","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573097618273935360"}],"author_id":"116716199","text":"RT @EU_ECHA: Making #biocides available on the EU market? You need to be on the #BPR Article95 list http://t.co/DyRIcabEB3 by1/09 http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":100,"end":122,"url":"http://t.co/DyRIcabEB3","expanded_url":"http://bit.ly/1zN3Px7","display_url":"bit.ly/1zN3Px7"}],"hashtags":[{"start":20,"end":29,"tag":"biocides"},{"start":80,"end":84,"tag":"BPR"}],"annotations":{}},"id":"573117442723082240","created_at":"2015-03-04T13:47:01.000Z","conversation_id":"573117442723082240","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573084737125916672"}],"author_id":"116716199","text":"RT @eu_echo: The #EU's efforts to combat the #Ebola virus are manifold. See full factsheet: http://t.co/CC00kduTiG #EbolaResponse http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"eu_echo","id":"470099591"}],"urls":[{"start":92,"end":114,"url":"http://t.co/CC00kduTiG","expanded_url":"http://bit.ly/18J41ln","display_url":"bit.ly/18J41ln"}],"hashtags":[{"start":17,"end":20,"tag":"EU"},{"start":45,"end":51,"tag":"Ebola"},{"start":115,"end":129,"tag":"EbolaResponse"}],"annotations":{}},"id":"573116786616471552","created_at":"2015-03-04T13:44:24.000Z","conversation_id":"573116786616471552","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @LV_MPA: New launch date for communications solution for license applications http://t.co/SbjUPdSC4D","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":81,"end":103,"url":"http://t.co/SbjUPdSC4D","expanded_url":"http://bit.ly/17PWOyZ","display_url":"bit.ly/17PWOyZ"}],"hashtags":{},"annotations":{}},"id":"573080658425323520","created_at":"2015-03-04T11:20:50.000Z","conversation_id":"573080658425323520","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573079318529744896"}],"author_id":"116716199","text":"RT @JeanGeorgesAE: Interesting to hear the views of patients and patient organisations on their interaction with @EMA_News. Exemplary in my…","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":113,"end":122,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{}},"id":"573079387437998080","created_at":"2015-03-04T11:15:47.000Z","conversation_id":"573079387437998080","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573065224024133632"}],"author_id":"116716199","text":"RT @NICEcomms: Our new #medicines optimisation guidance recommends involving people more in decisions about their care https://t.co/ITd1PcM…","possibly_sensitive":false,"public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":{},"hashtags":[{"start":23,"end":33,"tag":"medicines"}],"annotations":{}},"id":"573066844535443457","created_at":"2015-03-04T10:25:57.000Z","conversation_id":"573066844535443457","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"#Consultation open: @ICH_news draft implementation guide v2.0 for electronic common technical document (eCTD) v4.0: http://t.co/G9UKr3xuiF","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":20,"end":29,"username":"ICH_news","id":"305434870"}],"urls":[{"start":116,"end":138,"url":"http://t.co/G9UKr3xuiF","expanded_url":"http://bit.ly/1GfdBKo","display_url":"bit.ly/1GfdBKo"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"}],"annotations":{}},"id":"573058915442827264","created_at":"2015-03-04T09:54:27.000Z","conversation_id":"573058915442827264","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"573057438599008256"}],"author_id":"116716199","text":"@creuter4 @EFA_Patients @Suecos We're only involved in regulating medicines and not devices, clothing or equipment: http://t.co/Z7GrvcfhaG.","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"creuter4","id":"2166888937"},{"start":10,"end":23,"username":"EFA_Patients","id":"1299643704"},{"start":24,"end":31,"username":"SueCos","id":"711888939620114432"}],"urls":[{"start":116,"end":138,"url":"http://t.co/Z7GrvcfhaG","expanded_url":"http://bit.ly/XSfuFS","display_url":"bit.ly/XSfuFS"}],"hashtags":{},"annotations":{}},"id":"573058509740371968","created_at":"2015-03-04T09:52:50.000Z","conversation_id":"573047043381436416","attachments":{"media_keys":{}},"in_reply_to_user_id":"2166888937"},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573051641689214976"}],"author_id":"116716199","text":"RT @JamieNWilkinson: at the European Medicines Agency - Joint Patients' / Consumers' &amp; Healthcare Professionals' Working Party meeting","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"JamieNWilkinson","id":"210623862"}],"urls":{},"hashtags":{},"annotations":{}},"id":"573057842506305536","created_at":"2015-03-04T09:50:11.000Z","conversation_id":"573057842506305536","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573048724710150145"}],"author_id":"116716199","text":"RT @JeanGeorgesAE: Working Party with Patients' and Consumers' Organisations for two days at @EMA_News - happy to represent @AlzheimerEurop…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":93,"end":102,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{}},"id":"573055385835347968","created_at":"2015-03-04T09:40:25.000Z","conversation_id":"573055385835347968","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573047043381436416"}],"author_id":"116716199","text":"RT @EFA_Patients: New Clinical Trials Regulation - a major step forward to improve evidence for #medicines approval for different #patient …","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"}],"urls":{},"hashtags":[{"start":96,"end":106,"tag":"medicines"},{"start":130,"end":138,"tag":"patient"}],"annotations":{}},"id":"573055281279733760","created_at":"2015-03-04T09:40:00.000Z","conversation_id":"573055281279733760","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573045585885982721"}],"author_id":"116716199","text":"RT @EP_Industry: Today 14:30h in #EP: #Ebola workshop – lessons learned and prevention of future crisis. Program: http://t.co/MI56hUP0j1 @E…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":15,"username":"EP_Industry","id":"951326846"}],"urls":[{"start":114,"end":136,"url":"http://t.co/MI56hUP0j1","expanded_url":"http://ow.ly/JRYMH","display_url":"ow.ly/JRYMH"}],"hashtags":[{"start":33,"end":36,"tag":"EP"},{"start":38,"end":44,"tag":"Ebola"}],"annotations":{}},"id":"573054917302218752","created_at":"2015-03-04T09:38:33.000Z","conversation_id":"573054917302218752","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573045217785335808"}],"author_id":"116716199","text":"RT @egagenerics: @EMA_news /@US_FDA #PatientEngagement fellowship: a time to learn and share http://t.co/YIcP4BJEYM","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":17,"end":26,"username":"EMA_News","id":"116716199"},{"start":28,"end":35,"username":"US_FDA","id":"208120290"}],"urls":[{"start":93,"end":115,"url":"http://t.co/YIcP4BJEYM","expanded_url":"http://1.usa.gov/1Lyz0wB","display_url":"1.usa.gov/1Lyz0wB"}],"hashtags":[{"start":36,"end":54,"tag":"PatientEngagement"}],"annotations":{}},"id":"573054760762384385","created_at":"2015-03-04T09:37:56.000Z","conversation_id":"573054760762384385","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573043077876727808"}],"author_id":"116716199","text":"RT @edqm_news: Did you know? The #European #Pharmacopoeia Commission has just adopted a new strategy: http://t.co/i0ZZ866j4p","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":102,"end":124,"url":"http://t.co/i0ZZ866j4p","expanded_url":"http://bit.ly/1AN0RpP","display_url":"bit.ly/1AN0RpP"}],"hashtags":[{"start":33,"end":42,"tag":"European"},{"start":43,"end":57,"tag":"Pharmacopoeia"}],"annotations":{}},"id":"573054646324998144","created_at":"2015-03-04T09:37:29.000Z","conversation_id":"573054646324998144","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"573040431853916161"}],"author_id":"116716199","text":"RT @EFSA_EU: Open meeting of #EFSA experts on #GMOs takes place in Brussels today. Check the agenda http://t.co/sjyX6oudyt","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":100,"end":122,"url":"http://t.co/sjyX6oudyt","expanded_url":"http://bit.ly/1w1Rzaz","display_url":"bit.ly/1w1Rzaz"}],"hashtags":[{"start":29,"end":34,"tag":"EFSA"},{"start":46,"end":51,"tag":"GMOs"}],"annotations":[{"start":67,"end":74,"probability":0.9855,"type":"Place","normalized_text":"Brussels"}]},"id":"573054410760306688","created_at":"2015-03-04T09:36:33.000Z","conversation_id":"573054410760306688","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572787174749425665"}],"author_id":"116716199","text":"RT @ECDC_EU: #EbolaResponse ECDC continue efforts to help ensure outbreak is fully controlled eg coordinated deployment of experts http://t…","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":13,"end":27,"tag":"EbolaResponse"}],"annotations":{}},"id":"572816652624125954","created_at":"2015-03-03T17:51:47.000Z","conversation_id":"572816652624125954","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572787457130946560"}],"author_id":"116716199","text":"RT @eupatientsforum: Become a #Patient Expert with #eupati2015 Training Course! Apply before 31 March here: http://t.co/R5JqZD0EKr @eupatie…","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"urls":[{"start":108,"end":130,"url":"http://t.co/R5JqZD0EKr","expanded_url":"http://www.eu-patient.eu/Events/upcoming-events/eupati-expert-training-course/","display_url":"eu-patient.eu/Events/upcomin…"}],"hashtags":[{"start":30,"end":38,"tag":"Patient"},{"start":51,"end":62,"tag":"eupati2015"}],"annotations":{}},"id":"572816633024151552","created_at":"2015-03-03T17:51:42.000Z","conversation_id":"572816633024151552","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572794415108001792"}],"author_id":"116716199","text":"RT @IlaeWeb: International #Epilepsy Congress Istanbul Sept 2015 sbstract deadline extended to 6 March. Rules, info: http://t.co/f9TlN4KE2N","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"urls":[{"start":117,"end":139,"url":"http://t.co/f9TlN4KE2N","expanded_url":"http://www.epilepsyistanbul2015.org/abstracts/faq.228.html","display_url":"epilepsyistanbul2015.org/abstracts/faq.…"}],"hashtags":[{"start":27,"end":36,"tag":"Epilepsy"}],"annotations":[{"start":37,"end":53,"probability":0.4358,"type":"Organization","normalized_text":"Congress Istanbul"}]},"id":"572816490652672000","created_at":"2015-03-03T17:51:08.000Z","conversation_id":"572816490652672000","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572801289836490752"}],"author_id":"116716199","text":"RT @EFSA_EU: #EFSAExpo2015 conference: programme now available! http://t.co/OPl8JcnvFY","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":64,"end":86,"url":"http://t.co/OPl8JcnvFY","expanded_url":"http://bit.ly/1M4Rreh","display_url":"bit.ly/1M4Rreh"}],"hashtags":[{"start":13,"end":26,"tag":"EFSAExpo2015"}],"annotations":{}},"id":"572816314944913409","created_at":"2015-03-03T17:50:26.000Z","conversation_id":"572816314944913409","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572706538365833216"}],"author_id":"116716199","text":"RT @kardamyla: @eurordis Rare Disease Patient Group Commends EMA @EMA_News | RAPS http://t.co/tTUeFPpz0r via @sharethis","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"kardamyla","id":"59722141"},{"start":15,"end":24,"username":"eurordis","id":"26993786"},{"start":65,"end":74,"username":"EMA_News","id":"116716199"},{"start":109,"end":119,"username":"ShareThis","id":"14116807"}],"urls":[{"start":82,"end":104,"url":"http://t.co/tTUeFPpz0r","expanded_url":"http://shar.es/1WQVks","display_url":"shar.es/1WQVks"}],"hashtags":{},"annotations":{}},"id":"572780086841225217","created_at":"2015-03-03T15:26:29.000Z","conversation_id":"572780086841225217","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"#Consultation on @ICH_news draft implementation guide v2.0 for electronic common technical document (eCTD) v4.0: http://t.co/G9UKr3xuiF","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":17,"end":26,"username":"ICH_news","id":"305434870"}],"urls":[{"start":113,"end":135,"url":"http://t.co/G9UKr3xuiF","expanded_url":"http://bit.ly/1GfdBKo","display_url":"bit.ly/1GfdBKo"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"}],"annotations":{}},"id":"572740128738840576","created_at":"2015-03-03T12:47:42.000Z","conversation_id":"572740128738840576","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572675520153952256"}],"author_id":"116716199","text":"RT @IMI_JU: GetReal project wants your views on use of real world data in drug development &amp; clinical effectiveness assessment http://t.co/…","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"hashtags":{},"annotations":{}},"id":"572734821283332096","created_at":"2015-03-03T12:26:36.000Z","conversation_id":"572734821283332096","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572678901308252160"}],"author_id":"116716199","text":"RT @EU_Health: #EU high level conference #EbolaResponse, 03/03/15, Bxl. Watch live http://t.co/bETbhrL4KY More http://t.co/nFn1WDwMcY @euro…","possibly_sensitive":false,"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":83,"end":105,"url":"http://t.co/bETbhrL4KY","expanded_url":"http://europa.eu/!NY98Bt","display_url":"europa.eu/!NY98Bt"},{"start":111,"end":133,"url":"http://t.co/nFn1WDwMcY","expanded_url":"http://europa.eu/!Rk67Dk","display_url":"europa.eu/!Rk67Dk"}],"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":41,"end":55,"tag":"EbolaResponse"}],"annotations":{}},"id":"572734787833745408","created_at":"2015-03-03T12:26:28.000Z","conversation_id":"572734787833745408","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572682945628131328"}],"author_id":"116716199","text":"RT @EURLex: #health:protection&amp;surveillance zones established in relation to avian influenza #H5N8 in certain areas of #Hungary - http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"urls":{},"hashtags":[{"start":12,"end":19,"tag":"health"},{"start":97,"end":102,"tag":"H5N8"},{"start":123,"end":131,"tag":"Hungary"}],"annotations":{}},"id":"572734727683231744","created_at":"2015-03-03T12:26:14.000Z","conversation_id":"572734727683231744","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572705229323567104"}],"author_id":"116716199","text":"RT @Uroweb: Diagnosed with #prostate #cancer? Find some questions you can ask your doctor during consult: http://t.co/c80POu6JxD #EAUPatien…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"Uroweb","id":"114455333"}],"urls":[{"start":106,"end":128,"url":"http://t.co/c80POu6JxD","expanded_url":"http://bit.ly/1IC6R8h","display_url":"bit.ly/1IC6R8h"}],"hashtags":[{"start":27,"end":36,"tag":"prostate"},{"start":37,"end":44,"tag":"cancer"}],"annotations":{}},"id":"572734420471451648","created_at":"2015-03-03T12:25:01.000Z","conversation_id":"572734420471451648","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572709080470585344"}],"author_id":"116716199","text":"RT @edqm_news: One last day to sign up to receive this month's #EDQM newsletter! http://t.co/dKDLcYQXTn","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":81,"end":103,"url":"http://t.co/dKDLcYQXTn","expanded_url":"http://bit.ly/1BcFP6b","display_url":"bit.ly/1BcFP6b"}],"hashtags":[{"start":63,"end":68,"tag":"EDQM"}],"annotations":{}},"id":"572734351181553665","created_at":"2015-03-03T12:24:44.000Z","conversation_id":"572734351181553665","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the EPAR for #Zontivity (#vorapaxar), a #medicine to reduce occurrence of blood clots: http://t.co/qob1KbbR5n","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/qob1KbbR5n","expanded_url":"http://bit.ly/1wJcU3H","display_url":"bit.ly/1wJcU3H"}],"hashtags":[{"start":29,"end":39,"tag":"Zontivity"},{"start":41,"end":51,"tag":"vorapaxar"},{"start":56,"end":65,"tag":"medicine"}],"annotations":{}},"id":"572699943149969408","created_at":"2015-03-03T10:08:01.000Z","conversation_id":"572699943149969408","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the EPAR for #Cosentyx (#secukinumab), a new #medicine for plaque #psoriasis: http://t.co/XPeVnW9VO0","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/XPeVnW9VO0","expanded_url":"http://bit.ly/1DuTuly","display_url":"bit.ly/1DuTuly"}],"hashtags":[{"start":29,"end":38,"tag":"Cosentyx"},{"start":40,"end":52,"tag":"secukinumab"},{"start":61,"end":70,"tag":"medicine"},{"start":82,"end":92,"tag":"psoriasis"}],"annotations":{}},"id":"572699858865418241","created_at":"2015-03-03T10:07:41.000Z","conversation_id":"572699858865418241","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the EPAR for #Holoclar; #stemcell #medicine to replace damaged cells on the eye surface: http://t.co/BwGqOiCXTw","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/BwGqOiCXTw","expanded_url":"http://bit.ly/1wJet1w","display_url":"bit.ly/1wJet1w"}],"hashtags":[{"start":29,"end":38,"tag":"Holoclar"},{"start":40,"end":49,"tag":"stemcell"},{"start":50,"end":59,"tag":"medicine"}],"annotations":{}},"id":"572699718591119360","created_at":"2015-03-03T10:07:07.000Z","conversation_id":"572699718591119360","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the EPAR for #Rasagiline ratiopharm, a #medicine for #Parkinson's disease: http://t.co/VXFAOr4zkI","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/VXFAOr4zkI","expanded_url":"http://bit.ly/1K7SwEI","display_url":"bit.ly/1K7SwEI"}],"hashtags":[{"start":29,"end":40,"tag":"Rasagiline"},{"start":55,"end":64,"tag":"medicine"},{"start":69,"end":79,"tag":"Parkinson"}],"annotations":{}},"id":"572699625146216448","created_at":"2015-03-03T10:06:45.000Z","conversation_id":"572699625146216448","attachments":{"media_keys":{}}},{"source":"Twitter for iPhone","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572456424820748290"}],"author_id":"116716199","text":"RT @FDACBER: Learn about FDA’s progress on demographic information in #ClinicalTrials. http://t.co/FbhqwaI2ma","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":87,"end":109,"url":"http://t.co/FbhqwaI2ma","expanded_url":"http://go.usa.gov/3xBQh","display_url":"go.usa.gov/3xBQh"}],"hashtags":[{"start":70,"end":85,"tag":"ClinicalTrials"}],"annotations":[{"start":25,"end":27,"probability":0.8953,"type":"Organization","normalized_text":"FDA"}]},"id":"572461186236751873","created_at":"2015-03-02T18:19:17.000Z","conversation_id":"572461186236751873","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572445164205187072"}],"author_id":"116716199","text":"RT @EuropaBio: The @EU_Commission unveils top facts on EU action for #rarediseases http://t.co/n4jUx36rTJ","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"},{"start":19,"end":33,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":83,"end":105,"url":"http://t.co/n4jUx36rTJ","expanded_url":"http://ow.ly/JPnlq","display_url":"ow.ly/JPnlq"}],"hashtags":[{"start":69,"end":82,"tag":"rarediseases"}],"annotations":[{"start":55,"end":56,"probability":0.6164,"type":"Organization","normalized_text":"EU"}]},"id":"572445884157460480","created_at":"2015-03-02T17:18:28.000Z","conversation_id":"572445884157460480","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @AEMPSGOB: Report on therapeutic positioning of radium-223 (Xofigo®) in prostate cancer\nhttp://t.co/peKOJkyD1b","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":91,"end":113,"url":"http://t.co/peKOJkyD1b","expanded_url":"http://bit.ly/1EGbNID","display_url":"bit.ly/1EGbNID"}],"hashtags":{},"annotations":{}},"id":"572442223545077760","created_at":"2015-03-02T17:03:56.000Z","conversation_id":"572442223545077760","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572430570329911296"}],"author_id":"116716199","text":"RT @eupatientsforum: Did you miss the February issue of our #newsletter? Don't worry, you can find it here: http://t.co/SjjHOEQqGK","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"urls":[{"start":108,"end":130,"url":"http://t.co/SjjHOEQqGK","expanded_url":"http://www.eu-patient.eu/library/EPF-Mailing/","display_url":"eu-patient.eu/library/EPF-Ma…"}],"hashtags":[{"start":60,"end":71,"tag":"newsletter"}],"annotations":{}},"id":"572433258186731520","created_at":"2015-03-02T16:28:18.000Z","conversation_id":"572433258186731520","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572428550839640064"}],"author_id":"116716199","text":"RT @eu_eeas: Tuesday’s #EU-organised conference continues international #EbolaResponse. Watch opening/closing sessions live http://t.co/LAb…","possibly_sensitive":false,"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"eu_eeas","id":"80803819"}],"urls":{},"hashtags":[{"start":23,"end":26,"tag":"EU"},{"start":72,"end":86,"tag":"EbolaResponse"}],"annotations":{}},"id":"572432822499217408","created_at":"2015-03-02T16:26:34.000Z","conversation_id":"572432822499217408","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572428181992558592"}],"author_id":"116716199","text":"RT @IMI_JU: From our newsletter: NEWMEDS DupCheck tool spots duplicate enrolments in #ClinicalTrials http://t.co/3yql7Co2l6 http://t.co/EQm…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":101,"end":123,"url":"http://t.co/3yql7Co2l6","expanded_url":"http://www.dupcheck.org","display_url":"dupcheck.org"}],"hashtags":[{"start":85,"end":100,"tag":"ClinicalTrials"}],"annotations":{}},"id":"572432677439197184","created_at":"2015-03-02T16:26:00.000Z","conversation_id":"572432677439197184","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572427644236644353"}],"author_id":"116716199","text":"RT @EU_Health: #EU high level conference #EbolaResponse, 03/03/15, Bxl. Watch live http://t.co/bETbhrL4KY More http://t.co/nFn1WDwMcY @euro…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":83,"end":105,"url":"http://t.co/bETbhrL4KY","expanded_url":"http://europa.eu/!NY98Bt","display_url":"europa.eu/!NY98Bt"},{"start":111,"end":133,"url":"http://t.co/nFn1WDwMcY","expanded_url":"http://europa.eu/!Rk67Dk","display_url":"europa.eu/!Rk67Dk"}],"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":41,"end":55,"tag":"EbolaResponse"}],"annotations":{}},"id":"572432387088515073","created_at":"2015-03-02T16:24:51.000Z","conversation_id":"572432387088515073","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572426184954269696"}],"author_id":"116716199","text":"RT @egagenerics: #Generics manufacturers are obliged to monitor their products once they have been placed on the market http://t.co/RGObhUd…","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":{},"hashtags":[{"start":17,"end":26,"tag":"Generics"}],"annotations":{}},"id":"572431699478482944","created_at":"2015-03-02T16:22:07.000Z","conversation_id":"572431699478482944","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572420920951902208"}],"author_id":"116716199","text":"RT @cancereu: Interesting 1st session on choice of #endpoints.Many researchers focusing also on QoL,not only on overall survival http://t.c…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"urls":{},"hashtags":[{"start":51,"end":61,"tag":"endpoints"}],"annotations":{}},"id":"572421987450155008","created_at":"2015-03-02T15:43:31.000Z","conversation_id":"572421987450155008","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572419821071155200"}],"author_id":"116716199","text":"RT @Eurovaccine: @ECDC_EU on #measles problems in #Europe: Correct mis-perceptions that measles is a mild disease among other options http:…","possibly_sensitive":false,"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":17,"end":25,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":29,"end":37,"tag":"measles"},{"start":50,"end":57,"tag":"Europe"}],"annotations":{}},"id":"572421843291938816","created_at":"2015-03-02T15:42:57.000Z","conversation_id":"572421843291938816","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: French medicines agency public consultation: Updated good manufacturing practices guideline, until April 2 http://t.co/2XNE2CYJUM","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":117,"end":139,"url":"http://t.co/2XNE2CYJUM","expanded_url":"http://bit.ly/1Dw08rx","display_url":"bit.ly/1Dw08rx"}],"hashtags":{},"annotations":{}},"id":"572419746970382336","created_at":"2015-03-02T15:34:37.000Z","conversation_id":"572419746970382336","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572414455075753984"}],"author_id":"116716199","text":"RT @edqm_news: Our #European #Pharmacopoeia Webinar on #Biologicals is coming up soon! Join us and Dr Emmanuelle Charton on 19 March http:/…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":19,"end":28,"tag":"European"},{"start":29,"end":43,"tag":"Pharmacopoeia"},{"start":55,"end":67,"tag":"Biologicals"}],"annotations":[{"start":99,"end":119,"probability":0.8938,"type":"Person","normalized_text":"Dr Emmanuelle Charton"}]},"id":"572419288138706944","created_at":"2015-03-02T15:32:47.000Z","conversation_id":"572419288138706944","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572412656239423488"}],"author_id":"116716199","text":"RT @EUatUN: Tomorrow in Brussels, the #EU brings together 80 international delegations to discuss the ongoing #Ebola... http://t.co/WRAVqOb…","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"EUatUN","id":"125995973"}],"urls":{},"hashtags":[{"start":38,"end":41,"tag":"EU"},{"start":110,"end":116,"tag":"Ebola"}],"annotations":[{"start":24,"end":31,"probability":0.9921,"type":"Place","normalized_text":"Brussels"}]},"id":"572412989158121473","created_at":"2015-03-02T15:07:46.000Z","conversation_id":"572412989158121473","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572409030741782529"}],"author_id":"116716199","text":"RT @FDA_Drug_Info: Drug Safety Podcast on warnings to prohibit sharing of multi-dose diabetes pen devices among patients. Listen@ http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"hashtags":{},"annotations":{}},"id":"572409305279926272","created_at":"2015-03-02T14:53:07.000Z","conversation_id":"572409305279926272","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572404898513465344"}],"author_id":"116716199","text":"RT @EU_H2020: 25k deaths/yr in EU from #antibiotics resistance. Help crack the challenge! #HorizonPrize \nhttp://t.co/FJp0p7NXyg http://t.co…","possibly_sensitive":false,"public_metrics":{"retweet_count":40,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"urls":[{"start":105,"end":127,"url":"http://t.co/FJp0p7NXyg","expanded_url":"http://europa.eu/!UT98MG","display_url":"europa.eu/!UT98MG"}],"hashtags":[{"start":39,"end":51,"tag":"antibiotics"},{"start":90,"end":103,"tag":"HorizonPrize"}],"annotations":[{"start":31,"end":32,"probability":0.6865,"type":"Place","normalized_text":"EU"}]},"id":"572407084240805889","created_at":"2015-03-02T14:44:18.000Z","conversation_id":"572407084240805889","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572404898467328000"}],"author_id":"116716199","text":"RT @innovationunion: 25k deaths/yr in EU from #antibiotics resistance. Help crack the challenge! #HorizonPrize \nhttp://t.co/3FvNYI4pAL http…","possibly_sensitive":false,"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":112,"end":134,"url":"http://t.co/3FvNYI4pAL","expanded_url":"http://europa.eu/!UT98MG","display_url":"europa.eu/!UT98MG"}],"hashtags":[{"start":46,"end":58,"tag":"antibiotics"},{"start":97,"end":110,"tag":"HorizonPrize"}],"annotations":[{"start":38,"end":39,"probability":0.679,"type":"Place","normalized_text":"EU"}]},"id":"572407069552349185","created_at":"2015-03-02T14:44:14.000Z","conversation_id":"572407069552349185","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the assessment report for #Rasagiline ratiopharm, a #medicine for #Parkinson's disease: http://t.co/VXFAOr4zkI","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/VXFAOr4zkI","expanded_url":"http://bit.ly/1K7SwEI","display_url":"bit.ly/1K7SwEI"}],"hashtags":[{"start":42,"end":53,"tag":"Rasagiline"},{"start":68,"end":77,"tag":"medicine"},{"start":82,"end":92,"tag":"Parkinson"}],"annotations":{}},"id":"572395430505553920","created_at":"2015-03-02T13:57:59.000Z","conversation_id":"572395430505553920","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572389449541296128"}],"author_id":"116716199","text":"RT @edqm_news: From 1st March 2015, invoicing of inspection costs will be done differently: http://t.co/6n0yAEbd1a  #certificationofsuitabi…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":92,"end":114,"url":"http://t.co/6n0yAEbd1a","expanded_url":"http://bit.ly/1Aiz7w8","display_url":"bit.ly/1Aiz7w8"}],"hashtags":{},"annotations":{}},"id":"572389965650403329","created_at":"2015-03-02T13:36:16.000Z","conversation_id":"572389965650403329","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572388249282469888"}],"author_id":"116716199","text":"RT @innovationunion: International cooperation in research and innovation thanks to Horizon 2020 #H2020 http://t.co/dT9TIeO1Bu","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":104,"end":126,"url":"http://t.co/dT9TIeO1Bu","expanded_url":"http://youtu.be/LXYRPKy6nW0?a","display_url":"youtu.be/LXYRPKy6nW0?a"}],"hashtags":[{"start":97,"end":103,"tag":"H2020"}],"annotations":{}},"id":"572389921601818624","created_at":"2015-03-02T13:36:06.000Z","conversation_id":"572389921601818624","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572385330680205312"}],"author_id":"116716199","text":"RT @GCessak: Ambroxol and bromhexine expectorants: safety information to be updated http://t.co/QAuVr36p9h","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":84,"end":106,"url":"http://t.co/QAuVr36p9h","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/02/news_detail_002276.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":{}},"id":"572389797467181056","created_at":"2015-03-02T13:35:36.000Z","conversation_id":"572389797467181056","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572377650163023874"}],"author_id":"116716199","text":"RT @V_Andriukaitis: on #EU response to the #Ebolaoutbreak in West Africa http://t.co/EYmFgCMw8D  @StylianidesEU @MimicaEU","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"V_Andriukaitis","id":"575269517"},{"start":97,"end":111,"username":"StylianidesEU","id":"2413938919"},{"start":112,"end":121,"username":"MimicaEU","id":"1545333888"}],"urls":[{"start":73,"end":95,"url":"http://t.co/EYmFgCMw8D","expanded_url":"http://europa.eu/!nR43XH","display_url":"europa.eu/!nR43XH"}],"hashtags":[{"start":23,"end":26,"tag":"EU"},{"start":43,"end":57,"tag":"Ebolaoutbreak"}],"annotations":[{"start":61,"end":71,"probability":0.9497,"type":"Place","normalized_text":"West Africa"}]},"id":"572389581481500672","created_at":"2015-03-02T13:34:45.000Z","conversation_id":"572389581481500672","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the assessment report for #Holoclar; #stemcell #medicine to replace damaged cells on the eye surface: http://t.co/BwGqOiCXTw","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/BwGqOiCXTw","expanded_url":"http://bit.ly/1wJet1w","display_url":"bit.ly/1wJet1w"}],"hashtags":[{"start":42,"end":51,"tag":"Holoclar"},{"start":53,"end":62,"tag":"stemcell"},{"start":63,"end":72,"tag":"medicine"}],"annotations":{}},"id":"572369404924723200","created_at":"2015-03-02T12:14:34.000Z","conversation_id":"572369404924723200","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the assessment report for #Cosentyx (#secukinumab), a new #medicine for plaque #psoriasis:  http://t.co/XPeVnW9VO0","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/XPeVnW9VO0","expanded_url":"http://bit.ly/1DuTuly","display_url":"bit.ly/1DuTuly"}],"hashtags":[{"start":42,"end":51,"tag":"Cosentyx"},{"start":53,"end":65,"tag":"secukinumab"},{"start":74,"end":83,"tag":"medicine"},{"start":95,"end":105,"tag":"psoriasis"}],"annotations":{}},"id":"572368539283263490","created_at":"2015-03-02T12:11:08.000Z","conversation_id":"572368539283263490","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the assessment report for #Zontivity (#vorapaxar), a #medicine to reduce occurrence of blood clots: http://t.co/qob1KbbR5n","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/qob1KbbR5n","expanded_url":"http://bit.ly/1wJcU3H","display_url":"bit.ly/1wJcU3H"}],"hashtags":[{"start":42,"end":52,"tag":"Zontivity"},{"start":54,"end":64,"tag":"vorapaxar"},{"start":69,"end":78,"tag":"medicine"}],"annotations":{}},"id":"572367922829664256","created_at":"2015-03-02T12:08:41.000Z","conversation_id":"572367922829664256","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Risk of allergy and skin reactions to be included in safety information for #ambroxol and #bromhexine expectorants: http://t.co/sPGD4owb3S","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/sPGD4owb3S","expanded_url":"http://bit.ly/1JUXiFq","display_url":"bit.ly/1JUXiFq"}],"hashtags":[{"start":76,"end":85,"tag":"ambroxol"},{"start":90,"end":101,"tag":"bromhexine"}],"annotations":{}},"id":"572362361719431168","created_at":"2015-03-02T11:46:35.000Z","conversation_id":"572362361719431168","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"The highlights of last week's meeting of our committee for human #medicines (CHMP) are available on our website: http://t.co/VYHSHGvlR8","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/VYHSHGvlR8","expanded_url":"http://bit.ly/1DZvc6O","display_url":"bit.ly/1DZvc6O"}],"hashtags":[{"start":65,"end":75,"tag":"medicines"}],"annotations":{}},"id":"572361658363977728","created_at":"2015-03-02T11:43:47.000Z","conversation_id":"572361658363977728","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Last week we recommended #Jinarc (#tolvaptan) for approval in a rare #kidney #disease: http://t.co/D7VYTu34tn","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/D7VYTu34tn","expanded_url":"http://bit.ly/1AAQpTp","display_url":"bit.ly/1AAQpTp"}],"hashtags":[{"start":25,"end":32,"tag":"Jinarc"},{"start":34,"end":44,"tag":"tolvaptan"},{"start":69,"end":76,"tag":"kidney"},{"start":77,"end":85,"tag":"disease"}],"annotations":{}},"id":"572361378520018944","created_at":"2015-03-02T11:42:41.000Z","conversation_id":"572361378520018944","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Last week we recommended #Zykadia (#ceritinib) for approval in advanced non small cell #lung #cancer: http://t.co/IqASMlmw94","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/IqASMlmw94","expanded_url":"http://bit.ly/1AhgTEC","display_url":"bit.ly/1AhgTEC"}],"hashtags":[{"start":25,"end":33,"tag":"Zykadia"},{"start":35,"end":45,"tag":"ceritinib"},{"start":87,"end":92,"tag":"lung"},{"start":93,"end":100,"tag":"cancer"}],"annotations":{}},"id":"572361213994242048","created_at":"2015-03-02T11:42:02.000Z","conversation_id":"572361213994242048","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572358527639019520"}],"author_id":"116716199","text":"RT @BushbyKate: Ahead of todays #raredisease UK forum meeting @PHE_Screening describes @NHSEngland plans for @Orphanet &amp; registries https:/…","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"BushbyKate","id":"1216228962"}],"urls":{},"hashtags":[{"start":32,"end":44,"tag":"raredisease"}],"annotations":[{"start":45,"end":46,"probability":0.8808,"type":"Place","normalized_text":"UK"}]},"id":"572360412529889280","created_at":"2015-03-02T11:38:50.000Z","conversation_id":"572360412529889280","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572356448140857344"}],"author_id":"116716199","text":"RT @IFAHEurope: @V_Andriukaitis on Antimicrobial resistance: Ready to act &amp; invites all food &amp; feed chain stakeholders concerned to discuss…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":16,"end":31,"username":"V_Andriukaitis","id":"575269517"}],"urls":{},"hashtags":{},"annotations":{}},"id":"572360106744152064","created_at":"2015-03-02T11:37:38.000Z","conversation_id":"572360106744152064","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572355847155793920"}],"author_id":"116716199","text":"RT @EU_Health: #EU #EbolaResponse to West Africa outbreak: EU's total financial contribution &gt; €1.2 bn http://t.co/nFn1WDwMcY @StylianidesE…","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":106,"end":128,"url":"http://t.co/nFn1WDwMcY","expanded_url":"http://europa.eu/!Rk67Dk","display_url":"europa.eu/!Rk67Dk"}],"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":19,"end":33,"tag":"EbolaResponse"}],"annotations":[{"start":37,"end":47,"probability":0.9333,"type":"Place","normalized_text":"West Africa"}]},"id":"572360003618787329","created_at":"2015-03-02T11:37:13.000Z","conversation_id":"572360003618787329","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572355280383713280"}],"author_id":"116716199","text":"RT @EU_Commission: EU #EbolaResponse to the outbreak in West Africa - EU's total financial contribution over €1.2 bn http://t.co/Cz72lvqNIb…","possibly_sensitive":false,"public_metrics":{"retweet_count":31,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":117,"end":139,"url":"http://t.co/Cz72lvqNIb","expanded_url":"http://europa.eu/!Rk67Dk","display_url":"europa.eu/!Rk67Dk"}],"hashtags":[{"start":22,"end":36,"tag":"EbolaResponse"}],"annotations":[{"start":56,"end":66,"probability":0.9548,"type":"Place","normalized_text":"West Africa"},{"start":70,"end":71,"probability":0.3719,"type":"Organization","normalized_text":"EU"}]},"id":"572359978058706944","created_at":"2015-03-02T11:37:07.000Z","conversation_id":"572359978058706944","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572354683454398464"}],"author_id":"116716199","text":"RT @innovationunion: via @EU_Commission #EU response to the Ebola outbreak in West Africa http://t.co/NuZCbP5vMA","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"},{"start":25,"end":39,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":90,"end":112,"url":"http://t.co/NuZCbP5vMA","expanded_url":"http://dlvr.it/8nyKdq","display_url":"dlvr.it/8nyKdq"}],"hashtags":[{"start":40,"end":43,"tag":"EU"}],"annotations":[{"start":78,"end":88,"probability":0.9598,"type":"Place","normalized_text":"West Africa"}]},"id":"572359948627283968","created_at":"2015-03-02T11:37:00.000Z","conversation_id":"572359948627283968","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572353076071428097"}],"author_id":"116716199","text":"RT @ECDC_EU: ECDC is looking for an expert in Antimicrobial Resistance and Healthcare-associated Infections. Apply by 16 March: http://t.co…","possibly_sensitive":false,"public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":{},"annotations":{}},"id":"572359677817827328","created_at":"2015-03-02T11:35:55.000Z","conversation_id":"572359677817827328","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @AEMPSGOB: Want to know how medicines and health products are regulated in Spain? http://t.co/4epIFE7N9u","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":85,"end":107,"url":"http://t.co/4epIFE7N9u","expanded_url":"http://bit.ly/1M1pty9","display_url":"bit.ly/1M1pty9"}],"hashtags":{},"annotations":[{"start":78,"end":82,"probability":0.9988,"type":"Place","normalized_text":"Spain"}]},"id":"572359397676097536","created_at":"2015-03-02T11:34:48.000Z","conversation_id":"572359397676097536","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @URPLWMiPB: How to report adverse reactions #medicinesafety http://t.co/JZUs7eRGws","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":63,"end":85,"url":"http://t.co/JZUs7eRGws","expanded_url":"http://bit.ly/1E91AFC","display_url":"bit.ly/1E91AFC"}],"hashtags":[{"start":47,"end":62,"tag":"medicinesafety"}],"annotations":{}},"id":"572358947333652480","created_at":"2015-03-02T11:33:01.000Z","conversation_id":"572358947333652480","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ZVALatvija: 28 February 2015, Rare Disease Day, read more: http://t.co/6l4ZX40U9Q","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"ZVALatvija","id":"1576993495"}],"urls":[{"start":63,"end":85,"url":"http://t.co/6l4ZX40U9Q","expanded_url":"http://bit.ly/1E9sM5x","display_url":"bit.ly/1E9sM5x"}],"hashtags":{},"annotations":[{"start":34,"end":49,"probability":0.7574,"type":"Other","normalized_text":"Rare Disease Day"}]},"id":"572350640774623232","created_at":"2015-03-02T11:00:01.000Z","conversation_id":"572350640774623232","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572336556209524736"}],"author_id":"116716199","text":"RT @IFAHEurope: @IFAHEurope welcomes opportunity to talk #OneHealth with @V_Andriukaitis, @EU_Health, @EFSA_EU, FVO &amp; EU Food Chain http://…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":{},"hashtags":{},"annotations":{}},"id":"572350200376926209","created_at":"2015-03-02T10:58:16.000Z","conversation_id":"572350200376926209","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572335395230367744"}],"author_id":"116716199","text":"RT @IFAHEurope: Mtg w/ @V_Andriukaitis: IFAH-Europe pleased to present key priorities 2 @EU_Health, @EFSA_EU, FVO &amp; EU food chain http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":23,"end":38,"username":"V_Andriukaitis","id":"575269517"},{"start":88,"end":98,"username":"EU_Health","id":"606325697"},{"start":100,"end":108,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":{},"annotations":[{"start":45,"end":50,"probability":0.8793,"type":"Place","normalized_text":"Europe"}]},"id":"572350014653132800","created_at":"2015-03-02T10:57:31.000Z","conversation_id":"572350014653132800","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572334131125854208"}],"author_id":"116716199","text":"RT @ZVALatvija: Raise awareness in the Rare Disease Day February 28th, 2015, video: https://t.co/09kdyl07rs","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"ZVALatvija","id":"1576993495"}],"urls":[{"start":84,"end":107,"url":"https://t.co/09kdyl07rs","expanded_url":"https://www.youtube.com/watch?v=zQIeiQ7S6tQ","display_url":"youtube.com/watch?v=zQIeiQ…"}],"hashtags":{},"annotations":[{"start":39,"end":54,"probability":0.8787,"type":"Other","normalized_text":"Rare Disease Day"}]},"id":"572349594144772096","created_at":"2015-03-02T10:55:51.000Z","conversation_id":"572349594144772096","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"572327536123879424"}],"author_id":"116716199","text":"RT @edqm_news: Looking for #Certification Policy documents and guidelines? Find them all on one page for improved accessibility http://t.co…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":27,"end":41,"tag":"Certification"}],"annotations":{}},"id":"572349309661925376","created_at":"2015-03-02T10:54:43.000Z","conversation_id":"572349309661925376","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"571979908345405441"}],"author_id":"116716199","text":"@trinevillemann Issues on nationally authorised medicines need to be referred to us by @EU_Commission / Member State: http://t.co/y7P9Z9yo4l","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"},{"start":87,"end":101,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":118,"end":140,"url":"http://t.co/y7P9Z9yo4l","expanded_url":"http://bit.ly/133cMvv","display_url":"bit.ly/133cMvv"}],"hashtags":{},"annotations":{}},"id":"572328267732160513","created_at":"2015-03-02T09:31:07.000Z","conversation_id":"571979908345405441","attachments":{"media_keys":{}},"in_reply_to_user_id":"17966242"},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to answer our call for scientific data to review the monograph on #Fragaria vesca L., folium: http://t.co/9XxIr3X8Oa #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/9XxIr3X8Oa","expanded_url":"http://bit.ly/1yRFCzv","display_url":"bit.ly/1yRFCzv"}],"hashtags":[{"start":76,"end":85,"tag":"Fragaria"},{"start":127,"end":140,"tag":"consultation"}],"annotations":{}},"id":"571357418380251136","created_at":"2015-02-27T17:13:18.000Z","conversation_id":"571357418380251136","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to comment on draft #herbal monograph on #Carum carvi L. aetheroleum: http://t.co/KafAw4xmgW #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/KafAw4xmgW","expanded_url":"http://bit.ly/1CAjNbo","display_url":"bit.ly/1CAjNbo"}],"hashtags":[{"start":30,"end":37,"tag":"herbal"},{"start":51,"end":57,"tag":"Carum"},{"start":103,"end":116,"tag":"consultation"}],"annotations":{}},"id":"571357381495537664","created_at":"2015-02-27T17:13:09.000Z","conversation_id":"571357381495537664","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to comment on draft #herbal monograph on #Carum carvi L., fructus: http://t.co/HsqgSkn4jK #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/HsqgSkn4jK","expanded_url":"http://bit.ly/1zeto42","display_url":"bit.ly/1zeto42"}],"hashtags":[{"start":30,"end":37,"tag":"herbal"},{"start":51,"end":57,"tag":"Carum"},{"start":100,"end":113,"tag":"consultation"}],"annotations":{}},"id":"571357348222140416","created_at":"2015-02-27T17:13:01.000Z","conversation_id":"571357348222140416","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to comment on draft #herbal monograph on #Serenoa repens (W. Bartram) Small, fructus: http://t.co/n2G6WKdLD5 #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/n2G6WKdLD5","expanded_url":"http://bit.ly/1LQk6nl","display_url":"bit.ly/1LQk6nl"}],"hashtags":[{"start":30,"end":37,"tag":"herbal"},{"start":51,"end":59,"tag":"Serenoa"},{"start":119,"end":132,"tag":"consultation"}],"annotations":{}},"id":"571357308401426432","created_at":"2015-02-27T17:12:52.000Z","conversation_id":"571357308401426432","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to answer our call for data to review monograph on #Centaurium erythraea Rafn., herba: http://t.co/D0xiiOsWWC #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/D0xiiOsWWC","expanded_url":"http://bit.ly/1w9nJiz","display_url":"bit.ly/1w9nJiz"}],"hashtags":[{"start":61,"end":72,"tag":"Centaurium"},{"start":120,"end":133,"tag":"consultation"}],"annotations":{}},"id":"571357245419732992","created_at":"2015-02-27T17:12:37.000Z","conversation_id":"571357245419732992","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to answer our call for data to review monograph on #Salvia officinalis L., folium: http://t.co/p30cmPPkZB #consultation #herbal","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/p30cmPPkZB","expanded_url":"http://bit.ly/13610b9","display_url":"bit.ly/13610b9"}],"hashtags":[{"start":61,"end":68,"tag":"Salvia"},{"start":116,"end":129,"tag":"consultation"},{"start":130,"end":137,"tag":"herbal"}],"annotations":{}},"id":"571357124267274241","created_at":"2015-02-27T17:12:08.000Z","conversation_id":"571357124267274241","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to answer our call for data to review monograph on #Althaea officinalis L., radix: http://t.co/QQaGNKdRBt #consultation #herbal","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/QQaGNKdRBt","expanded_url":"http://bit.ly/16nYoaU","display_url":"bit.ly/16nYoaU"}],"hashtags":[{"start":61,"end":69,"tag":"Althaea"},{"start":116,"end":129,"tag":"consultation"},{"start":130,"end":137,"tag":"herbal"}],"annotations":{}},"id":"571357029513756673","created_at":"2015-02-27T17:11:45.000Z","conversation_id":"571357029513756673","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"571292657827389441"}],"author_id":"116716199","text":"RT @ECDC_EU: New #bornavirus strain in EU, linked to encephalitis cases in variegated squirrel breeders, Germany. Risk assessment: http://t…","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":17,"end":28,"tag":"bornavirus"}],"annotations":[{"start":39,"end":40,"probability":0.7535,"type":"Place","normalized_text":"EU"},{"start":105,"end":111,"probability":0.9801,"type":"Place","normalized_text":"Germany"}]},"id":"571343120979378176","created_at":"2015-02-27T16:16:29.000Z","conversation_id":"571343120979378176","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"571293684483919872"}],"author_id":"116716199","text":"RT @EFSA_EU: #Vacancy – Head of Resources and Support Department. Only a few days left to apply (Deadline: 3 March) //bit.ly/1CuGK1f","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":13,"end":21,"tag":"Vacancy"}],"annotations":[{"start":24,"end":63,"probability":0.4197,"type":"Organization","normalized_text":"Head of Resources and Support Department"}]},"id":"571343098661474304","created_at":"2015-02-27T16:16:24.000Z","conversation_id":"571343098661474304","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"571300070320181248"}],"author_id":"116716199","text":"RT @edqm_news: During its 150th session, the #PhEur Commission appointed the Chair and members of a new Working Party http://t.co/i0ZZ866j4p","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":118,"end":140,"url":"http://t.co/i0ZZ866j4p","expanded_url":"http://bit.ly/1AN0RpP","display_url":"bit.ly/1AN0RpP"}],"hashtags":[{"start":45,"end":51,"tag":"PhEur"}],"annotations":{}},"id":"571343059683831808","created_at":"2015-02-27T16:16:15.000Z","conversation_id":"571343059683831808","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"571313246034108417"}],"author_id":"116716199","text":"RT @EU_Health: #EU Committee #SCENHIR final opinion on #safety of bisphenol A in medical devices #BPA  http://t.co/efZdU8lAA2 http://t.co/u…","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":103,"end":125,"url":"http://t.co/efZdU8lAA2","expanded_url":"http://europa.eu/!vh79qN","display_url":"europa.eu/!vh79qN"}],"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":29,"end":37,"tag":"SCENHIR"},{"start":55,"end":62,"tag":"safety"},{"start":97,"end":101,"tag":"BPA"}],"annotations":{}},"id":"571342411764502528","created_at":"2015-02-27T16:13:40.000Z","conversation_id":"571342411764502528","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"571316550784962560"}],"author_id":"116716199","text":"RT @rarediseaseday: Have plans for today? Why not watch the @NIH #RareDisease Day webcast: https://t.co/oU3my1hhHp","possibly_sensitive":false,"public_metrics":{"retweet_count":31,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"},{"start":60,"end":64,"username":"NIH","id":"15134240"}],"urls":[{"start":91,"end":114,"url":"https://t.co/oU3my1hhHp","expanded_url":"https://events-support.com/events/NIH_Rare_Disease_Day/page/692","display_url":"events-support.com/events/NIH_Rar…"}],"hashtags":[{"start":65,"end":77,"tag":"RareDisease"}],"annotations":{}},"id":"571342375500574720","created_at":"2015-02-27T16:13:32.000Z","conversation_id":"571342375500574720","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"571316592207896576"}],"author_id":"116716199","text":"RT @ECDC_Flu: #Flu continues to affect most European countries, at much higher levels compared to previous #influenza season. http://t.co/U…","possibly_sensitive":false,"public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":{},"hashtags":[{"start":14,"end":18,"tag":"Flu"},{"start":107,"end":117,"tag":"influenza"}],"annotations":{}},"id":"571342321972867072","created_at":"2015-02-27T16:13:19.000Z","conversation_id":"571342321972867072","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"571324237014827008"}],"author_id":"116716199","text":"RT @EU_Health: Next week in #Bruxelles: #EU Summit on #Innovation for Active &amp; Healthy #Ageing http://t.co/FfgeS9GlPc  #AgeingSummit http:/…","possibly_sensitive":false,"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":99,"end":121,"url":"http://t.co/FfgeS9GlPc","expanded_url":"http://europa.eu/!NB94rB","display_url":"europa.eu/!NB94rB"}],"hashtags":[{"start":28,"end":38,"tag":"Bruxelles"},{"start":40,"end":43,"tag":"EU"},{"start":54,"end":65,"tag":"Innovation"},{"start":91,"end":98,"tag":"Ageing"},{"start":123,"end":136,"tag":"AgeingSummit"}],"annotations":{}},"id":"571342237939965952","created_at":"2015-02-27T16:12:59.000Z","conversation_id":"571342237939965952","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"571335909175656450"}],"author_id":"116716199","text":"RT @Eurovaccine: With #animation and #infographic RT @ECDC_EU: #Measles is more contagious than you think: \nhttp://t.co/b0q4Mdupcw http://t…","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":53,"end":61,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":108,"end":130,"url":"http://t.co/b0q4Mdupcw","expanded_url":"http://bit.ly/1FEMAfH","display_url":"bit.ly/1FEMAfH"}],"hashtags":[{"start":22,"end":32,"tag":"animation"},{"start":37,"end":49,"tag":"infographic"},{"start":63,"end":71,"tag":"Measles"}],"annotations":{}},"id":"571342102149382144","created_at":"2015-02-27T16:12:26.000Z","conversation_id":"571342102149382144","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"571339761614528513"}],"author_id":"116716199","text":"RT @MHRAgovuk: Why is patient involvement important in #HumanFactors? @FionaCLoud from @The_BKPA speaks at MHRA #ThinkPatientSafety http://…","possibly_sensitive":false,"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"},{"start":70,"end":81,"username":"FionaCLoud","id":"51031420"}],"urls":{},"hashtags":[{"start":55,"end":68,"tag":"HumanFactors"}],"annotations":{}},"id":"571342017185366018","created_at":"2015-02-27T16:12:06.000Z","conversation_id":"571342017185366018","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"571340318978777088"}],"author_id":"116716199","text":"RT @IAPOtweets: #RareDisease Day is tomorrow! Rare disease patients should have access to the healthcare they need: http://t.co/B0opWZNE23","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":116,"end":138,"url":"http://t.co/B0opWZNE23","expanded_url":"http://bit.ly/1atJUIs","display_url":"bit.ly/1atJUIs"}],"hashtags":[{"start":16,"end":28,"tag":"RareDisease"}],"annotations":{}},"id":"571341985136676865","created_at":"2015-02-27T16:11:58.000Z","conversation_id":"571341985136676865","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"#Ambroxol and #bromhexine expectorants: safety information to be updated: http://t.co/sPGD4owb3S","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":74,"end":96,"url":"http://t.co/sPGD4owb3S","expanded_url":"http://bit.ly/1JUXiFq","display_url":"bit.ly/1JUXiFq"}],"hashtags":[{"start":0,"end":9,"tag":"Ambroxol"},{"start":14,"end":25,"tag":"bromhexine"}],"annotations":{}},"id":"571337946315546625","created_at":"2015-02-27T15:55:56.000Z","conversation_id":"571337946315546625","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"#Zykadia (#ceritinib) recommended for approval in advanced non small cell #lung #cancer: http://t.co/IqASMlmw94","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/IqASMlmw94","expanded_url":"http://bit.ly/1AhgTEC","display_url":"bit.ly/1AhgTEC"}],"hashtags":[{"start":0,"end":8,"tag":"Zykadia"},{"start":10,"end":20,"tag":"ceritinib"},{"start":74,"end":79,"tag":"lung"},{"start":80,"end":87,"tag":"cancer"}],"annotations":{}},"id":"571337741616750592","created_at":"2015-02-27T15:55:07.000Z","conversation_id":"571337741616750592","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"#Jinarc (#tolvaptan) recommended for approval in rare #kidney #disease: http://t.co/D7VYTu34tn","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":72,"end":94,"url":"http://t.co/D7VYTu34tn","expanded_url":"http://bit.ly/1AAQpTp","display_url":"bit.ly/1AAQpTp"}],"hashtags":[{"start":0,"end":7,"tag":"Jinarc"},{"start":9,"end":19,"tag":"tolvaptan"},{"start":54,"end":61,"tag":"kidney"},{"start":62,"end":70,"tag":"disease"}],"annotations":{}},"id":"571337538474012672","created_at":"2015-02-27T15:54:18.000Z","conversation_id":"571337538474012672","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the highlights of this week's meeting of our committee for human #medicines (CHMP): http://t.co/VYHSHGvlR8","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/VYHSHGvlR8","expanded_url":"http://bit.ly/1DZvc6O","display_url":"bit.ly/1DZvc6O"}],"hashtags":[{"start":81,"end":91,"tag":"medicines"}],"annotations":{}},"id":"571337260240670722","created_at":"2015-02-27T15:53:12.000Z","conversation_id":"571337260240670722","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We are adjusting our fees on 1 April; decrease of 0.1% expected: http://t.co/gFIOgCCMbr","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":65,"end":87,"url":"http://t.co/gFIOgCCMbr","expanded_url":"http://bit.ly/1BZOA4l","display_url":"bit.ly/1BZOA4l"}],"hashtags":{},"annotations":{}},"id":"571248620151955456","created_at":"2015-02-27T10:00:58.000Z","conversation_id":"571248620151955456","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We're supporting @rarediseaseday tomorrow: http://t.co/2Vl4AlKtzi #RareDiseaseDay2015","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":17,"end":32,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":43,"end":65,"url":"http://t.co/2Vl4AlKtzi","expanded_url":"http://bit.ly/1wjX13m","display_url":"bit.ly/1wjX13m"}],"hashtags":[{"start":66,"end":85,"tag":"RareDiseaseDay2015"}],"annotations":{}},"id":"571248548483891200","created_at":"2015-02-27T10:00:41.000Z","conversation_id":"571248548483891200","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to answer our call for data to review monograph on #Althaea officinalis L., radix: http://t.co/QQaGNKdRBt #consultation #herbal","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/QQaGNKdRBt","expanded_url":"http://bit.ly/16nYoaU","display_url":"bit.ly/16nYoaU"}],"hashtags":[{"start":61,"end":69,"tag":"Althaea"},{"start":116,"end":129,"tag":"consultation"},{"start":130,"end":137,"tag":"herbal"}],"annotations":{}},"id":"571248065442684928","created_at":"2015-02-27T09:58:46.000Z","conversation_id":"571248065442684928","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to answer our call for data to review the monograph on #Salvia officinalis L., folium: http://t.co/p30cmPPkZB #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/p30cmPPkZB","expanded_url":"http://bit.ly/13610b9","display_url":"bit.ly/13610b9"}],"hashtags":[{"start":65,"end":72,"tag":"Salvia"},{"start":120,"end":133,"tag":"consultation"}],"annotations":{}},"id":"571247574218383360","created_at":"2015-02-27T09:56:49.000Z","conversation_id":"571247574218383360","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to answer our call for data to review the monograph on #Centaurium erythraea Rafn., herba: http://t.co/D0xiiOsWWC #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/D0xiiOsWWC","expanded_url":"http://bit.ly/1w9nJiz","display_url":"bit.ly/1w9nJiz"}],"hashtags":[{"start":65,"end":76,"tag":"Centaurium"},{"start":124,"end":137,"tag":"consultation"}],"annotations":{}},"id":"571247228821618688","created_at":"2015-02-27T09:55:27.000Z","conversation_id":"571247228821618688","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to comment on draft #herbal monograph on #Serenoa repens (W. Bartram) Small, fructus: http://t.co/n2G6WKdLD5 #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/n2G6WKdLD5","expanded_url":"http://bit.ly/1LQk6nl","display_url":"bit.ly/1LQk6nl"}],"hashtags":[{"start":30,"end":37,"tag":"herbal"},{"start":51,"end":59,"tag":"Serenoa"},{"start":119,"end":132,"tag":"consultation"}],"annotations":{}},"id":"571246777854246912","created_at":"2015-02-27T09:53:39.000Z","conversation_id":"571246777854246912","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to comment on draft #herbal monograph on #Carum carvi L., fructus: http://t.co/HsqgSkn4jK #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/HsqgSkn4jK","expanded_url":"http://bit.ly/1zeto42","display_url":"bit.ly/1zeto42"}],"hashtags":[{"start":30,"end":37,"tag":"herbal"},{"start":51,"end":57,"tag":"Carum"},{"start":100,"end":113,"tag":"consultation"}],"annotations":{}},"id":"571246169961181184","created_at":"2015-02-27T09:51:14.000Z","conversation_id":"571246169961181184","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to comment on draft #herbal monograph on #Carum carvi L. aetheroleum: http://t.co/KafAw4xmgW #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/KafAw4xmgW","expanded_url":"http://bit.ly/1CAjNbo","display_url":"bit.ly/1CAjNbo"}],"hashtags":[{"start":30,"end":37,"tag":"herbal"},{"start":51,"end":57,"tag":"Carum"},{"start":103,"end":116,"tag":"consultation"}],"annotations":{}},"id":"571245938121035776","created_at":"2015-02-27T09:50:19.000Z","conversation_id":"571245938121035776","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Two weeks to answer our call for scientific data to review the monograph on #Fragaria vesca L., folium: http://t.co/9XxIr3X8Oa #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/9XxIr3X8Oa","expanded_url":"http://bit.ly/1yRFCzv","display_url":"bit.ly/1yRFCzv"}],"hashtags":[{"start":76,"end":85,"tag":"Fragaria"},{"start":127,"end":140,"tag":"consultation"}],"annotations":{}},"id":"571245504434216960","created_at":"2015-02-27T09:48:36.000Z","conversation_id":"571245504434216960","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"571006004046856192"}],"author_id":"116716199","text":"RT @GCessak: Access to safe and efficient medicinal products and medical devices as the major goal of just signed MoU between @COFEPRIS &amp; @…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":126,"end":135,"username":"COFEPRIS","id":"194641267"}],"urls":{},"hashtags":{},"annotations":{}},"id":"571006113136676864","created_at":"2015-02-26T17:57:20.000Z","conversation_id":"571006113136676864","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"571005568367722496"}],"author_id":"116716199","text":"RT @GCessak: Developing of the Polish-Mexican cooperation in field of medicinal product &amp; medical devices by @COFEPRIS @URPLWMiPB http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":113,"end":122,"username":"COFEPRIS","id":"194641267"},{"start":123,"end":133,"username":"URPLWMiPB","id":"556679074"}],"urls":{},"hashtags":{},"annotations":{}},"id":"571006100759302145","created_at":"2015-02-26T17:57:17.000Z","conversation_id":"571006100759302145","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570999239595196416"}],"author_id":"116716199","text":"RT @EFSA_EU: #Vacancy – EFSA is hiring: Head of Scientific Evaluation of Regulated Products Department. Apply by 2 March http://t.co/j7SLxn…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":13,"end":21,"tag":"Vacancy"}],"annotations":{}},"id":"571004071148195840","created_at":"2015-02-26T17:49:13.000Z","conversation_id":"571004071148195840","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570994761521360897"}],"author_id":"116716199","text":"RT @egabiosimilars: Identification IDMP standards should facilitate the assessment of safety data across classes of medicines and therapeut…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":{},"hashtags":{},"annotations":{}},"id":"570997013023748097","created_at":"2015-02-26T17:21:11.000Z","conversation_id":"570997013023748097","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570991713696808960"}],"author_id":"116716199","text":"RT @EFSA_EU: In today’s newsletter we cover #AntimicrobialResistance, #Pesticides and more. Subscribe now http://t.co/X3cnWNEqAH http://t.c…","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":106,"end":128,"url":"http://t.co/X3cnWNEqAH","expanded_url":"http://bit.ly/1gBYrmo","display_url":"bit.ly/1gBYrmo"}],"hashtags":[{"start":44,"end":68,"tag":"AntimicrobialResistance"},{"start":70,"end":81,"tag":"Pesticides"}],"annotations":{}},"id":"570992040516960257","created_at":"2015-02-26T17:01:25.000Z","conversation_id":"570992040516960257","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We will be adjusting our fees on 1 April; decrease of 0.1% expected: http://t.co/gFIOgCCMbr","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":69,"end":91,"url":"http://t.co/gFIOgCCMbr","expanded_url":"http://bit.ly/1BZOA4l","display_url":"bit.ly/1BZOA4l"}],"hashtags":{},"annotations":{}},"id":"570990997766873091","created_at":"2015-02-26T16:57:17.000Z","conversation_id":"570990997766873091","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570986472507101184"}],"author_id":"116716199","text":"RT @EUintheUS: #AntimicrobialResistance: @EU_Commission launches €1M prize &amp; publishes progress report http://t.co/fHcmLlUU6W http://t.co/5…","possibly_sensitive":false,"public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EUintheUS","id":"217616314"},{"start":41,"end":55,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":107,"end":129,"url":"http://t.co/fHcmLlUU6W","expanded_url":"http://www.euintheus.org/press-media/antimicrobial-resistance-commission-launches-a-e1-million-prize-and-publishes-a-progress-report-of-its-action-plan/","display_url":"euintheus.org/press-media/an…"}],"hashtags":[{"start":15,"end":39,"tag":"AntimicrobialResistance"}],"annotations":{}},"id":"570986614400417792","created_at":"2015-02-26T16:39:51.000Z","conversation_id":"570986614400417792","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We're supporting @rarediseaseday on Saturday: http://t.co/2Vl4AlKtzi #RareDiseaseDay2015","possibly_sensitive":false,"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":3,"quote_count":0},"entities":{"mentions":[{"start":17,"end":32,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":46,"end":68,"url":"http://t.co/2Vl4AlKtzi","expanded_url":"http://bit.ly/1wjX13m","display_url":"bit.ly/1wjX13m"}],"hashtags":[{"start":69,"end":88,"tag":"RareDiseaseDay2015"}],"annotations":{}},"id":"570984599913947136","created_at":"2015-02-26T16:31:51.000Z","conversation_id":"570984599913947136","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570983236698046464"}],"author_id":"116716199","text":"RT @PROTECT_BR: The materials presented at the Benefit-Risk Workshop of the PROTECT Symposium at the EMA are now available on http://t.co/h…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"PROTECT_BR","id":"2354960784"}],"urls":{},"hashtags":{},"annotations":[{"start":47,"end":92,"probability":0.3582,"type":"Other","normalized_text":"Benefit-Risk Workshop of the PROTECT Symposium"}]},"id":"570983390117273600","created_at":"2015-02-26T16:27:03.000Z","conversation_id":"570983390117273600","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570982892026904576"}],"author_id":"116716199","text":"RT @Food_EU: #AMR report data on zoonotic &amp; indicator bacteria from humans, animals, food @ECDC_EU @EFSA_EU http://t.co/oykioY9JzS http://t…","possibly_sensitive":false,"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"Food_EU","id":"2874880006"},{"start":94,"end":102,"username":"ECDC_EU","id":"204752573"},{"start":103,"end":111,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":112,"end":134,"url":"http://t.co/oykioY9JzS","expanded_url":"http://europa.eu/!dC78xw","display_url":"europa.eu/!dC78xw"}],"hashtags":[{"start":13,"end":17,"tag":"AMR"}],"annotations":{}},"id":"570983365387661312","created_at":"2015-02-26T16:26:57.000Z","conversation_id":"570983365387661312","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570981676207235072"}],"author_id":"116716199","text":"RT @DrugInfoAssn: Key hearing on #biosimilar copy of #Remsima for rheumatoid arthritis and Crohn's disease postponed by @US_FDA http://t.co…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":120,"end":127,"username":"US_FDA","id":"208120290"}],"urls":{},"hashtags":[{"start":33,"end":44,"tag":"biosimilar"},{"start":53,"end":61,"tag":"Remsima"}],"annotations":{}},"id":"570982763307929600","created_at":"2015-02-26T16:24:33.000Z","conversation_id":"570982763307929600","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570977313623572480"}],"author_id":"116716199","text":"RT @EFSA_EU: What is #AntimicrobialResistance? http://t.co/uFNNetV6ER http://t.co/AmjWZxqxr6","possibly_sensitive":false,"public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":47,"end":69,"url":"http://t.co/uFNNetV6ER","expanded_url":"http://bit.ly/17AY0pN","display_url":"bit.ly/17AY0pN"},{"start":70,"end":92,"url":"http://t.co/AmjWZxqxr6","expanded_url":"https://twitter.com/EFSA_EU/status/570977313623572480/photo/1","display_url":"pic.twitter.com/AmjWZxqxr6"}],"hashtags":[{"start":21,"end":45,"tag":"AntimicrobialResistance"}],"annotations":{}},"id":"570978004953919488","created_at":"2015-02-26T16:05:39.000Z","conversation_id":"570978004953919488","attachments":{"media_keys":["3_570977312054718465"]}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570977277959405568"}],"author_id":"116716199","text":"RT @FDA_Drug_Info: FDA approves new drug for complicated abdominal and urinary tract infections: http://t.co/bP4ZJRldsd http://t.co/Mb6QCYU…","possibly_sensitive":false,"public_metrics":{"retweet_count":50,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":97,"end":119,"url":"http://t.co/bP4ZJRldsd","expanded_url":"http://go.usa.gov/3cGwF","display_url":"go.usa.gov/3cGwF"}],"hashtags":{},"annotations":[{"start":19,"end":21,"probability":0.7531,"type":"Organization","normalized_text":"FDA"}]},"id":"570977985769148417","created_at":"2015-02-26T16:05:34.000Z","conversation_id":"570977985769148417","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570972855879380995"}],"author_id":"116716199","text":"RT @FDACBER: Today is the 18th U.S. - Japan Cellular &amp; Gene Therapy Conference. Watch the live webcast. http://t.co/ftMDIwunD3","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":108,"end":130,"url":"http://t.co/ftMDIwunD3","expanded_url":"http://go.usa.gov/3cG2V","display_url":"go.usa.gov/3cG2V"}],"hashtags":{},"annotations":[{"start":31,"end":34,"probability":0.8106,"type":"Place","normalized_text":"U.S."},{"start":38,"end":77,"probability":0.5256,"type":"Other","normalized_text":"Japan Cellular & Gene Therapy Conference"}]},"id":"570973093751095297","created_at":"2015-02-26T15:46:08.000Z","conversation_id":"570973093751095297","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570968173450792960"}],"author_id":"116716199","text":"RT @EU_Health: Progress report @EU_Commission 5 y. Action Plan on Antimicrobial Resistance #AMR published http://t.co/Sxu700IYSA http://t.c…","possibly_sensitive":false,"public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":31,"end":45,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":106,"end":128,"url":"http://t.co/Sxu700IYSA","expanded_url":"http://europa.eu/!np67qk","display_url":"europa.eu/!np67qk"}],"hashtags":[{"start":91,"end":95,"tag":"AMR"}],"annotations":{}},"id":"570971198533865472","created_at":"2015-02-26T15:38:36.000Z","conversation_id":"570971198533865472","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570966510061142016"}],"author_id":"116716199","text":"RT @egabiosimilars: #DidYouKnow that EU approved biosimilar medicines are marketed in over 60 countries? #biosimilars #medicines #pharma","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":{},"hashtags":[{"start":20,"end":31,"tag":"DidYouKnow"},{"start":105,"end":117,"tag":"biosimilars"},{"start":118,"end":128,"tag":"medicines"},{"start":129,"end":136,"tag":"pharma"}],"annotations":[{"start":37,"end":38,"probability":0.8142,"type":"Organization","normalized_text":"EU"}]},"id":"570971129046831105","created_at":"2015-02-26T15:38:19.000Z","conversation_id":"570971129046831105","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570964237553676288"}],"author_id":"116716199","text":"RT @FDAanimalhealth: #FDA Releases Biannual Progress Report on Judicious Use of Antimicrobials in Food-producing Animals http://t.co/dgHgHC…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":{},"hashtags":[{"start":21,"end":25,"tag":"FDA"}],"annotations":{}},"id":"570964395041419264","created_at":"2015-02-26T15:11:34.000Z","conversation_id":"570964395041419264","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570959007730561024"}],"author_id":"116716199","text":"RT @CPME_EUROPA: Prevention of #CommunicableDiseases through #Vaccination is safe and effective. http://t.co/Xfbd3bigX8","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":15,"username":"CPME_EUROPA","id":"440810430"}],"urls":[{"start":97,"end":119,"url":"http://t.co/Xfbd3bigX8","expanded_url":"http://bit.ly/181J8AF","display_url":"bit.ly/181J8AF"}],"hashtags":[{"start":31,"end":52,"tag":"CommunicableDiseases"},{"start":61,"end":73,"tag":"Vaccination"}],"annotations":{}},"id":"570959309334577152","created_at":"2015-02-26T14:51:21.000Z","conversation_id":"570959309334577152","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570958145813651456"}],"author_id":"116716199","text":"RT @Moedas: Launch of €1m prize for a diagnostic test to fight antibiotic resistance thanks to #H2020  #HorizonPrize","possibly_sensitive":false,"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"Moedas","id":"20058825"}],"urls":{},"hashtags":[{"start":95,"end":101,"tag":"H2020"},{"start":103,"end":116,"tag":"HorizonPrize"}],"annotations":{}},"id":"570958325896089601","created_at":"2015-02-26T14:47:27.000Z","conversation_id":"570958325896089601","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570956774020386817"}],"author_id":"116716199","text":"RT @WHO: Seasons where there is a significant reduction in seasonal #flu vax protection are relatively rare - only 4 seasons during the pas…","possibly_sensitive":false,"public_metrics":{"retweet_count":39,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":68,"end":72,"tag":"flu"}],"annotations":{}},"id":"570958175744217088","created_at":"2015-02-26T14:46:51.000Z","conversation_id":"570958175744217088","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570956176445341696"}],"author_id":"116716199","text":"RT @FDA_MCMi: Examples of medical countermeasure regulatory science research previously funded under the BAA: http://t.co/BmafZB7kD7","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":110,"end":132,"url":"http://t.co/BmafZB7kD7","expanded_url":"http://ht.ly/JGaoz","display_url":"ht.ly/JGaoz"}],"hashtags":{},"annotations":{}},"id":"570958134082203648","created_at":"2015-02-26T14:46:41.000Z","conversation_id":"570958134082203648","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570955929199505408"}],"author_id":"116716199","text":"RT @WHO: The change allowed most of the viruses circulating in the #flu season to elude protection provided by the flu #vaccine 2/2","possibly_sensitive":false,"public_metrics":{"retweet_count":50,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":67,"end":71,"tag":"flu"},{"start":119,"end":127,"tag":"vaccine"}],"annotations":{}},"id":"570958118928195585","created_at":"2015-02-26T14:46:38.000Z","conversation_id":"570958118928195585","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570955861205618689"}],"author_id":"116716199","text":"RT @FDA_MCMi: New FDA BAA (funding): Advanced Research and Development of Regulatory Science http://t.co/DifDdVBIUn","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":93,"end":115,"url":"http://t.co/DifDdVBIUn","expanded_url":"http://ht.ly/JGad5","display_url":"ht.ly/JGad5"}],"hashtags":{},"annotations":[{"start":18,"end":20,"probability":0.4663,"type":"Organization","normalized_text":"FDA"}]},"id":"570958106232012802","created_at":"2015-02-26T14:46:35.000Z","conversation_id":"570958106232012802","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570955749444214784"}],"author_id":"116716199","text":"RT @WHO: Since Feb 2014, the genetic composition of the #H3N2 virus - the predominant flu virus in N. America &amp; Europe - changed significan…","possibly_sensitive":false,"public_metrics":{"retweet_count":43,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":56,"end":61,"tag":"H3N2"}],"annotations":[{"start":99,"end":108,"probability":0.7533,"type":"Place","normalized_text":"N. America"},{"start":112,"end":117,"probability":0.7074,"type":"Place","normalized_text":"Europe"}]},"id":"570958006797668352","created_at":"2015-02-26T14:46:11.000Z","conversation_id":"570958006797668352","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570955747133140992"}],"author_id":"116716199","text":"RT @eupatientsforum: The February issue of our #Newsletter is out today! Read and subscribe to keep up to date with our news and events: ht…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"urls":{},"hashtags":[{"start":47,"end":58,"tag":"Newsletter"}],"annotations":{}},"id":"570957992461512704","created_at":"2015-02-26T14:46:07.000Z","conversation_id":"570957992461512704","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570955193174634496"}],"author_id":"116716199","text":"RT @EU_Health: €1M #HorizonPrize 4 rapid diagnostic test to combat #antibioticresistance #antibiotics #AMR http://t.co/BVFjWIeQp9 http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":107,"end":129,"url":"http://t.co/BVFjWIeQp9","expanded_url":"http://europa.eu/!Qq66xF","display_url":"europa.eu/!Qq66xF"}],"hashtags":[{"start":19,"end":32,"tag":"HorizonPrize"},{"start":67,"end":88,"tag":"antibioticresistance"},{"start":89,"end":101,"tag":"antibiotics"},{"start":102,"end":106,"tag":"AMR"}],"annotations":{}},"id":"570957899159232513","created_at":"2015-02-26T14:45:45.000Z","conversation_id":"570957899159232513","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570954282318598145"}],"author_id":"116716199","text":"RT @WHO: Deciding on #influenza #vaccines composition in Feb. gives manufacturers sufficient time to have doses of vax ready before the flu…","possibly_sensitive":false,"public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":21,"end":31,"tag":"influenza"},{"start":32,"end":41,"tag":"vaccines"}],"annotations":{}},"id":"570957862417137664","created_at":"2015-02-26T14:45:36.000Z","conversation_id":"570957862417137664","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570951963740909568"}],"author_id":"116716199","text":"RT @EU_H2020: Everything you need to know about the #HorizonPrize on #antibiotics in this infographic:\nhttp://t.co/gZ6iLFNeh3 http://t.co/s…","possibly_sensitive":false,"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"urls":[{"start":103,"end":125,"url":"http://t.co/gZ6iLFNeh3","expanded_url":"http://bit.ly/1FwI0jA","display_url":"bit.ly/1FwI0jA"}],"hashtags":[{"start":52,"end":65,"tag":"HorizonPrize"},{"start":69,"end":81,"tag":"antibiotics"}],"annotations":{}},"id":"570957674243870720","created_at":"2015-02-26T14:44:52.000Z","conversation_id":"570957674243870720","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570951963736719361"}],"author_id":"116716199","text":"RT @innovationunion: Everything you need to know about the #HorizonPrize on #antibiotics in this infographic:\nhttp://t.co/7N8wT8JOpf http:/…","possibly_sensitive":false,"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":110,"end":132,"url":"http://t.co/7N8wT8JOpf","expanded_url":"http://bit.ly/1FwI0jA","display_url":"bit.ly/1FwI0jA"}],"hashtags":[{"start":59,"end":72,"tag":"HorizonPrize"},{"start":76,"end":88,"tag":"antibiotics"}],"annotations":{}},"id":"570957661296066561","created_at":"2015-02-26T14:44:48.000Z","conversation_id":"570957661296066561","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570951888771923968"}],"author_id":"116716199","text":"RT @WHO: Experts convened by WHO decide on the composition of seasonal #influenza #vaccines for the northern hemisphere in February every y…","possibly_sensitive":false,"public_metrics":{"retweet_count":38,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":71,"end":81,"tag":"influenza"},{"start":82,"end":91,"tag":"vaccines"}],"annotations":{}},"id":"570957645475160064","created_at":"2015-02-26T14:44:45.000Z","conversation_id":"570957645475160064","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570951443710119936"}],"author_id":"116716199","text":"RT @rarediseaseday: The theme of #RareDisease Day 2015 is Day by Day, Hand in Hand \n http://t.co/kBrb2ssIE5 What does that mean to you?","possibly_sensitive":false,"public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":85,"end":107,"url":"http://t.co/kBrb2ssIE5","expanded_url":"http://ow.ly/JG3Ym","display_url":"ow.ly/JG3Ym"}],"hashtags":[{"start":33,"end":45,"tag":"RareDisease"}],"annotations":{}},"id":"570957611643895808","created_at":"2015-02-26T14:44:37.000Z","conversation_id":"570957611643895808","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570949119960866816"}],"author_id":"116716199","text":"RT @WHO: Recommended composition of #influenza vaccines for use in the 2015-2016 northern hemisphere influenza season http://t.co/kKOWeilHtD","possibly_sensitive":false,"public_metrics":{"retweet_count":276,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":118,"end":140,"url":"http://t.co/kKOWeilHtD","expanded_url":"https://twitter.com/WHO/status/570949119960866816/photo/1","display_url":"pic.twitter.com/kKOWeilHtD"}],"hashtags":[{"start":36,"end":46,"tag":"influenza"}],"annotations":{}},"id":"570949414837194752","created_at":"2015-02-26T14:12:02.000Z","conversation_id":"570949414837194752","attachments":{"media_keys":["3_570949117960163329"]}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570947704576200704"}],"author_id":"116716199","text":"RT @EU_ECHA: Register for @EU_ECHA 10th Stakeholders' Day by 1 May #Sday10 http://t.co/LMGPcyqVyI","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"},{"start":26,"end":34,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":75,"end":97,"url":"http://t.co/LMGPcyqVyI","expanded_url":"http://bit.ly/1BV39U0","display_url":"bit.ly/1BV39U0"}],"hashtags":[{"start":67,"end":74,"tag":"Sday10"}],"annotations":{}},"id":"570948499250008064","created_at":"2015-02-26T14:08:24.000Z","conversation_id":"570948499250008064","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570941895737790464"}],"author_id":"116716199","text":"RT @edqm_news: Did you know? The #European #Pharmacopoeia Commission has just adopted a new strategy: http://t.co/i0ZZ866j4p","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":102,"end":124,"url":"http://t.co/i0ZZ866j4p","expanded_url":"http://bit.ly/1AN0RpP","display_url":"bit.ly/1AN0RpP"}],"hashtags":[{"start":33,"end":42,"tag":"European"},{"start":43,"end":57,"tag":"Pharmacopoeia"}],"annotations":{}},"id":"570942164231979008","created_at":"2015-02-26T13:43:14.000Z","conversation_id":"570942164231979008","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570941339233349632"}],"author_id":"116716199","text":"RT @euparkinsons: Personalised #medicine, #diagnostics &amp; the great ‘value’ #debate: http://t.co/g50xgoRZZR","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":88,"end":110,"url":"http://t.co/g50xgoRZZR","expanded_url":"http://bit.ly/1BzUZni","display_url":"bit.ly/1BzUZni"}],"hashtags":[{"start":31,"end":40,"tag":"medicine"},{"start":42,"end":54,"tag":"diagnostics"},{"start":79,"end":86,"tag":"debate"}],"annotations":{}},"id":"570942115288645632","created_at":"2015-02-26T13:43:02.000Z","conversation_id":"570942115288645632","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570939197118398465"}],"author_id":"116716199","text":"RT @EFSA_EU: How #EFSA and @ECDC_EU fight  #AntimicrobialResistance : #infographic http://t.co/uFNNetV6ER http://t.co/miXVXc2Nol","possibly_sensitive":false,"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":27,"end":35,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":83,"end":105,"url":"http://t.co/uFNNetV6ER","expanded_url":"http://bit.ly/17AY0pN","display_url":"bit.ly/17AY0pN"},{"start":106,"end":128,"url":"http://t.co/miXVXc2Nol","expanded_url":"https://twitter.com/EFSA_EU/status/570939197118398465/photo/1","display_url":"pic.twitter.com/miXVXc2Nol"}],"hashtags":[{"start":17,"end":22,"tag":"EFSA"},{"start":43,"end":67,"tag":"AntimicrobialResistance"},{"start":70,"end":82,"tag":"infographic"}],"annotations":{}},"id":"570941853069148160","created_at":"2015-02-26T13:42:00.000Z","conversation_id":"570941853069148160","attachments":{"media_keys":["3_570939195515998208"]}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570938942180040708"}],"author_id":"116716199","text":"RT @ECDC_EU: Treatment options for #Campylobacter infections are decreasing says new report by ECDC and @EFSA_EU http://t.co/FhihOJGh4V","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":104,"end":112,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":113,"end":135,"url":"http://t.co/FhihOJGh4V","expanded_url":"http://bit.ly/180Q1Ch","display_url":"bit.ly/180Q1Ch"}],"hashtags":[{"start":35,"end":49,"tag":"Campylobacter"}],"annotations":{}},"id":"570941777286455296","created_at":"2015-02-26T13:41:41.000Z","conversation_id":"570941777286455296","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570931407465291777"}],"author_id":"116716199","text":"RT @EAAD_EU: #Salmonella and #Campylobacter show significant levels of resistance to common #antimicrobials http://t.co/USVwhBhWEJ","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":[{"start":108,"end":130,"url":"http://t.co/USVwhBhWEJ","expanded_url":"http://bit.ly/1vBlPc0","display_url":"bit.ly/1vBlPc0"}],"hashtags":[{"start":13,"end":24,"tag":"Salmonella"},{"start":29,"end":43,"tag":"Campylobacter"},{"start":92,"end":107,"tag":"antimicrobials"}],"annotations":{}},"id":"570941385727197184","created_at":"2015-02-26T13:40:08.000Z","conversation_id":"570941385727197184","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"570940501056217089"}],"author_id":"116716199","text":"@itsmepanda1 @WHO Please forward your question to us at http://t.co/rMxJXL615X so that we can reply directly and in full.","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":12,"username":"itsmePanda1","id":"1312511150437924869"},{"start":13,"end":17,"username":"WHO","id":"14499829"}],"urls":[{"start":56,"end":78,"url":"http://t.co/rMxJXL615X","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"annotations":{}},"id":"570941249072599041","created_at":"2015-02-26T13:39:36.000Z","conversation_id":"570869018598510592","attachments":{"media_keys":{}},"in_reply_to_user_id":"232934834"},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570926598649741312"}],"author_id":"116716199","text":"RT @eurireland: #EU launches €1m prize for diagnostic test to combat #antibioticresistance. Details at: http://t.co/86iD4RnqDb #h2020 http:…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"eurireland","id":"44890795"}],"urls":[{"start":104,"end":126,"url":"http://t.co/86iD4RnqDb","expanded_url":"http://bit.ly/1vBH1i4","display_url":"bit.ly/1vBH1i4"}],"hashtags":[{"start":16,"end":19,"tag":"EU"},{"start":69,"end":90,"tag":"antibioticresistance"},{"start":127,"end":133,"tag":"h2020"}],"annotations":{}},"id":"570940403664486401","created_at":"2015-02-26T13:36:14.000Z","conversation_id":"570940403664486401","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570922949512962050"}],"author_id":"116716199","text":"RT @myESMO: New drugs to tackle cancer cell weak spots could end 'scattergun' chemotherapy | via @Telegraph  http://t.co/dm8lF4dNDz","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":97,"end":107,"username":"Telegraph","id":"16343974"}],"urls":[{"start":109,"end":131,"url":"http://t.co/dm8lF4dNDz","expanded_url":"http://ow.ly/JFRVg","display_url":"ow.ly/JFRVg"}],"hashtags":{},"annotations":{}},"id":"570939979762962432","created_at":"2015-02-26T13:34:33.000Z","conversation_id":"570939979762962432","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570920014322270208"}],"author_id":"116716199","text":"RT @NICESciAdvice: Don't forget the @EMA_News / @NICESciAdvice / HTA parallel advice procedure !! https://t.co/5jRcu8tZp0","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"NICESciAdvice","id":"2834291205"},{"start":36,"end":45,"username":"EMA_News","id":"116716199"},{"start":48,"end":62,"username":"NICESciAdvice","id":"2834291205"}],"urls":[{"start":98,"end":121,"url":"https://t.co/5jRcu8tZp0","expanded_url":"https://www.nice.org.uk/about/what-we-do/scientific-advice","display_url":"nice.org.uk/about/what-we-…"}],"hashtags":{},"annotations":{}},"id":"570939589327773696","created_at":"2015-02-26T13:33:00.000Z","conversation_id":"570939589327773696","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570919166787657728"}],"author_id":"116716199","text":"RT @NICESciAdvice: Applications for centralised proc. to @EMA_News will need to be submitted using electronic forms from July this year htt…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"NICESciAdvice","id":"2834291205"},{"start":57,"end":66,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{}},"id":"570939529483427840","created_at":"2015-02-26T13:32:46.000Z","conversation_id":"570939529483427840","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570916316543983616"}],"author_id":"116716199","text":"RT @EU_H2020: Compete, innovate &amp; win €1m! #HorizonPrize #antibiotics \nhttp://t.co/gZ6iLFvCSt\nhttp://t.co/kQFiyayCD3 http://t.co/Wppyy6Q3OO","possibly_sensitive":false,"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"urls":[{"start":75,"end":97,"url":"http://t.co/gZ6iLFvCSt","expanded_url":"http://bit.ly/1FwI0jA","display_url":"bit.ly/1FwI0jA"},{"start":98,"end":120,"url":"http://t.co/kQFiyayCD3","expanded_url":"http://bit.ly/1zh7j4E","display_url":"bit.ly/1zh7j4E"},{"start":121,"end":143,"url":"http://t.co/Wppyy6Q3OO","expanded_url":"https://twitter.com/EU_H2020/status/570916316543983616/photo/1","display_url":"pic.twitter.com/Wppyy6Q3OO"}],"hashtags":[{"start":47,"end":60,"tag":"HorizonPrize"},{"start":61,"end":73,"tag":"antibiotics"}],"annotations":{}},"id":"570939437212942336","created_at":"2015-02-26T13:32:24.000Z","conversation_id":"570939437212942336","attachments":{"media_keys":["3_570912028489068544"]}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570916300244983808"}],"author_id":"116716199","text":"RT @innovationunion: Compete, innovate &amp; win €1m! #HorizonPrize #antibiotics \nhttp://t.co/7N8wT91pgN\nhttp://t.co/Pc8GE6eqc5 http://t.co/gOX…","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":82,"end":104,"url":"http://t.co/7N8wT91pgN","expanded_url":"http://bit.ly/1FwI0jA","display_url":"bit.ly/1FwI0jA"},{"start":105,"end":127,"url":"http://t.co/Pc8GE6eqc5","expanded_url":"http://bit.ly/1zh7j4E","display_url":"bit.ly/1zh7j4E"}],"hashtags":[{"start":54,"end":67,"tag":"HorizonPrize"},{"start":68,"end":80,"tag":"antibiotics"}],"annotations":{}},"id":"570939424554524672","created_at":"2015-02-26T13:32:21.000Z","conversation_id":"570939424554524672","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570909146318557185"}],"author_id":"116716199","text":"RT @EFSA_EU: #EFSA  @ECDC_EU : #Salmonella and #Campylobacter show resistance to antimicrobial drugs  #AMR http://t.co/3sUX5MoFs0 http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":20,"end":28,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":107,"end":129,"url":"http://t.co/3sUX5MoFs0","expanded_url":"http://bit.ly/1Arwoig","display_url":"bit.ly/1Arwoig"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":31,"end":42,"tag":"Salmonella"},{"start":47,"end":61,"tag":"Campylobacter"},{"start":102,"end":106,"tag":"AMR"}],"annotations":{}},"id":"570938927177199616","created_at":"2015-02-26T13:30:22.000Z","conversation_id":"570938927177199616","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570908736593797120"}],"author_id":"116716199","text":"RT @EUlondonrep: Learn about the #EU's #EbolaResponse here: http://t.co/9jOi2HCQ7K which will be continued with #Ebola Conference in Brusse…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":60,"end":82,"url":"http://t.co/9jOi2HCQ7K","expanded_url":"http://bit.ly/1E7nTIx","display_url":"bit.ly/1E7nTIx"}],"hashtags":[{"start":33,"end":36,"tag":"EU"},{"start":39,"end":53,"tag":"EbolaResponse"},{"start":112,"end":118,"tag":"Ebola"}],"annotations":{}},"id":"570938885519360000","created_at":"2015-02-26T13:30:12.000Z","conversation_id":"570938885519360000","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570908040628727808"}],"author_id":"116716199","text":"RT @WHO: The #measles vaccine has been in use for 50 years. It is safe, effective and inexpensive http://t.co/DhVZkECqcq #vaccineswork","possibly_sensitive":false,"public_metrics":{"retweet_count":141,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":98,"end":120,"url":"http://t.co/DhVZkECqcq","expanded_url":"http://goo.gl/lO8Utq","display_url":"goo.gl/lO8Utq"}],"hashtags":[{"start":13,"end":21,"tag":"measles"},{"start":121,"end":134,"tag":"vaccineswork"}],"annotations":{}},"id":"570938698491154432","created_at":"2015-02-26T13:29:27.000Z","conversation_id":"570938698491154432","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570906187266461696"}],"author_id":"116716199","text":"RT @EC_AVService: #EC launches €1M #HorizonPrize for a diagnostic test to combat #antibioticresistance\nInfo: http://t.co/jyki8Sw59L http://…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"EC_AVService","id":"56392389"}],"urls":[{"start":109,"end":131,"url":"http://t.co/jyki8Sw59L","expanded_url":"http://europa.eu/!Qq66xF","display_url":"europa.eu/!Qq66xF"}],"hashtags":[{"start":18,"end":21,"tag":"EC"},{"start":35,"end":48,"tag":"HorizonPrize"},{"start":81,"end":102,"tag":"antibioticresistance"}],"annotations":{}},"id":"570938543197061120","created_at":"2015-02-26T13:28:50.000Z","conversation_id":"570938543197061120","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570902401202262016"}],"author_id":"116716199","text":"RT @EAAD_EU: Treatment options for #Campylobacter infections are decreasing says new report by ECDC and @EFSA_EU http://t.co/55PFRJkgDY","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"},{"start":104,"end":112,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":113,"end":135,"url":"http://t.co/55PFRJkgDY","expanded_url":"http://bit.ly/180Q1Ch","display_url":"bit.ly/180Q1Ch"}],"hashtags":[{"start":35,"end":49,"tag":"Campylobacter"}],"annotations":{}},"id":"570938355590021120","created_at":"2015-02-26T13:28:06.000Z","conversation_id":"570938355590021120","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570901123776716802"}],"author_id":"116716199","text":"RT @egagenerics: #Genericmedicines are subject to Good Manufacturing Practice (GMP) inspections http://t.co/RGObhUdg9o #EGAgenerics","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":96,"end":118,"url":"http://t.co/RGObhUdg9o","expanded_url":"http://bit.ly/1yM6AcQ","display_url":"bit.ly/1yM6AcQ"}],"hashtags":[{"start":17,"end":34,"tag":"Genericmedicines"},{"start":119,"end":131,"tag":"EGAgenerics"}],"annotations":{}},"id":"570938307850473473","created_at":"2015-02-26T13:27:54.000Z","conversation_id":"570938307850473473","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570900878325997568"}],"author_id":"116716199","text":"RT @EU_H2020: Launched! €1m #HorizonPrize for the better use of antibiotics. Are you up for the challenge? http://t.co/kQFiyayCD3 http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"urls":[{"start":107,"end":129,"url":"http://t.co/kQFiyayCD3","expanded_url":"http://bit.ly/1zh7j4E","display_url":"bit.ly/1zh7j4E"}],"hashtags":[{"start":28,"end":41,"tag":"HorizonPrize"}],"annotations":{}},"id":"570938235691651072","created_at":"2015-02-26T13:27:37.000Z","conversation_id":"570938235691651072","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570900857467719680"}],"author_id":"116716199","text":"RT @innovationunion: Launched! €1m #HorizonPrize for the better use of antibiotics. Are you up for the challenge? http://t.co/Pc8GE6eqc5 ht…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":114,"end":136,"url":"http://t.co/Pc8GE6eqc5","expanded_url":"http://bit.ly/1zh7j4E","display_url":"bit.ly/1zh7j4E"}],"hashtags":[{"start":35,"end":48,"tag":"HorizonPrize"}],"annotations":{}},"id":"570938223293296640","created_at":"2015-02-26T13:27:34.000Z","conversation_id":"570938223293296640","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570899124553457664"}],"author_id":"116716199","text":"RT @WHO: WHO recommends two doses of the #measles vaccine to ensure immunity and prevent outbreaks http://t.co/DhVZkECqcq #vaccineswork","possibly_sensitive":false,"public_metrics":{"retweet_count":109,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":99,"end":121,"url":"http://t.co/DhVZkECqcq","expanded_url":"http://goo.gl/lO8Utq","display_url":"goo.gl/lO8Utq"}],"hashtags":[{"start":41,"end":49,"tag":"measles"},{"start":122,"end":135,"tag":"vaccineswork"}],"annotations":{}},"id":"570900569881231360","created_at":"2015-02-26T10:57:57.000Z","conversation_id":"570900569881231360","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570897554872922113"}],"author_id":"116716199","text":"RT @WHO: #Measles vaccine is equally effective in the single or combined form (with rubella and/or mumps vax) http://t.co/DhVZkECqcq #vacci…","possibly_sensitive":false,"public_metrics":{"retweet_count":61,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":110,"end":132,"url":"http://t.co/DhVZkECqcq","expanded_url":"http://goo.gl/lO8Utq","display_url":"goo.gl/lO8Utq"}],"hashtags":[{"start":9,"end":17,"tag":"Measles"}],"annotations":{}},"id":"570897979147726849","created_at":"2015-02-26T10:47:39.000Z","conversation_id":"570897979147726849","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570895102429794305"}],"author_id":"116716199","text":"RT @edqm_news: Following creation of new state Telangana, #EDQM reminds holders of #CEP and applicants to update their applications http://…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":58,"end":63,"tag":"EDQM"},{"start":83,"end":87,"tag":"CEP"}],"annotations":[{"start":47,"end":55,"probability":0.4892,"type":"Place","normalized_text":"Telangana"}]},"id":"570897366687096832","created_at":"2015-02-26T10:45:13.000Z","conversation_id":"570897366687096832","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570892805406642177"}],"author_id":"116716199","text":"RT @ECDC_EU: Multi-drug resistance in #Salmonella still high in humans but co-resistance to important #antimicrobials remains low http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":38,"end":49,"tag":"Salmonella"},{"start":102,"end":117,"tag":"antimicrobials"}],"annotations":{}},"id":"570897052353355777","created_at":"2015-02-26T10:43:58.000Z","conversation_id":"570897052353355777","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570889865472155652"}],"author_id":"116716199","text":"RT @WHO: #Measles vaccine is often incorporated w/ rubella and/or mumps vax in countries where these illnesses are problems http://t.co/DhV…","possibly_sensitive":false,"public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":9,"end":17,"tag":"Measles"}],"annotations":{}},"id":"570896754008334336","created_at":"2015-02-26T10:42:47.000Z","conversation_id":"570896754008334336","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"570892780324712448"}],"author_id":"116716199","text":"@wigmore_welsh @EU_Health They're for medicines. See more information on our website here: http://t.co/Z7GrvcfhaG","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":14,"username":"wigmore_welsh","id":"32528318"},{"start":15,"end":25,"username":"EU_Health","id":"606325697"}],"urls":[{"start":91,"end":113,"url":"http://t.co/Z7GrvcfhaG","expanded_url":"http://bit.ly/XSfuFS","display_url":"bit.ly/XSfuFS"}],"hashtags":{},"annotations":{}},"id":"570893062563602432","created_at":"2015-02-26T10:28:07.000Z","conversation_id":"570888982256586752","attachments":{"media_keys":{}},"in_reply_to_user_id":"32528318"},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"570892330074578944"}],"author_id":"116716199","text":"@wigmore_welsh @EU_Health You can read more about what marketing authorisations are here: http://t.co/Z7GrvcfhaG","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":14,"username":"wigmore_welsh","id":"32528318"},{"start":15,"end":25,"username":"EU_Health","id":"606325697"}],"urls":[{"start":90,"end":112,"url":"http://t.co/Z7GrvcfhaG","expanded_url":"http://bit.ly/XSfuFS","display_url":"bit.ly/XSfuFS"}],"hashtags":{},"annotations":{}},"id":"570892618986610688","created_at":"2015-02-26T10:26:21.000Z","conversation_id":"570888982256586752","attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"570892179603906560"}],"author_id":"116716199","text":"@wigmore_welsh @EU_Health But from July they will have to use an online electronic application form instead.","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":14,"username":"wigmore_welsh","id":"32528318"},{"start":15,"end":25,"username":"EU_Health","id":"606325697"}],"urls":{},"hashtags":{},"annotations":{}},"id":"570892330074578944","created_at":"2015-02-26T10:25:12.000Z","conversation_id":"570888982256586752","attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"570890997766467585"}],"author_id":"116716199","text":"@wigmore_welsh @EU_Health Currently companies applying to us for marketing authorisations can use a form in Word...","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":14,"username":"wigmore_welsh","id":"32528318"},{"start":15,"end":25,"username":"EU_Health","id":"606325697"}],"urls":{},"hashtags":{},"annotations":{}},"id":"570892179603906560","created_at":"2015-02-26T10:24:36.000Z","conversation_id":"570888982256586752","attachments":{"media_keys":{}},"in_reply_to_user_id":"32528318"},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Applications for centralised procedures will need to be submitted using our electronic forms from July this year: http://t.co/8oELC4i9lk","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/8oELC4i9lk","expanded_url":"http://bit.ly/1wopBGA","display_url":"bit.ly/1wopBGA"}],"hashtags":{},"annotations":{}},"id":"570888982256586752","created_at":"2015-02-26T10:11:54.000Z","conversation_id":"570888982256586752","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570886942923083776"}],"author_id":"116716199","text":"RT @ECDC_EU: New ECDC and @EFSA_EU report on #antimicrobial resistance in zoonotic bacteria from humans, animals and food http://t.co/4mcYT…","possibly_sensitive":false,"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":26,"end":34,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":45,"end":59,"tag":"antimicrobial"}],"annotations":{}},"id":"570887752859983872","created_at":"2015-02-26T10:07:01.000Z","conversation_id":"570887752859983872","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570885283891318784"}],"author_id":"116716199","text":"RT @WHO: WHO strongly recommends 95% or greater national vaccination coverage against #measles http://t.co/DhVZkECqcq #vaccineswork","possibly_sensitive":false,"public_metrics":{"retweet_count":95,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":95,"end":117,"url":"http://t.co/DhVZkECqcq","expanded_url":"http://goo.gl/lO8Utq","display_url":"goo.gl/lO8Utq"}],"hashtags":[{"start":86,"end":94,"tag":"measles"},{"start":118,"end":131,"tag":"vaccineswork"}],"annotations":{}},"id":"570887560463065088","created_at":"2015-02-26T10:06:15.000Z","conversation_id":"570887560463065088","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570878640201838592"}],"author_id":"116716199","text":"RT @rarediseaseday: 2 days to go until #RareDisease Day 2015! Still time to organise your awareness-raising activity: http://t.co/Ssr9bLqNl6","possibly_sensitive":false,"public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":118,"end":140,"url":"http://t.co/Ssr9bLqNl6","expanded_url":"http://www.rarediseaseday.org/send-us-your-event","display_url":"rarediseaseday.org/send-us-your-e…"}],"hashtags":[{"start":39,"end":51,"tag":"RareDisease"}],"annotations":{}},"id":"570887207050981376","created_at":"2015-02-26T10:04:51.000Z","conversation_id":"570887207050981376","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570876517686874112"}],"author_id":"116716199","text":"RT @WHO: #Measles outbreaks continue to occur in #Europe because of pockets of un- or underimmunized people http://t.co/U7ssfrHiR8","possibly_sensitive":false,"public_metrics":{"retweet_count":100,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":108,"end":130,"url":"http://t.co/U7ssfrHiR8","expanded_url":"http://goo.gl/CkMzKk","display_url":"goo.gl/CkMzKk"}],"hashtags":[{"start":9,"end":17,"tag":"Measles"},{"start":49,"end":56,"tag":"Europe"}],"annotations":{}},"id":"570887107507593216","created_at":"2015-02-26T10:04:27.000Z","conversation_id":"570887107507593216","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @Aifa_ufficiale: ICYMI @luca__pani: new ways for Italian reports of suspected adverse reactions http://t.co/WppOy1kRj2 #pharmacovigilance","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"},{"start":26,"end":37,"username":"luca__pani","id":"2176193576"}],"urls":[{"start":99,"end":121,"url":"http://t.co/WppOy1kRj2","expanded_url":"http://bit.ly/1FwmmvQ","display_url":"bit.ly/1FwmmvQ"}],"hashtags":[{"start":122,"end":140,"tag":"pharmacovigilance"}],"annotations":{}},"id":"570886222161297408","created_at":"2015-02-26T10:00:56.000Z","conversation_id":"570886222161297408","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @luca__pani: In case you missed it: new ways for Italian reports of suspected adverse reactions http://t.co/hltjcDVv5a #pharmacovigilance","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"urls":[{"start":99,"end":121,"url":"http://t.co/hltjcDVv5a","expanded_url":"http://bit.ly/1FwlOpV","display_url":"bit.ly/1FwlOpV"}],"hashtags":[{"start":122,"end":140,"tag":"pharmacovigilance"}],"annotations":{}},"id":"570885609218297856","created_at":"2015-02-26T09:58:30.000Z","conversation_id":"570885609218297856","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @Legemiddelinfo: It has not been shown that testosterone treatment provides an increased risk of heart attack: http://t.co/31TyVFgQGM","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":[{"start":114,"end":136,"url":"http://t.co/31TyVFgQGM","expanded_url":"http://bit.ly/1Fwl449","display_url":"bit.ly/1Fwl449"}],"hashtags":{},"annotations":{}},"id":"570884731732148224","created_at":"2015-02-26T09:55:01.000Z","conversation_id":"570884731732148224","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570625555852353536"}],"author_id":"116716199","text":"RT @EU_Health: Health Technology Assessment Network - 4th meeting in Brussels, 23/03/15 -- agenda http://t.co/CZmbVpp6zT #HTA http://t.co/Q…","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":98,"end":120,"url":"http://t.co/CZmbVpp6zT","expanded_url":"http://europa.eu/!gk38fh","display_url":"europa.eu/!gk38fh"}],"hashtags":[{"start":121,"end":125,"tag":"HTA"}],"annotations":[{"start":69,"end":76,"probability":0.99,"type":"Place","normalized_text":"Brussels"}]},"id":"570655901000077312","created_at":"2015-02-25T18:45:43.000Z","conversation_id":"570655901000077312","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570628902730600449"}],"author_id":"116716199","text":"RT @EATGx: Presenting the new and improved http://t.co/26vKprXyGQ – your source for TB news!: We are pleased to announce t... http://t.co/5…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":9,"username":"EATGx","id":"273916420"}],"urls":[{"start":43,"end":65,"url":"http://t.co/26vKprXyGQ","expanded_url":"http://TBOnline.info","display_url":"TBOnline.info"}],"hashtags":{},"annotations":{}},"id":"570655851003944960","created_at":"2015-02-25T18:45:31.000Z","conversation_id":"570655851003944960","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570629818850676736"}],"author_id":"116716199","text":"RT @EFSAJournal: #Glycaemic carbohydrates and contribution to normal #cognitive function http://t.co/MAMjEcLOlY","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"urls":[{"start":89,"end":111,"url":"http://t.co/MAMjEcLOlY","expanded_url":"http://www.efsa.europa.eu/en/efsajournal/pub/4027.htm","display_url":"efsa.europa.eu/en/efsajournal…"}],"hashtags":[{"start":17,"end":27,"tag":"Glycaemic"},{"start":69,"end":79,"tag":"cognitive"}],"annotations":{}},"id":"570655801720897539","created_at":"2015-02-25T18:45:20.000Z","conversation_id":"570655801720897539","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570632711334985728"}],"author_id":"116716199","text":"RT @ECDC_TB: ECDC will continue to support Romania with implementation of new national TB strategic plan: http://t.co/kmmQnYioSq (ro)","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"urls":[{"start":106,"end":128,"url":"http://t.co/kmmQnYioSq","expanded_url":"http://bit.ly/17yEDO4","display_url":"bit.ly/17yEDO4"}],"hashtags":{},"annotations":[{"start":43,"end":49,"probability":0.9765,"type":"Place","normalized_text":"Romania"}]},"id":"570655768007069697","created_at":"2015-02-25T18:45:12.000Z","conversation_id":"570655768007069697","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570633920385032193"}],"author_id":"116716199","text":"RT @ECDC_HIVAIDS: Encouraging results on #PrEP at #CROI2015: ECDC will assess how they can advance Europe’s #HIV prevention strategies http…","possibly_sensitive":false,"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"ECDC_HIVAIDS","id":"2182569746"}],"urls":{},"hashtags":[{"start":41,"end":46,"tag":"PrEP"},{"start":50,"end":59,"tag":"CROI2015"},{"start":108,"end":112,"tag":"HIV"}],"annotations":[{"start":99,"end":104,"probability":0.9669,"type":"Place","normalized_text":"Europe"}]},"id":"570655744523145217","created_at":"2015-02-25T18:45:06.000Z","conversation_id":"570655744523145217","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570636756288057344"}],"author_id":"116716199","text":"RT @IAPOtweets: IAPO members - the deadline for nominations to join the IAPO Governing Board is this Friday. Contact us for more: http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":{},"hashtags":{},"annotations":[{"start":72,"end":91,"probability":0.6647,"type":"Organization","normalized_text":"IAPO Governing Board"}]},"id":"570655721760681984","created_at":"2015-02-25T18:45:00.000Z","conversation_id":"570655721760681984","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570640630172532736"}],"author_id":"116716199","text":"RT @Eu2P: Conference on the Safety Paradigm for Medicines – Changes and Challenges from Drug Discovery to Usage http://t.co/PVUvlD5OVI via …","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"}],"urls":[{"start":112,"end":134,"url":"http://t.co/PVUvlD5OVI","expanded_url":"http://www.eufeps.org/node/88","display_url":"eufeps.org/node/88"}],"hashtags":{},"annotations":{}},"id":"570655692585115648","created_at":"2015-02-25T18:44:54.000Z","conversation_id":"570655692585115648","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570654108241301505"}],"author_id":"116716199","text":"RT @FDAanimalhealth: Find information on Recent Animal Drug Approvals - http://t.co/9N5aeAk2VA","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":72,"end":94,"url":"http://t.co/9N5aeAk2VA","expanded_url":"http://1.usa.gov/1qrcj3o","display_url":"1.usa.gov/1qrcj3o"}],"hashtags":{},"annotations":[{"start":41,"end":68,"probability":0.3324,"type":"Organization","normalized_text":"Recent Animal Drug Approvals"}]},"id":"570655572279865344","created_at":"2015-02-25T18:44:25.000Z","conversation_id":"570655572279865344","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570654516321890306"}],"author_id":"116716199","text":"RT @MHRAgovuk: Contact our innovation office for scientific information &amp; regulatory advice on devices/medicines #HealthInnovation http://t…","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"urls":{},"hashtags":[{"start":117,"end":134,"tag":"HealthInnovation"}],"annotations":{}},"id":"570655544966557696","created_at":"2015-02-25T18:44:18.000Z","conversation_id":"570655544966557696","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"#Regulatory information: electronic application forms become mandatory for centralised procedures from July: http://t.co/8oELC4i9lk","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/8oELC4i9lk","expanded_url":"http://bit.ly/1wopBGA","display_url":"bit.ly/1wopBGA"}],"hashtags":[{"start":0,"end":11,"tag":"Regulatory"}],"annotations":{}},"id":"570655019491594240","created_at":"2015-02-25T18:42:13.000Z","conversation_id":"570655019491594240","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570612915180605440"}],"author_id":"116716199","text":"RT @FDA_Drug_Info: Participate or comment on FDA #breastcancer patient-focused meeting on April 2: http://t.co/oIfC0YYiip and http://t.co/G…","possibly_sensitive":false,"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":99,"end":121,"url":"http://t.co/oIfC0YYiip","expanded_url":"http://go.usa.gov/3cnhG","display_url":"go.usa.gov/3cnhG"}],"hashtags":[{"start":49,"end":62,"tag":"breastcancer"}],"annotations":[{"start":45,"end":47,"probability":0.6498,"type":"Organization","normalized_text":"FDA"}]},"id":"570613054620209152","created_at":"2015-02-25T15:55:28.000Z","conversation_id":"570613054620209152","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570557876239888385"}],"author_id":"116716199","text":"RT @ESEndocrinology: A worthy contribution to the controversial area #GHR d3/fl polymorphism and central #adiposity @uniofgothenburg http:/…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"},{"start":116,"end":132,"username":"uniofgothenburg","id":"35720969"}],"urls":{},"hashtags":[{"start":69,"end":73,"tag":"GHR"},{"start":105,"end":115,"tag":"adiposity"}],"annotations":{}},"id":"570597022740451328","created_at":"2015-02-25T14:51:46.000Z","conversation_id":"570597022740451328","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570568907876126721"}],"author_id":"116716199","text":"RT @EFSA_EU: #CallForTender – Assistance to the Assessment Methodology Unit for #statistical analyses, #DataManagement http://t.co/zVefHZ4t…","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":13,"end":27,"tag":"CallForTender"},{"start":80,"end":92,"tag":"statistical"},{"start":103,"end":118,"tag":"DataManagement"}],"annotations":{}},"id":"570596946177626113","created_at":"2015-02-25T14:51:27.000Z","conversation_id":"570596946177626113","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570571950428463104"}],"author_id":"116716199","text":"RT @edqm_news: European Committee CD-P-TO elaborates guide on collection and storage of #cordblood http://t.co/mysXJuXz2E #stemcells","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":99,"end":121,"url":"http://t.co/mysXJuXz2E","expanded_url":"http://bit.ly/1AXWFVQ","display_url":"bit.ly/1AXWFVQ"}],"hashtags":[{"start":88,"end":98,"tag":"cordblood"},{"start":122,"end":132,"tag":"stemcells"}],"annotations":{}},"id":"570596903773184000","created_at":"2015-02-25T14:51:17.000Z","conversation_id":"570596903773184000","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570577160609660928"}],"author_id":"116716199","text":"RT @euparkinsons: 1st novel discovery of a physical predictor of freezing in #Parkinson's disease: http://t.co/9Qn75CF39E","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":99,"end":121,"url":"http://t.co/9Qn75CF39E","expanded_url":"http://bit.ly/1DTvnQY","display_url":"bit.ly/1DTvnQY"}],"hashtags":[{"start":77,"end":87,"tag":"Parkinson"}],"annotations":{}},"id":"570596806050123777","created_at":"2015-02-25T14:50:54.000Z","conversation_id":"570596806050123777","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570581879746924544"}],"author_id":"116716199","text":"RT @NICEcomms: Updated guidance on the diagnosis and management of irritable bowel syndrome in adults out now: https://t.co/xAF9SVjD0O","possibly_sensitive":false,"public_metrics":{"retweet_count":47,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":111,"end":134,"url":"https://t.co/xAF9SVjD0O","expanded_url":"https://www.nice.org.uk/guidance/cg61","display_url":"nice.org.uk/guidance/cg61"}],"hashtags":{},"annotations":{}},"id":"570596391208263680","created_at":"2015-02-25T14:49:15.000Z","conversation_id":"570596391208263680","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570588339260104704"}],"author_id":"116716199","text":"RT @EAHPtweet: Fresh via #EJHP online first: #pharmacist assessment of drug-related problems on an #oncology ward in Norway http://t.co/hCi…","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":{},"hashtags":[{"start":25,"end":30,"tag":"EJHP"},{"start":45,"end":56,"tag":"pharmacist"},{"start":99,"end":108,"tag":"oncology"}],"annotations":[{"start":117,"end":122,"probability":0.9903,"type":"Place","normalized_text":"Norway"}]},"id":"570596264930349057","created_at":"2015-02-25T14:48:45.000Z","conversation_id":"570596264930349057","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"570582046428545024"}],"author_id":"116716199","text":"@CitelineAndyB We publish orphan designation summaries in monthly batches, following the EC decisions. Next batches to be published shortly.","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":14,"username":"CitelineAndyB","id":"2360127492"}],"urls":{},"hashtags":{},"annotations":{}},"id":"570596057245196288","created_at":"2015-02-25T14:47:55.000Z","conversation_id":"570582046428545024","attachments":{"media_keys":{}},"in_reply_to_user_id":"2360127492"},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Apply by 17 April to our concession for #pharmacovigilance training: http://t.co/suUSdhMUNH #procurement","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":69,"end":91,"url":"http://t.co/suUSdhMUNH","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"hashtags":[{"start":40,"end":58,"tag":"pharmacovigilance"},{"start":92,"end":104,"tag":"procurement"}],"annotations":{}},"id":"570550307115167744","created_at":"2015-02-25T11:46:08.000Z","conversation_id":"570550307115167744","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the #agenda of this week's human #medicines committee (CHMP) meeting: http://t.co/zHoNkSn5w9","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/zHoNkSn5w9","expanded_url":"http://bit.ly/1DQQFi7","display_url":"bit.ly/1DQQFi7"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":49,"end":59,"tag":"medicines"}],"annotations":{}},"id":"570549129174249472","created_at":"2015-02-25T11:41:27.000Z","conversation_id":"570549129174249472","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570268320651452416"}],"author_id":"116716199","text":"RT @DrugInfoAssn: Complimentary #Webinar Mar 12 with @goBalto : How to Cut #ClinicalTrial Timelines in Half http://t.co/CyxZuBIG4P","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":53,"end":61,"username":"goBalto","id":"18644961"}],"urls":[{"start":108,"end":130,"url":"http://t.co/CyxZuBIG4P","expanded_url":"http://ow.ly/JzDM1","display_url":"ow.ly/JzDM1"}],"hashtags":[{"start":32,"end":40,"tag":"Webinar"},{"start":75,"end":89,"tag":"ClinicalTrial"}],"annotations":{}},"id":"570269314051383297","created_at":"2015-02-24T17:09:34.000Z","conversation_id":"570269314051383297","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570268172881932288"}],"author_id":"116716199","text":"RT @EFSA_EU: New #traineeships at EFSA. We are looking for new #science graduates in #FoodSafety and other areas. Deadline 23/03 http://t.c…","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":17,"end":30,"tag":"traineeships"},{"start":63,"end":71,"tag":"science"},{"start":85,"end":96,"tag":"FoodSafety"}],"annotations":{}},"id":"570269281969184770","created_at":"2015-02-24T17:09:26.000Z","conversation_id":"570269281969184770","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Apply now for our concession for #pharmacovigilance training. Deadline is 17 April: http://t.co/suUSdhMUNH #procurement","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/suUSdhMUNH","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"hashtags":[{"start":33,"end":51,"tag":"pharmacovigilance"},{"start":107,"end":119,"tag":"procurement"}],"annotations":{}},"id":"570266316503957504","created_at":"2015-02-24T16:57:39.000Z","conversation_id":"570266316503957504","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"570264229808353281"}],"author_id":"116716199","text":"@TheLeeWilliams @PROTECT_BR Not yet. Please keep an eye on the event page: http://t.co/o9gp5fv3zy","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":16,"end":27,"username":"PROTECT_BR","id":"2354960784"}],"urls":[{"start":75,"end":97,"url":"http://t.co/o9gp5fv3zy","expanded_url":"http://bit.ly/1DkJpda","display_url":"bit.ly/1DkJpda"}],"hashtags":{},"annotations":{}},"id":"570265239712862209","created_at":"2015-02-24T16:53:22.000Z","conversation_id":"570264229808353281","attachments":{"media_keys":{}},"in_reply_to_user_id":"3722601"},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've just published the #agenda of this week's human #medicines committee (CHMP) meeting: http://t.co/zHoNkSn5w9","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/zHoNkSn5w9","expanded_url":"http://bit.ly/1DQQFi7","display_url":"bit.ly/1DQQFi7"}],"hashtags":[{"start":25,"end":32,"tag":"agenda"},{"start":54,"end":64,"tag":"medicines"}],"annotations":{}},"id":"570248880765460481","created_at":"2015-02-24T15:48:22.000Z","conversation_id":"570248880765460481","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"The #minutes of the January meeting of our #veterinary #medicines committee (CVMP) are available on our website: http://t.co/4yvrbsA7dd","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/4yvrbsA7dd","expanded_url":"http://bit.ly/1FNQ5Uw","display_url":"bit.ly/1FNQ5Uw"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":43,"end":54,"tag":"veterinary"},{"start":55,"end":65,"tag":"medicines"}],"annotations":{}},"id":"570248031112712193","created_at":"2015-02-24T15:44:59.000Z","conversation_id":"570248031112712193","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570236836800389120"}],"author_id":"116716199","text":"RT @FDACBER: What you need to know about #measles and the Measles-Mumps-Rubella (MMR) vaccine http://t.co/EbsBFzqmQ0 #vaccineswork","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":94,"end":116,"url":"http://t.co/EbsBFzqmQ0","expanded_url":"http://go.usa.gov/3cCvj","display_url":"go.usa.gov/3cCvj"}],"hashtags":[{"start":41,"end":49,"tag":"measles"},{"start":117,"end":130,"tag":"vaccineswork"}],"annotations":{}},"id":"570242538889723905","created_at":"2015-02-24T15:23:10.000Z","conversation_id":"570242538889723905","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @AEMPSGOB: Day on the BIFAP database as a source of information on research into medicine, Madrid, 27 March http://t.co/pcD6tJysFn","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":111,"end":133,"url":"http://t.co/pcD6tJysFn","expanded_url":"http://bit.ly/1LzqiOu","display_url":"bit.ly/1LzqiOu"}],"hashtags":{},"annotations":[{"start":94,"end":99,"probability":0.8256,"type":"Place","normalized_text":"Madrid"}]},"id":"570241623008915456","created_at":"2015-02-24T15:19:32.000Z","conversation_id":"570241623008915456","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @AEMPSGOB: International meeting of authorities on the sale of medicines on the Internet http://t.co/1qvaWW1hiT","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":92,"end":114,"url":"http://t.co/1qvaWW1hiT","expanded_url":"http://bit.ly/1vvbMVQ","display_url":"bit.ly/1vvbMVQ"}],"hashtags":{},"annotations":{}},"id":"570236710325489664","created_at":"2015-02-24T15:00:00.000Z","conversation_id":"570236710325489664","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570217846007058432"}],"author_id":"116716199","text":"RT @EU_ECHA: Working with #biocides? Read about the changes in the approval of in situ generated #biocidal active substances http://t.co/QX…","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":{},"hashtags":[{"start":26,"end":35,"tag":"biocides"},{"start":97,"end":106,"tag":"biocidal"}],"annotations":{}},"id":"570236457375432705","created_at":"2015-02-24T14:59:00.000Z","conversation_id":"570236457375432705","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570211042153918465"}],"author_id":"116716199","text":"RT @egabiosimilars: EMA kicks off the implementation of international standards for the identification of medicines in the EU http://t.co/m…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":{},"hashtags":{},"annotations":{}},"id":"570236181599932416","created_at":"2015-02-24T14:57:54.000Z","conversation_id":"570236181599932416","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570199762751918080"}],"author_id":"116716199","text":"RT @EU_ECHA: Four new practical guides provide hands-on advice on data sharing under the #biocides regulation http://t.co/B8N8gW994c","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":110,"end":132,"url":"http://t.co/B8N8gW994c","expanded_url":"http://bit.ly/1a61PVp","display_url":"bit.ly/1a61PVp"}],"hashtags":[{"start":89,"end":98,"tag":"biocides"}],"annotations":{}},"id":"570235715533078528","created_at":"2015-02-24T14:56:03.000Z","conversation_id":"570235715533078528","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570190301366779904"}],"author_id":"116716199","text":"RT @eurordis: Our President Terkel Andersen closes @rarediseaseday #RareEU2015 event. Thank you to all who participated! http://t.co/l36VtA…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":51,"end":66,"username":"rarediseaseday","id":"19982434"}],"urls":{},"hashtags":[{"start":67,"end":78,"tag":"RareEU2015"}],"annotations":[{"start":18,"end":42,"probability":0.4997,"type":"Person","normalized_text":"President Terkel Andersen"}]},"id":"570235232890310656","created_at":"2015-02-24T14:54:08.000Z","conversation_id":"570235232890310656","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: Report from the French medicines agency working group on #medicineinteractions, 12 January 2015 http://t.co/iVBGrWXC8Q","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":106,"end":128,"url":"http://t.co/iVBGrWXC8Q","expanded_url":"http://bit.ly/1vvazxY","display_url":"bit.ly/1vvazxY"}],"hashtags":[{"start":67,"end":88,"tag":"medicineinteractions"}],"annotations":{}},"id":"570234825275285504","created_at":"2015-02-24T14:52:31.000Z","conversation_id":"570234825275285504","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570178879098363904"}],"author_id":"116716199","text":"RT @eurordis: Nathalie Bere from @EMA_News “50% of patient contributions to protocol assistance results in advice being given to a company”…","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":33,"end":42,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":14,"end":26,"probability":0.9951,"type":"Person","normalized_text":"Nathalie Bere"}]},"id":"570212243570339841","created_at":"2015-02-24T13:22:47.000Z","conversation_id":"570212243570339841","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570178078728699904"}],"author_id":"116716199","text":"RT @eurordis: #Retinitispigmentosa patient Helma \"I am grateful to EURORDIS for training that allows me to bring #patientvoice to @EMA_News…","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":130,"end":139,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":14,"end":34,"tag":"Retinitispigmentosa"},{"start":113,"end":126,"tag":"patientvoice"}],"annotations":{}},"id":"570212119062441984","created_at":"2015-02-24T13:22:17.000Z","conversation_id":"570212119062441984","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570176475875446785"}],"author_id":"116716199","text":"RT @eurordis: Patient Helma &amp; N. Bere discuss patient contribution to scientific advice procedure at the @EMA_News #RareEU2015 http://t.co/…","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":109,"end":118,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":119,"end":130,"tag":"RareEU2015"}],"annotations":[{"start":30,"end":36,"probability":0.8334,"type":"Person","normalized_text":"N. Bere"}]},"id":"570212053308342272","created_at":"2015-02-24T13:22:02.000Z","conversation_id":"570212053308342272","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570173864103309312"}],"author_id":"116716199","text":"RT @EuropaBio: Fighting #counterfeitmedicines thanks to the brand-new EMVO system http://t.co/gFliaA8U15 #fakemeds","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"}],"urls":[{"start":82,"end":104,"url":"http://t.co/gFliaA8U15","expanded_url":"http://ow.ly/JvrQS","display_url":"ow.ly/JvrQS"}],"hashtags":[{"start":24,"end":45,"tag":"counterfeitmedicines"},{"start":105,"end":114,"tag":"fakemeds"}],"annotations":{}},"id":"570211800471486464","created_at":"2015-02-24T13:21:01.000Z","conversation_id":"570211800471486464","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570170596350431232"}],"author_id":"116716199","text":"RT @edqm_news: Do you know what BSP stands for and what its mission is? http://t.co/obrR9uOdm3 #European #Pharmacopoeia #biologicals","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":72,"end":94,"url":"http://t.co/obrR9uOdm3","expanded_url":"http://bit.ly/1JGq2l3","display_url":"bit.ly/1JGq2l3"}],"hashtags":[{"start":95,"end":104,"tag":"European"},{"start":105,"end":119,"tag":"Pharmacopoeia"},{"start":120,"end":132,"tag":"biologicals"}],"annotations":[{"start":32,"end":34,"probability":0.4308,"type":"Person","normalized_text":"BSP"}]},"id":"570211179056005120","created_at":"2015-02-24T13:18:33.000Z","conversation_id":"570211179056005120","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: French medicines agency call for patient-association projects: health products, initiatives for proper use http://t.co/hRaW5RuhDm","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":117,"end":139,"url":"http://t.co/hRaW5RuhDm","expanded_url":"http://bit.ly/1AG5nX5","display_url":"bit.ly/1AG5nX5"}],"hashtags":{},"annotations":{}},"id":"570210929402626048","created_at":"2015-02-24T13:17:34.000Z","conversation_id":"570210929402626048","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570168376842186752"}],"author_id":"116716199","text":"RT @eurordis: Send us your questions for today's event using #RareEU2015 or on the EURORDIS website http://t.co/8Ees2TkprK #RareDisease","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":[{"start":100,"end":122,"url":"http://t.co/8Ees2TkprK","expanded_url":"http://ow.ly/IlYV3","display_url":"ow.ly/IlYV3"}],"hashtags":[{"start":61,"end":72,"tag":"RareEU2015"},{"start":123,"end":135,"tag":"RareDisease"}],"annotations":{}},"id":"570210607888248832","created_at":"2015-02-24T13:16:17.000Z","conversation_id":"570210607888248832","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570161806485946368"}],"author_id":"116716199","text":"RT @edqm_news: Looking for advice on how to use #monograph \"Substances for #pharmaceutical use\"? Join #PhEur Training Session http://t.co/p…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":48,"end":58,"tag":"monograph"},{"start":75,"end":90,"tag":"pharmaceutical"},{"start":102,"end":108,"tag":"PhEur"}],"annotations":{}},"id":"570210283085545472","created_at":"2015-02-24T13:15:00.000Z","conversation_id":"570210283085545472","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570160729040539648"}],"author_id":"116716199","text":"RT @eurordis: #MEP @debackerphil speaking at #RareEU2015 event. Watch #live here http://t.co/8Ees2TkprK @Europarl_EN #EU_Health http://t.co…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":19,"end":32,"username":"debackerphil","id":"44019567"},{"start":104,"end":116,"username":"Europarl_EN","id":"36329597"}],"urls":[{"start":81,"end":103,"url":"http://t.co/8Ees2TkprK","expanded_url":"http://ow.ly/IlYV3","display_url":"ow.ly/IlYV3"}],"hashtags":[{"start":14,"end":18,"tag":"MEP"},{"start":45,"end":56,"tag":"RareEU2015"},{"start":70,"end":75,"tag":"live"},{"start":117,"end":127,"tag":"EU_Health"}],"annotations":{}},"id":"570209650555146240","created_at":"2015-02-24T13:12:29.000Z","conversation_id":"570209650555146240","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570160196410085376"}],"author_id":"116716199","text":"RT @eurordis: .@V_Andriukaitis #RareEU2015 “I believe European action can make a difference in improving the lives of people living with a …","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":15,"end":30,"username":"V_Andriukaitis","id":"575269517"}],"urls":{},"hashtags":[{"start":31,"end":42,"tag":"RareEU2015"}],"annotations":{}},"id":"570209567805706240","created_at":"2015-02-24T13:12:09.000Z","conversation_id":"570209567805706240","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570159868453240832"}],"author_id":"116716199","text":"RT @V_Andriukaitis: Thanks @eurordis for bringing us together on #RareEU2015 Day - let's all step up action to give all patients the right …","possibly_sensitive":false,"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"V_Andriukaitis","id":"575269517"},{"start":27,"end":36,"username":"eurordis","id":"26993786"}],"urls":{},"hashtags":[{"start":65,"end":76,"tag":"RareEU2015"}],"annotations":{}},"id":"570209533978644480","created_at":"2015-02-24T13:12:01.000Z","conversation_id":"570209533978644480","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570159252444205056"}],"author_id":"116716199","text":"RT @eurordis: .@V_Andriukaitis #RareEU2015 “20 national #raredisease plans have been adopted in #EU. We must encourage the other 8 #members…","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":15,"end":30,"username":"V_Andriukaitis","id":"575269517"}],"urls":{},"hashtags":[{"start":31,"end":42,"tag":"RareEU2015"},{"start":56,"end":68,"tag":"raredisease"},{"start":96,"end":99,"tag":"EU"}],"annotations":{}},"id":"570159813759508480","created_at":"2015-02-24T09:54:27.000Z","conversation_id":"570159813759508480","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570158452368142337"}],"author_id":"116716199","text":"RT @eurordis: .@V_Andriukaitis #RareEU2015 “#Raredisease expertise is scattered; this is where #EU can help. We can foster research &amp; knowl…","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":15,"end":30,"username":"V_Andriukaitis","id":"575269517"}],"urls":{},"hashtags":[{"start":31,"end":42,"tag":"RareEU2015"},{"start":44,"end":56,"tag":"Raredisease"},{"start":95,"end":98,"tag":"EU"}],"annotations":{}},"id":"570159742905155584","created_at":"2015-02-24T09:54:10.000Z","conversation_id":"570159742905155584","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570158113040547840"}],"author_id":"116716199","text":"RT @eurordis: #Live @V_Andriukaitis opens our @rarediseaseday #RareEU2015 event. Watch online http://t.co/8Ees2TkprK @EU_Commission http://…","possibly_sensitive":false,"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":20,"end":35,"username":"V_Andriukaitis","id":"575269517"},{"start":46,"end":61,"username":"rarediseaseday","id":"19982434"},{"start":117,"end":131,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":94,"end":116,"url":"http://t.co/8Ees2TkprK","expanded_url":"http://ow.ly/IlYV3","display_url":"ow.ly/IlYV3"}],"hashtags":[{"start":14,"end":19,"tag":"Live"},{"start":62,"end":73,"tag":"RareEU2015"}],"annotations":{}},"id":"570158319836512256","created_at":"2015-02-24T09:48:31.000Z","conversation_id":"570158319836512256","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570148476006354944"}],"author_id":"116716199","text":"RT @eupatientsforum: Today our member @eurordis organises their @rarediseaseday event. Join online http://t.co/kvtYzHm2MR from 10:30 #RareE…","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"},{"start":38,"end":47,"username":"eurordis","id":"26993786"},{"start":64,"end":79,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":99,"end":121,"url":"http://t.co/kvtYzHm2MR","expanded_url":"http://www.eurordis.org/rareeu2015","display_url":"eurordis.org/rareeu2015"}],"hashtags":{},"annotations":{}},"id":"570152167585263618","created_at":"2015-02-24T09:24:04.000Z","conversation_id":"570152167585263618","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570147428483121153"}],"author_id":"116716199","text":"RT @kardamyla: @rarediseaseday Policy event live today - follow on http://t.co/di3olKRoqt @EMA_News Nathalie Bere and patient input in scie…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"kardamyla","id":"59722141"},{"start":15,"end":30,"username":"rarediseaseday","id":"19982434"},{"start":90,"end":99,"username":"EMA_News","id":"116716199"}],"urls":[{"start":67,"end":89,"url":"http://t.co/di3olKRoqt","expanded_url":"http://ow.ly/IlYV3","display_url":"ow.ly/IlYV3"}],"hashtags":{},"annotations":[{"start":100,"end":112,"probability":0.9918,"type":"Person","normalized_text":"Nathalie Bere"}]},"id":"570152034927845376","created_at":"2015-02-24T09:23:32.000Z","conversation_id":"570152034927845376","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"570146446252638208"}],"author_id":"116716199","text":"RT @eurordis: Starting in 30 mins - our @rarediseaseday event #live! Participate online: http://t.co/8Ees2TkprK Track the event with #RareE…","possibly_sensitive":false,"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":40,"end":55,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":89,"end":111,"url":"http://t.co/8Ees2TkprK","expanded_url":"http://ow.ly/IlYV3","display_url":"ow.ly/IlYV3"}],"hashtags":[{"start":62,"end":67,"tag":"live"}],"annotations":{}},"id":"570151912575782914","created_at":"2015-02-24T09:23:03.000Z","conversation_id":"570151912575782914","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"569908862305890304"}],"author_id":"116716199","text":"RT @my_ueg: On June 4-6 NeuroGastro 2015 brings together leading experts and emerging investigators in #neurogastroenterology  http://t.co/…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"my_ueg","id":"487344065"}],"urls":{},"hashtags":[{"start":103,"end":125,"tag":"neurogastroenterology"}],"annotations":{}},"id":"569914466101547008","created_at":"2015-02-23T17:39:31.000Z","conversation_id":"569914466101547008","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the #minutes of our committee for #veterinary #medicines (CVMP) in January: http://t.co/4yvrbsivOD","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/4yvrbsivOD","expanded_url":"http://bit.ly/1FNQ5Uw","display_url":"bit.ly/1FNQ5Uw"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":50,"end":61,"tag":"veterinary"},{"start":62,"end":72,"tag":"medicines"}],"annotations":{}},"id":"569892102282178560","created_at":"2015-02-23T16:10:39.000Z","conversation_id":"569892102282178560","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"569888299818586112"}],"author_id":"116716199","text":"@BarbraIFPA Apologies, we will correct this tweet. The CHMP January minutes are not yet publihsed, when available we will tweet the link.","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":{},"hashtags":{},"annotations":{}},"id":"569891322531864576","created_at":"2015-02-23T16:07:34.000Z","conversation_id":"569884820207239170","attachments":{"media_keys":{}},"in_reply_to_user_id":"610847692"},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"#Regulatory information: we've introduced weekly start dates for assessment of type II #variations from March: http://t.co/pjYGAFqwNX","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/pjYGAFqwNX","expanded_url":"http://bit.ly/17jwTiU","display_url":"bit.ly/17jwTiU"}],"hashtags":[{"start":0,"end":11,"tag":"Regulatory"},{"start":87,"end":98,"tag":"variations"}],"annotations":{}},"id":"569884494704074752","created_at":"2015-02-23T15:40:26.000Z","conversation_id":"569884494704074752","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"#Regulatory information: committee chairs no longer to sign opinion documents by hand from March 2015: http://t.co/SbUgWupSV7","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/SbUgWupSV7","expanded_url":"http://bit.ly/186EVwE","display_url":"bit.ly/186EVwE"}],"hashtags":[{"start":0,"end":11,"tag":"Regulatory"}],"annotations":{}},"id":"569884459408998400","created_at":"2015-02-23T15:40:17.000Z","conversation_id":"569884459408998400","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"569866293043732481"}],"author_id":"116716199","text":"RT @FDADeviceInfo: Moving Toward a National Medical Device Postmarket Surveillance System http://t.co/x1N6qfPUqL #fda #medicaldevice","possibly_sensitive":false,"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":17,"username":"FDADeviceInfo","id":"140427956"}],"urls":[{"start":90,"end":112,"url":"http://t.co/x1N6qfPUqL","expanded_url":"http://1.usa.gov/1DK6gBM","display_url":"1.usa.gov/1DK6gBM"}],"hashtags":[{"start":113,"end":117,"tag":"fda"},{"start":118,"end":132,"tag":"medicaldevice"}],"annotations":{}},"id":"569883004908249088","created_at":"2015-02-23T15:34:30.000Z","conversation_id":"569883004908249088","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: #ANSM has published its work programme for 2015: http://t.co/5uYWtDd2bF http://t.co/9XLss3Zjj0","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":59,"end":81,"url":"http://t.co/5uYWtDd2bF","expanded_url":"http://bit.ly/1EmUQD4","display_url":"bit.ly/1EmUQD4"},{"start":82,"end":104,"url":"http://t.co/9XLss3Zjj0","expanded_url":"http://bit.ly/1D3aXkT","display_url":"bit.ly/1D3aXkT"}],"hashtags":[{"start":10,"end":15,"tag":"ANSM"}],"annotations":{}},"id":"569862033728000000","created_at":"2015-02-23T14:11:11.000Z","conversation_id":"569862033728000000","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"569793716237570049"}],"author_id":"116716199","text":"RT @edqm_news: What #plasma components are used in Europe? Join the #EDQM Symposium on 22-23 September for more information http://t.co/bfY…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":20,"end":27,"tag":"plasma"},{"start":68,"end":73,"tag":"EDQM"}],"annotations":[{"start":51,"end":56,"probability":0.9959,"type":"Place","normalized_text":"Europe"}]},"id":"569830059353214976","created_at":"2015-02-23T12:04:07.000Z","conversation_id":"569830059353214976","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"569799167217946624"}],"author_id":"116716199","text":"RT @eurordis: All you need to know about #raredisease resource centres for in one policy document. Download our #factsheet now: http://t.co…","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"hashtags":[{"start":41,"end":53,"tag":"raredisease"},{"start":112,"end":122,"tag":"factsheet"}],"annotations":{}},"id":"569829982358401024","created_at":"2015-02-23T12:03:49.000Z","conversation_id":"569829982358401024","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"569807307086950400"}],"author_id":"116716199","text":"RT @EFSA_EU: #science, #innovation and society: plenary session on 15 Oct #EFSAExpo2015 http://t.co/GJUFkLAtXq","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":88,"end":110,"url":"http://t.co/GJUFkLAtXq","expanded_url":"http://bit.ly/1FNZb3U","display_url":"bit.ly/1FNZb3U"}],"hashtags":[{"start":13,"end":21,"tag":"science"},{"start":23,"end":34,"tag":"innovation"},{"start":74,"end":87,"tag":"EFSAExpo2015"}],"annotations":{}},"id":"569829860882948097","created_at":"2015-02-23T12:03:20.000Z","conversation_id":"569829860882948097","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"569813852990382080"}],"author_id":"116716199","text":"RT @edqm_news: The aim of the #PaedForm is to improve accessibility to suitable and age-appropriate formulations for children http://t.co/S…","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":30,"end":39,"tag":"PaedForm"}],"annotations":{}},"id":"569829725398536192","created_at":"2015-02-23T12:02:48.000Z","conversation_id":"569829725398536192","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"569815923114315776"}],"author_id":"116716199","text":"RT @EHA_Hematology: Register now for the Hematology Tutorial on diagnosis, prognosis and management today of hematologic malignancies... ht…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"EHA_Hematology","id":"279001852"}],"urls":{},"hashtags":{},"annotations":{}},"id":"569829685422637056","created_at":"2015-02-23T12:02:38.000Z","conversation_id":"569829685422637056","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"569779140267782144"}],"author_id":"116716199","text":"RT @edqm_news: What is #cordblood? How is it obtained? What is it used for? New EDQM guide for parents answers all their questions: http://…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":23,"end":33,"tag":"cordblood"}],"annotations":{}},"id":"569791541339938816","created_at":"2015-02-23T09:31:04.000Z","conversation_id":"569791541339938816","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"569785862277472256"}],"author_id":"116716199","text":"RT @EU_Health: Plenary meeting #EU Platform 4 #Diet, Physical Activity &amp; #Health 19.02 - presentations available #EUDietPlatform http://t.c…","possibly_sensitive":false,"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"hashtags":[{"start":31,"end":34,"tag":"EU"},{"start":46,"end":51,"tag":"Diet"},{"start":77,"end":84,"tag":"Health"},{"start":117,"end":132,"tag":"EUDietPlatform"}],"annotations":{}},"id":"569791413774385153","created_at":"2015-02-23T09:30:33.000Z","conversation_id":"569791413774385153","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Identification of #medicines: we're establishing an EU task force to implement new international #standards: http://t.co/jvGvYXGPJq","possibly_sensitive":false,"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/jvGvYXGPJq","expanded_url":"http://bit.ly/1JtvpnN","display_url":"bit.ly/1JtvpnN"}],"hashtags":[{"start":18,"end":28,"tag":"medicines"},{"start":97,"end":107,"tag":"standards"}],"annotations":[{"start":52,"end":53,"probability":0.5685,"type":"Organization","normalized_text":"EU"}]},"id":"568802158310764544","created_at":"2015-02-20T15:59:37.000Z","conversation_id":"568802158310764544","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"#Regulatory information: we've introduced weekly start dates for assessment of type II #variations from March: http://t.co/pjYGAFqwNX","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/pjYGAFqwNX","expanded_url":"http://bit.ly/17jwTiU","display_url":"bit.ly/17jwTiU"}],"hashtags":[{"start":0,"end":11,"tag":"Regulatory"},{"start":87,"end":98,"tag":"variations"}],"annotations":{}},"id":"568800751998398464","created_at":"2015-02-20T15:54:01.000Z","conversation_id":"568800751998398464","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"#Regulatory information: committee chairs no longer to sign opinion documents by hand from March 2015: http://t.co/SbUgWupSV7","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/SbUgWupSV7","expanded_url":"http://bit.ly/186EVwE","display_url":"bit.ly/186EVwE"}],"hashtags":[{"start":0,"end":11,"tag":"Regulatory"}],"annotations":{}},"id":"568800402403155968","created_at":"2015-02-20T15:52:38.000Z","conversation_id":"568800402403155968","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568704331282849792"}],"author_id":"116716199","text":"RT @myESMO: New HPV vaccine offers greater protection against #cervicalcancer than current vaccine http://t.co/wHob9ZLunu","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":99,"end":121,"url":"http://t.co/wHob9ZLunu","expanded_url":"http://ow.ly/JmS53","display_url":"ow.ly/JmS53"}],"hashtags":[{"start":62,"end":77,"tag":"cervicalcancer"}],"annotations":{}},"id":"568799470214901760","created_at":"2015-02-20T15:48:56.000Z","conversation_id":"568799470214901760","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568712654690390016"}],"author_id":"116716199","text":"RT @ECDC_Flu: In this week’s @Eurosurveillanc: Assessment of human #influenza pandemic scenarios in Europe: http://t.co/MUGLuobJKa","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":29,"end":45,"username":"Eurosurveillanc","id":"455839750"}],"urls":[{"start":108,"end":130,"url":"http://t.co/MUGLuobJKa","expanded_url":"http://bit.ly/17j0A3D","display_url":"bit.ly/17j0A3D"}],"hashtags":[{"start":67,"end":77,"tag":"influenza"}],"annotations":[{"start":100,"end":105,"probability":0.9953,"type":"Place","normalized_text":"Europe"}]},"id":"568799410307657728","created_at":"2015-02-20T15:48:41.000Z","conversation_id":"568799410307657728","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568714589715767296"}],"author_id":"116716199","text":"RT @EU_Health: Seen our #EU #Health newsletter? Focus on #healthy #lifestyles @guntisbelevics @eu2015lv http://t.co/gQrc5DzeSI http://t.co/…","possibly_sensitive":false,"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":78,"end":93,"username":"guntisbelevics","id":"138015667"},{"start":94,"end":103,"username":"eu2015lv","id":"3217949032"}],"urls":[{"start":104,"end":126,"url":"http://t.co/gQrc5DzeSI","expanded_url":"http://europa.eu/!gG67Nr","display_url":"europa.eu/!gG67Nr"}],"hashtags":[{"start":24,"end":27,"tag":"EU"},{"start":28,"end":35,"tag":"Health"},{"start":57,"end":65,"tag":"healthy"},{"start":66,"end":77,"tag":"lifestyles"}],"annotations":{}},"id":"568799376807747584","created_at":"2015-02-20T15:48:33.000Z","conversation_id":"568799376807747584","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568745429052948480"}],"author_id":"116716199","text":"RT @ESEndocrinology: #Genotype and #phenotype information from patients with suspected #Pendred Syndrome  #hypothyroidism @NHSBartsHealth h…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"},{"start":122,"end":137,"username":"NHSBartsHealth","id":"988868700"}],"urls":{},"hashtags":[{"start":21,"end":30,"tag":"Genotype"},{"start":35,"end":45,"tag":"phenotype"},{"start":87,"end":95,"tag":"Pendred"},{"start":106,"end":121,"tag":"hypothyroidism"}],"annotations":{}},"id":"568799178492653568","created_at":"2015-02-20T15:47:46.000Z","conversation_id":"568799178492653568","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568772133892923392"}],"author_id":"116716199","text":"RT @FDACBER: New draft guidance: Investigating &amp; Reporting Adverse Reactions Related to Human Cells &amp; Tissue Based Products http://t.co/qEc…","possibly_sensitive":false,"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":{},"hashtags":{},"annotations":{}},"id":"568799020962992129","created_at":"2015-02-20T15:47:09.000Z","conversation_id":"568799020962992129","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568781784185507840"}],"author_id":"116716199","text":"RT @edqm_news: Did you know? The #PhEur began elaborating #monographs on #biologicals in the 70s, starting with #vaccines. Webinar: http://…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":33,"end":39,"tag":"PhEur"},{"start":58,"end":69,"tag":"monographs"},{"start":73,"end":85,"tag":"biologicals"},{"start":112,"end":121,"tag":"vaccines"}],"annotations":{}},"id":"568798807179300864","created_at":"2015-02-20T15:46:18.000Z","conversation_id":"568798807179300864","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568791920396410880"}],"author_id":"116716199","text":"RT @AlzheimerEurope: Our practical guidelines for people with #dementia on #continence care at home are now available on our website: http:…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"urls":{},"hashtags":[{"start":62,"end":71,"tag":"dementia"},{"start":75,"end":86,"tag":"continence"}],"annotations":{}},"id":"568798705480015872","created_at":"2015-02-20T15:45:53.000Z","conversation_id":"568798705480015872","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Data requirements for veterinary medicines to prevent vector-borne disease transmission in dogs &amp; cats: http://t.co/zT342ZupGv #consultation","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/zT342ZupGv","expanded_url":"http://bit.ly/1EkygIL","display_url":"bit.ly/1EkygIL"}],"hashtags":[{"start":131,"end":144,"tag":"consultation"}],"annotations":{}},"id":"568796173429018624","created_at":"2015-02-20T15:35:50.000Z","conversation_id":"568796173429018624","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Our committee for human #medicines (CHMP) meets next week. We'll pubilsh highlights next Friday: http://t.co/8Awscmna2V","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/8Awscmna2V","expanded_url":"http://bit.ly/1DG0kYI","display_url":"bit.ly/1DG0kYI"}],"hashtags":[{"start":24,"end":34,"tag":"medicines"}],"annotations":{}},"id":"568795936199188480","created_at":"2015-02-20T15:34:53.000Z","conversation_id":"568795936199188480","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We're establishing an EU task force to implement new international #standards on identification of #medicines: http://t.co/jvGvYXGPJq","possibly_sensitive":false,"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/jvGvYXGPJq","expanded_url":"http://bit.ly/1JtvpnN","display_url":"bit.ly/1JtvpnN"}],"hashtags":[{"start":67,"end":77,"tag":"standards"},{"start":99,"end":109,"tag":"medicines"}],"annotations":[{"start":22,"end":23,"probability":0.6118,"type":"Organization","normalized_text":"EU"}]},"id":"568731868813762561","created_at":"2015-02-20T11:20:18.000Z","conversation_id":"568731868813762561","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Comment on data requirements for #veterinary #medicines to prevent vector-borne disease transmission in dogs &amp; cats: http://t.co/zT342ZupGv","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":121,"end":143,"url":"http://t.co/zT342ZupGv","expanded_url":"http://bit.ly/1EkygIL","display_url":"bit.ly/1EkygIL"}],"hashtags":[{"start":33,"end":44,"tag":"veterinary"},{"start":45,"end":55,"tag":"medicines"}],"annotations":{}},"id":"568699928979091456","created_at":"2015-02-20T09:13:23.000Z","conversation_id":"568699928979091456","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568684026988503040"}],"author_id":"116716199","text":"RT @EU_eHealth: #eHealth solution for home-based monitoring of patients with #arthritis: http://t.co/ymMG0VExZ4 #telehealth @ELECTOR_eHealt…","possibly_sensitive":false,"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"urls":[{"start":89,"end":111,"url":"http://t.co/ymMG0VExZ4","expanded_url":"http://www.elector.eu/","display_url":"elector.eu"}],"hashtags":[{"start":16,"end":24,"tag":"eHealth"},{"start":77,"end":87,"tag":"arthritis"},{"start":112,"end":123,"tag":"telehealth"}],"annotations":{}},"id":"568699255839461376","created_at":"2015-02-20T09:10:43.000Z","conversation_id":"568699255839461376","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568698507365879808"}],"author_id":"116716199","text":"RT @euparkinsons: Treatment of  later stages of #Parkinson's  - pharmacological\napproaches now &amp; in the future http://t.co/amJz0WRAPd","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":115,"end":137,"url":"http://t.co/amJz0WRAPd","expanded_url":"http://www.epda.eu.com/en/research-papers/2015/02-12-transneurodegen/","display_url":"epda.eu.com/en/research-pa…"}],"hashtags":[{"start":48,"end":58,"tag":"Parkinson"}],"annotations":{}},"id":"568698947822358528","created_at":"2015-02-20T09:09:29.000Z","conversation_id":"568698947822358528","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Our committee for human #medicines (CHMP) meets next week. Highlights out next Friday: http://t.co/8Awscmna2V","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/8Awscmna2V","expanded_url":"http://bit.ly/1DG0kYI","display_url":"bit.ly/1DG0kYI"}],"hashtags":[{"start":24,"end":34,"tag":"medicines"}],"annotations":{}},"id":"568698801415966720","created_at":"2015-02-20T09:08:54.000Z","conversation_id":"568698801415966720","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568430330664898560"}],"author_id":"116716199","text":"RT @IMI_JU: Just published on the #IMI website – summary of recent Q &amp; As about IMI 2 Call 3 topic RADAR #CNS http://t.co/JNz45Mid6o","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":114,"end":136,"url":"http://t.co/JNz45Mid6o","expanded_url":"http://bit.ly/19CpbSp","display_url":"bit.ly/19CpbSp"}],"hashtags":[{"start":34,"end":38,"tag":"IMI"},{"start":109,"end":113,"tag":"CNS"}],"annotations":{}},"id":"568446515099897856","created_at":"2015-02-19T16:26:25.000Z","conversation_id":"568446515099897856","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568385034622767104"}],"author_id":"116716199","text":"RT @PROTECT_BR: Launched! Visit http://t.co/4d1QWT3s8u to learn more about our recommendations on benefit-risk assessment. @IMI_JU http://t…","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"PROTECT_BR","id":"2354960784"},{"start":123,"end":130,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":32,"end":54,"url":"http://t.co/4d1QWT3s8u","expanded_url":"http://PROTECTBenefitRisk.eu","display_url":"PROTECTBenefitRisk.eu"}],"hashtags":{},"annotations":{}},"id":"568407972277305344","created_at":"2015-02-19T13:53:15.000Z","conversation_id":"568407972277305344","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568395129511391232"}],"author_id":"116716199","text":"RT @EU_ECHA: We are looking for a legal #adviser (AD8). #Apply by 9 March. All details are available here http://t.co/fZlbqZsI0s #Eujobs #E…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":106,"end":128,"url":"http://t.co/fZlbqZsI0s","expanded_url":"http://bit.ly/15xbvBD","display_url":"bit.ly/15xbvBD"}],"hashtags":[{"start":40,"end":48,"tag":"adviser"},{"start":56,"end":62,"tag":"Apply"},{"start":129,"end":136,"tag":"Eujobs"}],"annotations":{}},"id":"568407815611674624","created_at":"2015-02-19T13:52:38.000Z","conversation_id":"568407815611674624","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568400117843267584"}],"author_id":"116716199","text":"RT @edqm_news: Don’t miss the opportunity to hear the latest news on #biologicals directly from Dr Emmanuelle Charton! http://t.co/G583qLwx…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":69,"end":81,"tag":"biologicals"}],"annotations":[{"start":96,"end":116,"probability":0.7094,"type":"Person","normalized_text":"Dr Emmanuelle Charton"}]},"id":"568407724121317376","created_at":"2015-02-19T13:52:16.000Z","conversation_id":"568407724121317376","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568401737763192832"}],"author_id":"116716199","text":"RT @IDFEuropeBxl: What's the state of #diabetes policies in Europe? Infographic via @EurActiv http://t.co/7HUUtc9GSE cc @EU_CHRODIS http://…","possibly_sensitive":false,"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"IDFEuropeBXL","id":"848831221"},{"start":84,"end":93,"username":"EURACTIV","id":"14808226"}],"urls":[{"start":94,"end":116,"url":"http://t.co/7HUUtc9GSE","expanded_url":"http://goo.gl/4slAsG","display_url":"goo.gl/4slAsG"}],"hashtags":[{"start":38,"end":47,"tag":"diabetes"}],"annotations":[{"start":60,"end":65,"probability":0.9876,"type":"Place","normalized_text":"Europe"}]},"id":"568407680328597504","created_at":"2015-02-19T13:52:06.000Z","conversation_id":"568407680328597504","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568095112301039616"}],"author_id":"116716199","text":"RT @EFSA_EU: #EFSAExpo2015, #WholeGenomeSequencing, #MolecularTyping. Subscribe now to the EFSA newsletter http://t.co/X3cnWNEqAH http://t.…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":107,"end":129,"url":"http://t.co/X3cnWNEqAH","expanded_url":"http://bit.ly/1gBYrmo","display_url":"bit.ly/1gBYrmo"}],"hashtags":[{"start":13,"end":26,"tag":"EFSAExpo2015"},{"start":28,"end":50,"tag":"WholeGenomeSequencing"},{"start":52,"end":68,"tag":"MolecularTyping"}],"annotations":{}},"id":"568095291976646657","created_at":"2015-02-18T17:10:46.000Z","conversation_id":"568095291976646657","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"und","referenced_tweets":[{"type":"retweeted","id":"568081404166213632"}],"author_id":"116716199","text":"RT @EuropaBio: @FinancialTimes on #earlyaccessschemes #adaptivelicencing #healthcare #patients #biotech4life @EMA_News https://t.co/aRsXU1f…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"},{"start":15,"end":30,"username":"FinancialTimes","id":"4898091"},{"start":109,"end":118,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":34,"end":53,"tag":"earlyaccessschemes"},{"start":54,"end":72,"tag":"adaptivelicencing"},{"start":73,"end":84,"tag":"healthcare"},{"start":85,"end":94,"tag":"patients"},{"start":95,"end":108,"tag":"biotech4life"}],"annotations":{}},"id":"568088032458502144","created_at":"2015-02-18T16:41:56.000Z","conversation_id":"568088032458502144","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568086527223443456"}],"author_id":"116716199","text":"RT @egagenerics: 2015 FDA Social Media Guidelines to Bring More Clarity?  http://t.co/LzJE0DEkVS #hcsmeu #hcsm #healthsocmed","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":74,"end":96,"url":"http://t.co/LzJE0DEkVS","expanded_url":"http://blog.schwartzmsl.com/2015_fda_social_media_guidelines_to_bring_more_clarity/","display_url":"blog.schwartzmsl.com/2015_fda_socia…"}],"hashtags":[{"start":97,"end":104,"tag":"hcsmeu"},{"start":105,"end":110,"tag":"hcsm"},{"start":111,"end":124,"tag":"healthsocmed"}],"annotations":[{"start":22,"end":24,"probability":0.5911,"type":"Organization","normalized_text":"FDA"}]},"id":"568087925050761216","created_at":"2015-02-18T16:41:30.000Z","conversation_id":"568087925050761216","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: Call for patient association projects: submit your application before 15 April at midnight http://t.co/qDDxcGTE5x","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":101,"end":123,"url":"http://t.co/qDDxcGTE5x","expanded_url":"http://bit.ly/17TtVT9","display_url":"bit.ly/17TtVT9"}],"hashtags":{},"annotations":{}},"id":"568087666492903424","created_at":"2015-02-18T16:40:28.000Z","conversation_id":"568087666492903424","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568078122987466752"}],"author_id":"116716199","text":"RT @rarediseaseday: The #RareDisease Day video recognises the millions of people whose daily lives are impacted by #raredisease http://t.co…","possibly_sensitive":false,"public_metrics":{"retweet_count":48,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"urls":{},"hashtags":[{"start":24,"end":36,"tag":"RareDisease"},{"start":115,"end":127,"tag":"raredisease"}],"annotations":{}},"id":"568087177822932992","created_at":"2015-02-18T16:38:32.000Z","conversation_id":"568087177822932992","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568073749507018752"}],"author_id":"116716199","text":"RT @DrugInfoAssn: The @US_FDA extends the deadline for comments on the proposed #generic labeling rules until April 27 http://t.co/PzJNUuNP…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":22,"end":29,"username":"US_FDA","id":"208120290"}],"urls":{},"hashtags":[{"start":80,"end":88,"tag":"generic"}],"annotations":{}},"id":"568075604966412288","created_at":"2015-02-18T15:52:33.000Z","conversation_id":"568075604966412288","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568073725578502144"}],"author_id":"116716199","text":"RT @EFSA_EU: Still 10 days to register to #EFSA stakeholders meetings on #feed additives applications in Barcelona on 5 May http://t.co/0mO…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":42,"end":47,"tag":"EFSA"},{"start":73,"end":78,"tag":"feed"}],"annotations":[{"start":105,"end":113,"probability":0.9679,"type":"Place","normalized_text":"Barcelona"}]},"id":"568074133759782912","created_at":"2015-02-18T15:46:42.000Z","conversation_id":"568074133759782912","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"Translations of #safety #signal recommendations will make EU product-information updates easier: http://t.co/H9UEidBTnz  #pharmacovigilance","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/H9UEidBTnz","expanded_url":"http://bit.ly/1AkATdb","display_url":"bit.ly/1AkATdb"}],"hashtags":[{"start":16,"end":23,"tag":"safety"},{"start":24,"end":31,"tag":"signal"},{"start":121,"end":139,"tag":"pharmacovigilance"}],"annotations":{}},"id":"568069821667135488","created_at":"2015-02-18T15:29:34.000Z","conversation_id":"568069821667135488","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"The #minutes of the January meeting of our #orphan medicines committee (COMP) are now available: http://t.co/csPL2QuvfX","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/csPL2QuvfX","expanded_url":"http://bit.ly/1EnE8Bm","display_url":"bit.ly/1EnE8Bm"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":43,"end":50,"tag":"orphan"}],"annotations":{}},"id":"568069210892578816","created_at":"2015-02-18T15:27:08.000Z","conversation_id":"568069210892578816","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568062488085860353"}],"author_id":"116716199","text":"RT @FDACBER: CBER invites biologics facilities to participate in their Regulatory Site Visit Training Program. http://t.co/1x2uJpHFMs","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":111,"end":133,"url":"http://t.co/1x2uJpHFMs","expanded_url":"http://go.usa.gov/338dT","display_url":"go.usa.gov/338dT"}],"hashtags":{},"annotations":{}},"id":"568067784762114051","created_at":"2015-02-18T15:21:28.000Z","conversation_id":"568067784762114051","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568055610689900544"}],"author_id":"116716199","text":"RT @US_FDA: Here is this week's Patient Network Newsletter with all the latest updates from the FDA. http://t.co/iN3oEEuTc8","possibly_sensitive":false,"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":101,"end":123,"url":"http://t.co/iN3oEEuTc8","expanded_url":"http://go.usa.gov/339TJ","display_url":"go.usa.gov/339TJ"}],"hashtags":{},"annotations":[{"start":96,"end":98,"probability":0.804,"type":"Organization","normalized_text":"FDA"}]},"id":"568067366954909696","created_at":"2015-02-18T15:19:49.000Z","conversation_id":"568067366954909696","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568055444683558912"}],"author_id":"116716199","text":"RT @edqm_news: The programme for the Symposium on #Plasma for Direct Clinical Use\n22-23 September 2015 is now online! Take a look: http://t…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":50,"end":57,"tag":"Plasma"}],"annotations":{}},"id":"568067339566104576","created_at":"2015-02-18T15:19:42.000Z","conversation_id":"568067339566104576","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568054427699060736"}],"author_id":"116716199","text":"RT @edqm_news: From 1st March 2015, invoicing of inspection costs will be done differently: http://t.co/6n0yAEbd1a #certificationofsuitabil…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":92,"end":114,"url":"http://t.co/6n0yAEbd1a","expanded_url":"http://bit.ly/1Aiz7w8","display_url":"bit.ly/1Aiz7w8"}],"hashtags":{},"annotations":{}},"id":"568067221538381824","created_at":"2015-02-18T15:19:14.000Z","conversation_id":"568067221538381824","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568047823872245760"}],"author_id":"116716199","text":"RT @rarediseaseday: Thank you to everyone who has already signed up to the #RareDisease Day #Thunderclap campaign! Join us now: http://t.co…","possibly_sensitive":false,"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"urls":{},"hashtags":[{"start":75,"end":87,"tag":"RareDisease"},{"start":92,"end":104,"tag":"Thunderclap"}],"annotations":{}},"id":"568066410859118592","created_at":"2015-02-18T15:16:01.000Z","conversation_id":"568066410859118592","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568045795284525057"}],"author_id":"116716199","text":"RT @edqm_news: UPDATED: List of Groups of Experts &amp; Working Parties http://t.co/8nhtxQ4ApD  #european #pharmacopoeia","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":72,"end":94,"url":"http://t.co/8nhtxQ4ApD","expanded_url":"http://bit.ly/1uAr8b9","display_url":"bit.ly/1uAr8b9"}],"hashtags":[{"start":96,"end":105,"tag":"european"},{"start":106,"end":120,"tag":"pharmacopoeia"}],"annotations":{}},"id":"568066316608929792","created_at":"2015-02-18T15:15:38.000Z","conversation_id":"568066316608929792","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: The French medicines agency has publiShed an update on the topics dscussed at the last #PRAC meeting http://t.co/YZej1ViUQG","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":111,"end":133,"url":"http://t.co/YZej1ViUQG","expanded_url":"http://bit.ly/1FsOuDr","display_url":"bit.ly/1FsOuDr"}],"hashtags":[{"start":97,"end":102,"tag":"PRAC"}],"annotations":{}},"id":"568066088002588673","created_at":"2015-02-18T15:14:44.000Z","conversation_id":"568066088002588673","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568036657418637312"}],"author_id":"116716199","text":"RT @AlzheimerEurope: Read our report on the first @IMI_EPAD project communications meeting in Barcelona on 12 Feb: http://t.co/rmr5vm7gdL h…","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":50,"end":59,"username":"IMI_EPAD","id":"2979700941"}],"urls":[{"start":115,"end":137,"url":"http://t.co/rmr5vm7gdL","expanded_url":"http://goo.gl/YRBQV3","display_url":"goo.gl/YRBQV3"}],"hashtags":{},"annotations":[{"start":94,"end":102,"probability":0.9831,"type":"Place","normalized_text":"Barcelona"}]},"id":"568065765582229505","created_at":"2015-02-18T15:13:27.000Z","conversation_id":"568065765582229505","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568034479475957760"}],"author_id":"116716199","text":"RT @FDAanimalhealth: Where can I get information on a drug my veterinarian prescribed? http://t.co/I09gKTXxJm","possibly_sensitive":false,"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":87,"end":109,"url":"http://t.co/I09gKTXxJm","expanded_url":"http://1.usa.gov/1DCC4qv","display_url":"1.usa.gov/1DCC4qv"}],"hashtags":{},"annotations":{}},"id":"568065591652847616","created_at":"2015-02-18T15:12:45.000Z","conversation_id":"568065591652847616","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568032379564138496"}],"author_id":"116716199","text":"RT @eurordis: Read the stories of @RareDiseaseDay 2015 video participants Pietro, Beatrice &amp; Rita. #RareDisease http://t.co/uEzKfbnfXB","possibly_sensitive":false,"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":34,"end":49,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":116,"end":138,"url":"http://t.co/uEzKfbnfXB","expanded_url":"http://ow.ly/JbBEn","display_url":"ow.ly/JbBEn"}],"hashtags":[{"start":103,"end":115,"tag":"RareDisease"}],"annotations":[{"start":74,"end":79,"probability":0.8095,"type":"Person","normalized_text":"Pietro"},{"start":82,"end":89,"probability":0.7834,"type":"Person","normalized_text":"Beatrice"},{"start":93,"end":96,"probability":0.9058,"type":"Person","normalized_text":"Rita"}]},"id":"568065465341362177","created_at":"2015-02-18T15:12:15.000Z","conversation_id":"568065465341362177","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568012949945778176"}],"author_id":"116716199","text":"RT @EU_ECHA: Register for #EFSA_EU #conference \"Shaping the future of food safety, together\" by 15 May http://t.co/T1D7G5GJ1j","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":103,"end":125,"url":"http://t.co/T1D7G5GJ1j","expanded_url":"http://bit.ly/1EgohUD","display_url":"bit.ly/1EgohUD"}],"hashtags":[{"start":26,"end":34,"tag":"EFSA_EU"},{"start":35,"end":46,"tag":"conference"}],"annotations":{}},"id":"568065075296256000","created_at":"2015-02-18T15:10:42.000Z","conversation_id":"568065075296256000","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the #minutes of the January meeting of our #orphan medicines committee (COMP): http://t.co/csPL2QuvfX","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/csPL2QuvfX","expanded_url":"http://bit.ly/1EnE8Bm","display_url":"bit.ly/1EnE8Bm"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":59,"end":66,"tag":"orphan"}],"annotations":{}},"id":"568005351968256000","created_at":"2015-02-18T11:13:23.000Z","conversation_id":"568005351968256000","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568003638465048576"}],"author_id":"116716199","text":"RT @EU_Health: .@EMA_News publishes translations of recommendations on #safety #signals in all #EU languages http://t.co/6pLQnrG5sH #pharma…","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":25,"username":"EMA_News","id":"116716199"}],"urls":[{"start":109,"end":131,"url":"http://t.co/6pLQnrG5sH","expanded_url":"http://bit.ly/1AkATdb","display_url":"bit.ly/1AkATdb"}],"hashtags":[{"start":71,"end":78,"tag":"safety"},{"start":79,"end":87,"tag":"signals"},{"start":95,"end":98,"tag":"EU"}],"annotations":{}},"id":"568004685078114304","created_at":"2015-02-18T11:10:44.000Z","conversation_id":"568004685078114304","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"568003410282348544"}],"author_id":"116716199","text":"RT @NICEcomms: Lots of coverage this morning for our draft #antimicrobial stewardship guideline. Read and comment on the draft:http://t.co/…","possibly_sensitive":false,"public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":{},"hashtags":[{"start":59,"end":73,"tag":"antimicrobial"}],"annotations":{}},"id":"568004655785095168","created_at":"2015-02-18T11:10:37.000Z","conversation_id":"568004655785095168","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @URPLWMiPB: Full information on reporting adverse reactions is available on the Polish medicines agency website http://t.co/9lJj6pvKmG","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":115,"end":137,"url":"http://t.co/9lJj6pvKmG","expanded_url":"http://bit.ly/1znbgWp","display_url":"bit.ly/1znbgWp"}],"hashtags":{},"annotations":{}},"id":"568004282957623296","created_at":"2015-02-18T11:09:08.000Z","conversation_id":"568004282957623296","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: Advice and recommendations from the January 2015 Committee on #Orphan #Medicines (COMP) at the #EMA http://t.co/gt8sl1MAdv","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":110,"end":132,"url":"http://t.co/gt8sl1MAdv","expanded_url":"http://bit.ly/1DCCQUw","display_url":"bit.ly/1DCCQUw"}],"hashtags":[{"start":72,"end":79,"tag":"Orphan"},{"start":80,"end":90,"tag":"Medicines"},{"start":105,"end":109,"tag":"EMA"}],"annotations":{}},"id":"568003655057739776","created_at":"2015-02-18T11:06:39.000Z","conversation_id":"568003655057739776","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We now publish translations of our recommendations on #safety #signals in all EU languages: http://t.co/H9UEidBTnz #pharmacovigilance","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/H9UEidBTnz","expanded_url":"http://bit.ly/1AkATdb","display_url":"bit.ly/1AkATdb"}],"hashtags":[{"start":54,"end":61,"tag":"safety"},{"start":62,"end":70,"tag":"signals"},{"start":115,"end":133,"tag":"pharmacovigilance"}],"annotations":{}},"id":"568002733439107072","created_at":"2015-02-18T11:02:59.000Z","conversation_id":"568002733439107072","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @INFARMED_IP: Update of the National Formulary of Medicines: medicines for the treatment of hepatitis C http://t.co/fUsdqOaZtm","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":107,"end":129,"url":"http://t.co/fUsdqOaZtm","expanded_url":"http://bit.ly/1zn9YuB","display_url":"bit.ly/1zn9YuB"}],"hashtags":{},"annotations":{}},"id":"568000946942439424","created_at":"2015-02-18T10:55:53.000Z","conversation_id":"568000946942439424","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @URPLWMiPB: How to report undesirable effects of medicines http://t.co/LkHCVp1XWk","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":62,"end":84,"url":"http://t.co/LkHCVp1XWk","expanded_url":"http://bit.ly/1zn9RPH","display_url":"bit.ly/1zn9RPH"}],"hashtags":{},"annotations":{}},"id":"568000541734916096","created_at":"2015-02-18T10:54:16.000Z","conversation_id":"568000541734916096","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567984370109296640"}],"author_id":"116716199","text":"RT @myESMO: FDA approves lenvatinib for differentiated #thyroidcancer refractory to iodine-131 http://t.co/N5254Nm8ou","possibly_sensitive":false,"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":95,"end":117,"url":"http://t.co/N5254Nm8ou","expanded_url":"http://ow.ly/Jf3L2","display_url":"ow.ly/Jf3L2"}],"hashtags":[{"start":55,"end":69,"tag":"thyroidcancer"}],"annotations":[{"start":12,"end":14,"probability":0.7726,"type":"Organization","normalized_text":"FDA"}]},"id":"567985221313925121","created_at":"2015-02-18T09:53:24.000Z","conversation_id":"567985221313925121","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567979625311293440"}],"author_id":"116716199","text":"RT @PrimaryCare4um: @NIVEL_RESEARCH start #EU project ARNA to curb #antibiotic resistance @EMA_news @EU_Health @PPGroenewegen @UAntwerpen h…","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":20,"end":35,"username":"Nivel_research","id":"40857506"},{"start":90,"end":99,"username":"EMA_News","id":"116716199"},{"start":100,"end":110,"username":"EU_Health","id":"606325697"},{"start":111,"end":125,"username":"PPGroenewegen","id":"2550181231"},{"start":126,"end":137,"username":"UAntwerpen","id":"91511905"}],"urls":{},"hashtags":[{"start":42,"end":45,"tag":"EU"},{"start":67,"end":78,"tag":"antibiotic"}],"annotations":{}},"id":"567985125297938432","created_at":"2015-02-18T09:53:01.000Z","conversation_id":"567985125297938432","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"The assessment report for #Senshio (#ospemifene), a #medicine to treat #vulvovaginal #atrophy, is now on our website: http://t.co/3AoCor8A1a","possibly_sensitive":false,"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/3AoCor8A1a","expanded_url":"http://bit.ly/1MtPolg","display_url":"bit.ly/1MtPolg"}],"hashtags":[{"start":26,"end":34,"tag":"Senshio"},{"start":36,"end":47,"tag":"ospemifene"},{"start":52,"end":61,"tag":"medicine"},{"start":71,"end":84,"tag":"vulvovaginal"},{"start":85,"end":93,"tag":"atrophy"}],"annotations":{}},"id":"567977542558355456","created_at":"2015-02-18T09:22:53.000Z","conversation_id":"567977542558355456","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @GCessak: 20th anniversary of the European Medicines Agency (EMA) http://t.co/Wm6dsscv2V http://t.co/CXU14lK1ev","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":69,"end":91,"url":"http://t.co/Wm6dsscv2V","expanded_url":"http://bit.ly/1A53pAw","display_url":"bit.ly/1A53pAw"},{"start":92,"end":114,"url":"http://t.co/CXU14lK1ev","expanded_url":"http://bit.ly/1yVOSCk","display_url":"bit.ly/1yVOSCk"}],"hashtags":{},"annotations":[{"start":37,"end":61,"probability":0.5635,"type":"Other","normalized_text":"European Medicines Agency"}]},"id":"567977210407227392","created_at":"2015-02-18T09:21:34.000Z","conversation_id":"567977210407227392","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567972904677343232"}],"author_id":"116716199","text":"RT @GCessak: BBC News | Doctors told to reduce prescriptions for antibiotics http://t.co/XXQevoh8Im","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":77,"end":99,"url":"http://t.co/XXQevoh8Im","expanded_url":"http://www.bbc.com/news/health-31515623","display_url":"bbc.com/news/health-31…"}],"hashtags":{},"annotations":[{"start":13,"end":20,"probability":0.8746,"type":"Organization","normalized_text":"BBC News"}]},"id":"567976966047076352","created_at":"2015-02-18T09:20:35.000Z","conversation_id":"567976966047076352","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @luca__pani: The Italian medicines agency updates documents on transparency, performance and anti-corruption http://t.co/0WBPmm6NGf","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"urls":[{"start":112,"end":134,"url":"http://t.co/0WBPmm6NGf","expanded_url":"http://bit.ly/1yVOt2F","display_url":"bit.ly/1yVOt2F"}],"hashtags":{},"annotations":{}},"id":"567976830428418048","created_at":"2015-02-18T09:20:03.000Z","conversation_id":"567976830428418048","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567969118311329792"}],"author_id":"116716199","text":"RT @edqm_news: Don't miss the latest #certification activity report published this week! http://t.co/YYrA8Gc4Qg #CEP","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":89,"end":111,"url":"http://t.co/YYrA8Gc4Qg","expanded_url":"http://bit.ly/1AQZLuT","display_url":"bit.ly/1AQZLuT"}],"hashtags":[{"start":37,"end":51,"tag":"certification"},{"start":112,"end":116,"tag":"CEP"}],"annotations":{}},"id":"567976384473276416","created_at":"2015-02-18T09:18:17.000Z","conversation_id":"567976384473276416","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the assessment report for #Senshio (#ospemifene), a #medicine to treat #vulvovaginal atrophy: http://t.co/3AoCor8A1a","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/3AoCor8A1a","expanded_url":"http://bit.ly/1MtPolg","display_url":"bit.ly/1MtPolg"}],"hashtags":[{"start":42,"end":50,"tag":"Senshio"},{"start":52,"end":63,"tag":"ospemifene"},{"start":68,"end":77,"tag":"medicine"},{"start":87,"end":100,"tag":"vulvovaginal"}],"annotations":{}},"id":"567692318015512576","created_at":"2015-02-17T14:29:30.000Z","conversation_id":"567692318015512576","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567382310824456192"}],"author_id":"116716199","text":"RT @IAPOtweets: Did you miss our February newsletter? Featuring changing laws, new positions and fresh resources. Catch up here: http://t.c…","possibly_sensitive":false,"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":{},"hashtags":{},"annotations":{}},"id":"567621216845185025","created_at":"2015-02-17T09:46:58.000Z","conversation_id":"567621216845185025","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We've published the assessment report for #Otezla (#apremilast), for plaque #psoriasis and psoriatic #arthritis: http://t.co/1fn1Sq8n9a","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/1fn1Sq8n9a","expanded_url":"http://bit.ly/1zi2RmU","display_url":"bit.ly/1zi2RmU"}],"hashtags":[{"start":42,"end":49,"tag":"Otezla"},{"start":51,"end":62,"tag":"apremilast"},{"start":76,"end":86,"tag":"psoriasis"},{"start":101,"end":111,"tag":"arthritis"}],"annotations":{}},"id":"567620638790406144","created_at":"2015-02-17T09:44:40.000Z","conversation_id":"567620638790406144","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We're hosting and broadcasting a symposium this week to present the final, key findings of the @PROTECT_BR project: http://t.co/lRocoU4PcR","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":95,"end":106,"username":"PROTECT_BR","id":"2354960784"}],"urls":[{"start":116,"end":138,"url":"http://t.co/lRocoU4PcR","expanded_url":"http://bit.ly/1L30H0d","display_url":"bit.ly/1L30H0d"}],"hashtags":{},"annotations":{}},"id":"567620545353875456","created_at":"2015-02-17T09:44:18.000Z","conversation_id":"567620545353875456","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567608891908046848"}],"author_id":"116716199","text":"RT @edqm_news: EDQM to present new edition of Guide to the Preparation, Use &amp; Quality Assurance of Blood Components at #ISBTLondon http://t…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":123,"end":134,"tag":"ISBTLondon"}],"annotations":{}},"id":"567615246635106304","created_at":"2015-02-17T09:23:15.000Z","conversation_id":"567615246635106304","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567610812043628546"}],"author_id":"116716199","text":"RT @EAHPtweet: We need YOU to tell us how to tailor our annual Congress to YOUR needs! Complete our short needs assessment survey.. https:/…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":{},"hashtags":{},"annotations":[{"start":63,"end":70,"probability":0.4749,"type":"Organization","normalized_text":"Congress"}]},"id":"567615213466583040","created_at":"2015-02-17T09:23:07.000Z","conversation_id":"567615213466583040","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567611923534184448"}],"author_id":"116716199","text":"RT @edqm_news: Our mission is to contribute to the basic human right of access to good quality medicines and #healthcare http://t.co/NVxJvq…","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"hashtags":[{"start":109,"end":120,"tag":"healthcare"}],"annotations":{}},"id":"567615180151214080","created_at":"2015-02-17T09:22:59.000Z","conversation_id":"567615180151214080","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567612506907377664"}],"author_id":"116716199","text":"RT @IMI_JU: Read about IMI’s #Ebola projects in this article from @MedNous http://t.co/Xt5FACmO6n","possibly_sensitive":false,"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":66,"end":74,"username":"MedNous","id":"617258499"}],"urls":[{"start":75,"end":97,"url":"http://t.co/Xt5FACmO6n","expanded_url":"http://bit.ly/1JmZkOp","display_url":"bit.ly/1JmZkOp"}],"hashtags":[{"start":29,"end":35,"tag":"Ebola"}],"annotations":{}},"id":"567615059300716544","created_at":"2015-02-17T09:22:30.000Z","conversation_id":"567615059300716544","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567359642310049792"}],"author_id":"116716199","text":"RT @EUlondonrep: Work for the EU:Vacancy for Director of the European Monitoring Centre for Drugs and Drug Addiction @EMCDDA Lisbon http://…","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":117,"end":124,"username":"EMCDDA","id":"50638521"}],"urls":{},"hashtags":{},"annotations":[{"start":125,"end":130,"probability":0.6716,"type":"Place","normalized_text":"Lisbon"}]},"id":"567360837921542145","created_at":"2015-02-16T16:32:19.000Z","conversation_id":"567360837921542145","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567358638575325184"}],"author_id":"116716199","text":"RT @NICEcomms: Try the new mobile-friendly NICE Evidence Search: http://t.co/3m7l7mqOnn.","possibly_sensitive":false,"public_metrics":{"retweet_count":44,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":65,"end":87,"url":"http://t.co/3m7l7mqOnn","expanded_url":"http://www.evidence.nhs.uk","display_url":"evidence.nhs.uk"}],"hashtags":{},"annotations":{}},"id":"567360795395522560","created_at":"2015-02-16T16:32:09.000Z","conversation_id":"567360795395522560","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567355691271462912"}],"author_id":"116716199","text":"RT @rarediseaseday: The 2015 video is OUT - bring people #livingwith a #raredisease out of the shadows: http://t.co/fyysRiZUsF http://t.co/…","possibly_sensitive":false,"public_metrics":{"retweet_count":401,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":104,"end":126,"url":"http://t.co/fyysRiZUsF","expanded_url":"http://ow.ly/J8oHn","display_url":"ow.ly/J8oHn"}],"hashtags":[{"start":57,"end":68,"tag":"livingwith"},{"start":71,"end":83,"tag":"raredisease"}],"annotations":{}},"id":"567358299801403393","created_at":"2015-02-16T16:22:14.000Z","conversation_id":"567358299801403393","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567352889954545664"}],"author_id":"116716199","text":"RT @rarediseaseday: The 2015 video is OUT - bring people #livingwith a #raredisease out of the shadows: http://t.co/E5efcA3PJv http://t.co/…","possibly_sensitive":false,"public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"urls":[{"start":104,"end":126,"url":"http://t.co/E5efcA3PJv","expanded_url":"http://ow.ly/IRuCn","display_url":"ow.ly/IRuCn"}],"hashtags":[{"start":57,"end":68,"tag":"livingwith"},{"start":71,"end":83,"tag":"raredisease"}],"annotations":{}},"id":"567358231249711105","created_at":"2015-02-16T16:21:57.000Z","conversation_id":"567358231249711105","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567350762402230273"}],"author_id":"116716199","text":"RT @edqm_news: Have you heard of the #PaedForm project? http://t.co/SR5Vb5Ru0Q #european #pharmacopoeia","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":56,"end":78,"url":"http://t.co/SR5Vb5Ru0Q","expanded_url":"http://bit.ly/1DIJusK","display_url":"bit.ly/1DIJusK"}],"hashtags":[{"start":37,"end":46,"tag":"PaedForm"},{"start":79,"end":88,"tag":"european"},{"start":89,"end":103,"tag":"pharmacopoeia"}],"annotations":{}},"id":"567358151289495552","created_at":"2015-02-16T16:21:38.000Z","conversation_id":"567358151289495552","attachments":{"media_keys":{}}},{"source":"Bitly","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"We're hosting and broadcasting a symposium this week to present the final, key findings of the @PROTECT_BR project: http://t.co/lRocoU4PcR","possibly_sensitive":false,"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":95,"end":106,"username":"PROTECT_BR","id":"2354960784"}],"urls":[{"start":116,"end":138,"url":"http://t.co/lRocoU4PcR","expanded_url":"http://bit.ly/1L30H0d","display_url":"bit.ly/1L30H0d"}],"hashtags":{},"annotations":{}},"id":"567347808320376832","created_at":"2015-02-16T15:40:32.000Z","conversation_id":"567347808320376832","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567345868383473664"}],"author_id":"116716199","text":"RT @eurordis: Feb 24: see @V_Andriukaitis speak at our #RareEU2015 event http://t.co/VcXM32wvzb @EU_Health @EU_Commission http://t.co/xoQgA…","possibly_sensitive":false,"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":26,"end":41,"username":"V_Andriukaitis","id":"575269517"},{"start":96,"end":106,"username":"EU_Health","id":"606325697"},{"start":107,"end":121,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":73,"end":95,"url":"http://t.co/VcXM32wvzb","expanded_url":"http://ow.ly/HKQEU","display_url":"ow.ly/HKQEU"}],"hashtags":[{"start":55,"end":66,"tag":"RareEU2015"}],"annotations":{}},"id":"567345970565120000","created_at":"2015-02-16T15:33:14.000Z","conversation_id":"567345970565120000","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567343743259643904"}],"author_id":"116716199","text":"RT @EU_ECHA: We are looking for a scientific officer - exposure/human health (AD6). #Apply by 9 March http://t.co/fZlbqZsI0s #EU_ECHA #Eujo…","possibly_sensitive":false,"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":102,"end":124,"url":"http://t.co/fZlbqZsI0s","expanded_url":"http://bit.ly/15xbvBD","display_url":"bit.ly/15xbvBD"}],"hashtags":[{"start":84,"end":90,"tag":"Apply"},{"start":125,"end":133,"tag":"EU_ECHA"}],"annotations":{}},"id":"567345383702294529","created_at":"2015-02-16T15:30:54.000Z","conversation_id":"567345383702294529","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: The French medicines agency has published a summary of the January meeting of the Paediatric Committee http://t.co/Th7xLqmsZs","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":113,"end":135,"url":"http://t.co/Th7xLqmsZs","expanded_url":"http://bit.ly/1zijP4I","display_url":"bit.ly/1zijP4I"}],"hashtags":{},"annotations":[{"start":92,"end":111,"probability":0.7717,"type":"Organization","normalized_text":"Paediatric Committee"}]},"id":"567338740713287681","created_at":"2015-02-16T15:04:31.000Z","conversation_id":"567338740713287681","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":{},"author_id":"116716199","text":"RT @ansm: French medicines agency is launching 4th call for projects with patient associations. Closes 15 April 2015. http://t.co/4Ge3amqgc6","possibly_sensitive":false,"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":118,"end":140,"url":"http://t.co/4Ge3amqgc6","expanded_url":"http://bit.ly/1DgXmeE","display_url":"bit.ly/1DgXmeE"}],"hashtags":{},"annotations":{}},"id":"567329449851772930","created_at":"2015-02-16T14:27:35.000Z","conversation_id":"567329449851772930","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567322597252407296"}],"author_id":"116716199","text":"RT @IFAHEurope: Check it out! @IFAHEurope annual report 2014 now online: http://t.co/VZwrkZBwb3","possibly_sensitive":false,"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":{},"hashtags":{},"annotations":{}},"id":"567324624078532608","created_at":"2015-02-16T14:08:25.000Z","conversation_id":"567324624078532608","attachments":{"media_keys":{}}},{"source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567321071960223744"}],"author_id":"116716199","text":"RT @EU_Health: Unsafe food is linked to the deaths of approx 2m ppl/year @WHO will highlight #SafeFood on #WorldHealthDay - 7 April http://…","possibly_sensitive":false,"public_metrics":{"retweet_count":25,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":73,"end":77,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":93,"end":102,"tag":"SafeFood"},{"start":106,"end":121,"tag":"WorldHealthDay"}],"annotations":{}},"id":"567324569070231552","created_at":"2015-02-16T14:08:12.000Z","conversation_id":"567324569070231552","attachments":{"media_keys":{}}}]
